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 Abstract 
Probe-based confocal laser endomicroscopy (pCLE) is an emerging imaging tool that allows real-time 
in situ morphological imaging at cellular and subcellular resolution. Its ability to image morphological 
features of epithelial surfaces of the gastrointestinal tract, biliary tree and respiratory tree rendered 
differentiation of macroscopically inconspicuous neoplastic and non-neoplastic tissues possible in 
real-time. However, its role outwith the endoluminal environment for surgical applications has been 
comparatively sparsely investigated and little reported on its ability to characterise morphological 
features beyond endoluminal applications. This thesis aims to systematically evaluate the potential 
pCLE has in visualization of soft tissue morphology in applications pertaining to breast conserving 
surgery (BCS), parathyroid surgery and thyroid surgery; whereby morphological information 
regarding cavity wall margin status, tissue-specific entity and  viability status of preserved parathyroid 
glands (PG), respectively, could potentially guide decision-making intraoperatively. 
The perceptions that pCLE imaging is confined to endoluminal mucosal surfaces, the inability of 
pCLE to perform image acquisition through sterile transparent sheaths and the inability of surgeons to 
interpret pCLE images were interrogated using three small feasibility studies. Firstly, in a study 
carried out on a live, anaesthetised, porcine model, pCLE image acquisition of morphological 
architecture of soft tissues of the neck e.g. thyroid, lymph nodes, adipose, skeletal and smooth 
muscles, were shown to be feasible in an intraoperative field and the presence dried blood on the tissue 
surface did not impede the consistency of morphological architecture visualization. Secondly, we 
demonstrated that utilization of a sterile transparent sheath did not impede pCLE image acquisition 
and that the quality of images obtained was comparable to that of without the sheath. Thirdly, we have 
shown that surgeons with little or no histopathology background were able to acquire the relevant 
pattern recognition skills to interpret pCLE images following a training session utilizing a validated 
pCLE morphological classification from colorectal lesions. 
Building upon these discoveries, we elucidated the potential of pCLE to image neoplastic and non-
neoplastic breast morphology with the envisaged application of identifying residual cancerous foci 
 intraoperatively, thereby guiding operative decision making based on real-time breast cavity scanning 
during BCS. Preliminary ex vivo analyses from 71 freshly excised, acriflavine-stained neoplastic and 
non-neoplastic tissues samples from 50 breast cancer patients show excellent correlation with 
histopathology findings. In particular, the glandular structures, adipocytes and collagen fibres of non-
neoplastic breast tissues were readily visualised on pCLE images. These were distinguishable from the 
markedly haphazard and hypercellular architecture exhibited by invasive and non-invasive carcinoma. 
We developed a classification based on description of pCLE morphology unique to neoplastic and 
non-neoplastic breast morphology and validated this with 17 histopathologists and surgeons through a 
systematic pattern recognition training session based on this classification where they were 
subsequently subjected to objective assessment of 50 pCLE images while blinded to histopathology 
results. The overall mean accuracy of pCLE image interpretation for histopathologists and surgeons 
were 94% and 92%, respectively. The overall inter-observer agreement was ‘almost perfect’ (κ=0.81) 
for the former and ‘substantial’ (κ=0.77), for the latter.  
We explored the role of intravenous fluorescein sodium (FS) in a prospective, cross-sectional, 
observational study of 10 patients undergoing BCS where they received between 1.5ml to 3.5ml of 
intravenous bolus of 10% fluorescein sodium (FS) intraoperatively. Ex vivo analyses of FS-stained 
breast samples showed that dense fibrous tissue response evoked by infiltrating tumor cells were 
readily visualised as fluorescent regions with haphazardly arranged, amorphous-looking collagen 
fibres. However, the lack of nuclei visualization rendered differentiation of neoplastic from non-
neoplastic tissues impossible. Nevertheless, the uniformity that FS staining imparts to all tissue layers 
facilitated creation of longer and meaningful pCLE mosaics. These findings could have important 
implications where tissue deformation could result in AH-stained layers intermittently fail to coincide 
with the optical slice imaged at the respective depth.  
The promising findings of AH-stained breast tissues were found to be potentially relevant in 
parathyroid surgery. Similar analyses on freshly excised AH-stained parathyroid specimens from 35 
patients undergoing parathyroidectomy for primary and secondary hyperparathyroidism showed nest-
like arrangements of parenchymal cells, fibrovascular septum and microfollicles of diseased PGs were 
 readily identifiable on CE images and these were consistent with histopathological findings. Following 
pattern recognition training based on an in-house developed classification system, these were 
distinguishable from epithelial-lined thyroid follicles and polygonal-shaped adipocytes with mean 
accuracies of 94% and 93% for histopathologists and surgeons, respectively, and high overall inter-
observer agreement, κ=0.82. Where intraoperative identification of diseased PGs presents a challenge 
especially in multi-glandular disease and re-operative surgery, pCLE could potentially facilitate its 
recognition.  
Finally, the role for pCLE imaging of PG vasculature was explored by means of an intraoperative 
clinical study utilising a sterile-transparent draped pCLE probe on 20 patients undergoing thyroid and 
parathyroid surgery. Utilising intravenous FS, branched-vessels including capillary networks were 
readily visualised. Vascular flow on viable glands was depicted by unidirectional, high velocity thrusts 
of dark-coloured erythrocytes within hyperfluorescent vessels or diffusely in the parenchyma whereas 
these were absent on non-viable (post-excision) glands. Further analysis on preserved PGs showed that 
absence of blood flow was found in patients who had sub-optimal post-operative parathyroid function. 
Given that visual assessment of tissue discolouration is not a reliable method of determining 
parathyroid gland viability during thyroidectomy, information regarding viability of preserved PGs 
decisions could potentially aid decisions pertinent to autotransplantation remains challenging. 
This thesis significantly expands upon the potential intraoperative applications of pCLE. Evidently, 
these findings are preliminary and warrant further evaluation in well-powered clinical trials. However 
a systematic approach to investigate the optimal trade-offs between the optical resolution requirements 
of tissue morphology visualization and deployability of pCLE probe holds the key to successful 
clinical translation. In particular, evaluation of a robust mechatronically enhanced platform equipped 
with the flexibility to cater for tissue surface deformation and precision mechanisms that generates 
accurate spatio-temporal localisation in real-time to aid intraoperative decision making constitutes the 
next stage of research priorities. 
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Chapter 1: Introduction and Overview  
 
1.1  Introduction 
Recent improvements in fibre optic technology and miniaturization of optics have enabled the 
development of a probe-based confocal endomicroscope (pCLE) that is capable of producing high 
resolution in situ in vivo imaging of cellular morphology by optical sectioning. These probes are 
designed to be inserted into one of the working channels of the endoscope, enabling tissues to be 
imaged in situ without the need for biopsy. This method of obtaining real-time ‘virtual histology’ 
images has the potential to facilitate clinicians make immediate decisions pertaining to the immediate 
management of their patients. Since the inception of this technology, scientific and clinical 
communities worldwide are keen for pCLE to fulfil its full potential as evidenced from the vast 
number of publications pertaining to envisaged applications in the gastrointestinal tract, biliary tree, 
respiratory tract, urology and more recently, on pancreatic cysts.  
 
There is however an obvious gap in the evaluation of pCLE as a potential imaging tool for surgical 
applications. One of many challenges a surgeon faces in the operating theatre is the inability to 
recognise inconspicuous disease on the tissues being operated on. When this pertains to breast cancer 
surgery, tumor cells could potentially be left behind resulting in tumor recurrence, poorer prognosis or 
reoperations. During parathyroid surgery to remove the diseased parathyroid glands, distinguishing 
these glands from adjacent tissues can be difficult to distinguish thereby frozen sections are 
occasionally performed to obtain real-time diagnostic information pertaining to the tissue entity being 
queried. These are time-consuming, costly and might not be reliable. Preservation of viable 
parathyroid glands is essential to ensure adequate parathyroid function post-operatively. However, 
devascularisation can occur as a result of inadvertent trauma and this might not be apparent at the time 
of surgery.   
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The aim of this thesis is to systematically explore and evaluate the ability of pCLE to image 
morphological architecture of tissues pertinent to the aforementioned intraoperative applications and 
assess the feasibility of surgeons to interpret these images. The strengths and limitations of pCLE 
imaging are identified objectively thereby forms the scientific basis for future work to be carried out to 
fulfil its full potential as an imaging adjunct that facilitates decision-making during surgery.  
 
1.2 Thesis chapter synopsis 
Chapter 1: This provides an overview on the rationale of technological assessment on intraoperative 
applications where significant gaps currently exist, the key scientific contributions of this thesis and a 
list of academic achievements generated from this thesis. 
 
Chapter 2: This includes a comprehensive overview of pCLE, describing its development, potential 
clinical applications and challenges associated with deployment of pCLE miniprobe. The chapter also 
discusses the current gap that exists pertaining to the use of pCLE for surgical applications. Real-time 
morphological information pertaining to tumor margin status, tissue type identity and tissue viability 
status has been identified as the three “core surgical themes” that warrant exploration. An overview of 
the current intraoperative challenges relevant to these themes such as assessment of tumor-free cavity 
margin status in breast cancer surgery; identification of parathyroid glands during bilateral neck 
dissection; and preservation of viable parathyroid glands during total thyroidectomy is presented 
alongside the envisaged clinical impact pCLE has on intraoperative decision-making. Lastly, the 
results of two pilot studies are summarised – the presence of dried blood on the tissue surface and the 
use of a sterile transparent sheath did not interfere with pCLE image acquisitions. Surgeons were able 
to interpret pCLE images obtained from the lower gastrointestinal tract with high accuracy rates 
(>90%). Whilst these studies support the notion of an in situ in vivo pCLE image acquisition and 
interpretation by the surgeon, its ability to image tissue morphological architecture relevant to the 
aforementioned applications warrants systematic evaluation and thereby is the focus of the following 
chapters in this thesis (Figure 1.1). 
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Chapter 3: This chapter describes a prospective, cross-sectional, observational study that was carried 
out on freshly excised human breast specimens containing 50 tumor and 21 non-tumor sections. 
Utilizing acriflavine hydrochloride as the fluorescent agent and histology slides of the corresponding 
sections for gold standard comparison, morphological features of invasive and non-invasive breast 
cancers were readily visualized and distinguished on pCLE images. Following evaluations with two 
experienced breast pathologists, a novel classification that consists of pCLE descriptions of glandular 
and stromal morphology components was developed. Seventeen surgeons and pathologists were 
invited to complete a pattern recognition training session based on this classification. Following 
completion of their training, blinded assessments on their accuracies of image interpretation was 
carried out on 50 anonymous pCLE images (25 neoplastic and 25 non-neoplastic).  
 
The mean accuracies for surgeons and pathologists were 94% (range 90-100%) and 92% (range 84-
98%), respectively. The mean interobserver agreement for pathologists were ‘excellent’, κ=0.82 
(95%CI, 0.79-0.85); and ‘substantial’ for surgeons, κ=0.74 (95%CI, 0.70-0.78). Given the flexibility 
and size of pCLE miniprobe, there might be potential role for pCLE to be deployed against the cavity 
walls created during breast conserving surgery for breast cancer. Evidently, real-time identification of 
residual tumor cells on these walls could potentially be used to guide decision-making pertaining to 
further excision during the index surgery.  
 
Chapter 4: This chapter evaluates the use of intravenous fluorescein independently or in conjunction 
with topical acriflavine hydrochloride to highlight morphological architecture of neoplastic and non-
neoplastic human breast tissues. Ten patients undergoing breast conserving surgery for breast cancer 
were given intravenous fluorescein intraoperatively. pCLE image acquisition was performed on tumor 
and non-tumor specimens post-operatively before and after further staining with topical acriflavine.  
 
Tumor stromal morphology was depicted as markedly heterogeneous fluorescent regions with 
relatively haphazard appearance as compared to that the homogenous appearance of non-tumor 
sections. Further staining with topical acriflavine showed that the stroma adjacent to infiltrating bands 
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of neoplastic cells project an opaque grey-like appearance akin to that of a halo effect. These findings 
were consistent with the pathognomic findings of stromal desmoplastic reaction in invasive breast 
cancer. The mean length of mosaics created from the combined fluorescein- and acriflavine-stained 
sections was significantly longer than that of acriflavine-stained only sections. Evidently, the use of 
fluorescein sodium increases the overall morphological architecture visualised; allows uniform 
staining of all tissue layers; and consequently, increases the length of pCLE mosaics created. The 
addition of intravenous fluorescein as an additional fluorescent agent could potentially facilitate 
acquisition of higher quality mosaics thereby increases the yield of residual disease detection during 
cavity wall scanning, thus warrants intraoperative in situ evaluation.   
 
Chapter 5: This chapter details another exciting prospective, cross-sectional, observational study on 
the role of acriflavine hydrochloride as a potential fluorescent agent to facilitate tissue differentiation 
during parathyroid surgery. Freshly excised parathyroid and non-parathyroid (thyroid and fibrofatty) 
tissues were obtained from 35 patients that underwent parathyroidectomy and thyroidectomy for 
benign and malignancy diseases. Consistent with histopathology findings, nest-like arrangement of 
parenchymal cells, fibrovascular septum, microfollicles and cystic spaces of parathyroid tissues were 
readily identifiable on pCLE images. Similarly, colloid-filled thyroid follicles were easily 
distinguishable from the polygonal-shaped hyperfluorescent borders of fat cells. Mean accuracy of 
pCLE image interpretation for pathologists and surgeons were 94% (range 93-94%) and 93% (91-
94%), respectively. The mean inter-observer agreement for tissue type identification among 
pathologists was ‘excellent’, κ=0.86 (95%CI, 0.82-0.90); and ‘substantial’ among surgeons, κ=0.80 
(95%CI, 0.75-0.85). In light of these novel findings, intraoperative in situ evaluation of CE’s role in 
tissue differentiation is warranted. 
 
Chapter 6: This chapter describes the first human clinical trial investigating the feasibility of in situ in 
vivo imaging of parathyroid gland vascular morphology using pCLE. Twenty patients undergoing 
parathyroidectomy for primary hyperparathyroidism and total thyroidectomy for benign and malignant 
disease received 1.5-2.5ml of 10% intravenous fluorescein intraoperatively. For both groups of 
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patients, pCLE imaging was performed by deploying a sterile-draped pCLE miniprobe onto 
parathyroid glands with carefully preserved vascular pedicle to ensure viability. However for the 
parathyroidectomy patients, pCLE imaging was repeated following excision/pedicle obliteration for 
comparison of viability features on its vasculature.  
 
A wide array of morphological vasculature was readily visualised including single, branching, 
overlapping vessels of various sizes including capillary networks. Vascular flow on viable glands was 
depicted by unidirectional, high velocity thrusts of dark-coloured erythrocytes within hyperfluorescent 
vessels whereas these were absent on non-viable glands. The overall sensitivity, specificity, and 
accuracy of non-viability on pCLE images was 92% (range 78-100%), 97% (range 90-100%) and 95% 
(range 85-100%), respectively. Further validation in the total thyroidectomy group showed that 
preserved parathyroid glands with empty blood vessels visualised demonstrated permanent loss of 
parathyroid function post-operatively. These findings suggest that visualization of empty or static 
vessels, especially larger sized vessels, could potentially indicate impending ischaemia on that gland.  
 
 
Figure 1.1 The experimental chapters develop from three ‘core surgical themes’ highlighted in Chapter 2. 
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1.3 The main scientific contributions in this thesis  
The 10 main scientific contributions in this thesis that advance pCLE knowledge, understanding and 
its potential clinical impact are: 
1. The creation of an extensive library of pCLE images depicting neoplastic and non-neoplastic 
breast morphology; parathyroid and non-parathyroid morphology; and parathyroid vascular 
morphology.  
2. The confirmation that pCLE image acquisition of tissue morphology is feasible when a sterile 
transparent drape is used as an interface between probe-tip and blood-stained tissue surface. 
3. The first description of neoplastic and non-neoplastic changes on glandular and stromal 
components of the breast on pCLE images; and the resulting scientific interests towards 
intraoperative applications 
4. The first description of parathyroid and thyroid parenchymal morphology on pCLE images; 
and the resulting scientific interests towards intraoperative deployment. 
5. The development and validation of  a novel classification system to facilitate recognition of 
neoplastic and non-neoplastic breast morphology on pCLE images  
6. Pattern recognition skills required for pCLE image interpretation can be learnt easily and 
quickly by surgeons following a structured training session on the basics of histology and 
corresponding pCLE images. 
7. The use of intravenous fluorescein during surgery for pCLE image acquisition is feasible and 
safe in humans and provides interpretable images of vascular and non-vascular morphology.  
8. The first human description of parathyroid gland vascular morphology and morphological 
features associated with non-viability   
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9. The findings that patients who develop permanent hypoparathyroidism had empty or static 
vessels visualised on preserved parathyroid glands during total thyroidectomy 
10. The conclusion that further modifications to the pCLE miniprobe’s field of view, resolution 
and technological adjuncts to improve stability of miniprobe deployment is warranted to 
facilitate translation into intraoperative use.  
 
1.4 Prizes and publications associated with this thesis 
The prizes, awards and grants listed below were awarded to research work included in this thesis: 
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Chapter 2: Overview of probe-based confocal 
laser endomicroscopy  
 
2.1 Evolution of probe-based confocal laser endomicroscopy  
2.1.1 Principles of confocal microscopy 
The confocal microscope was first invented by Marvin Minsky in 1955 when he was a junior research 
fellow at Harvard University, and its principles were subsequently patented in 1957 (1). The 
motivation for its development was to overcome some of the limitations encountered with 
conventional white light microscopy. The latter utilises a light source to illuminate the tissues evenly 
and thereby causes the optical pathways of the entire tissue excited at the same time creating an 
unfocused and blurred image in the unsectioned tissue. In order to eliminate the unfocused 
background, these specimens inevitably need to be excised, fixed and sectioned to generate 3-10µm 
thin slices. By doing so, the reflections obtained from tissue illumination are limited to those contained 
in these thin slices thereby enabling focused and sharp images to be acquired (Figure 2.1).  
Evidently, conventional white light microscopy warrants tissue fixation and sectioning, a lengthy 
process that often requires several days. Recognising these limitations, Marvin described the 
application of point illumination and a pinhole in front of the optical detector to eliminate out-of-focus 
signals from being captured. In this case, both the condenser and objective lens had the same focal 
point hence the term ‘confocal’ . The point illumination source is focused directly into the tissue, 
illuminating a single point (focal plane) at any given time. The resulting illuminations from that focal 
plane are then passed through the pinhole, which acts as a filter to reject non-focal illuminations from 
the layers above and below the focal plane (Figure 2.1). Given that only one point in the tissue sample 
is illuminated at a time, additional lateral and axial scanning is required to create a 2D or 3D image of 
the tissue specimen. All in all, confocal microscopy allows image acquisition of tissue specimens to be 
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carried out in real-time with the tissue integrity preserved. The depth and the thickness of the focal 
plane are determined by the wavelength of the light, the numerical aperture of the objective lens and 
the optical properties of the specimen.  
 
 
Figure 2.1 Optical pathways of tissues on conventional white light microscopy and confocal microscopy. (A) 
The clarity of the image produced by white light microscopy emanated from the pathways created from a thinly 
sliced sample as no other ‘out of focus’ pathways were created. (B) Confocal microscope illuminates a thick 
block of sample but only allow pathways created from that optical slice (confocal slice) to be filtered through the 
pinhole, hence eliminating all other out of focused pathways.      
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Over the years, confocal microscopy has emerged as popular imaging tool for high resolution imaging 
of cells and tissues. However due to the size of the microscope, most descriptions on in vivo studies 
were pertinent to clinical applications on accessible tissues and organs such as the eye (2), skin (3-5) 
and the oral cavity (5-7). There were promising studies pertaining to potential applications in surgery, 
however these preliminary findings were confined to feasibility work on excised tissues (8, 9) (Figure 
2.2).  The large microscope objective lens renders application of this technology to in vivo imaging of 
tissues impossible (10). It is evident that two considerable changes to its optical and physical 
characteristics are warranted. Firstly, the scanning mechanism and image acquisition rate needs to be 
faster in order to minimise movement artefacts as tissues within the body are highly susceptible to 
physiological movements and deformation (10). Secondly, significant miniaturisation on one of its 
image acquisition component is required to facilitate access to deeper organs where the clinical 
benefits of its real-time in situ image acquisition could be fully evaluated and ascertained (11).  
The ground-breaking advancement in the translation of confocal microscopy to in vivo imaging of 
tissues emanated from the use of fibre optics in place of a traditional confocal pinhole, to preserve the 
optical sectioning properties of the conventional confocal microscopy system (Figure 2.2) (12-14). 
Evidently, we have a system that is now comprised of the light source being separated from the 
detector pinhole with the optical fibre acting as the intermediate component that increases the 
versatility for imaging ‘difficult to reach’ regions in the body such as applications pertaining to 
endoscopy, laparoscopy and minimally invasive open surgery (small incisions) (15). These optical 
fibres serve as versatile tool to deliver and collect illumination from tissues from a predefined focal 
plane (confocal) and this is made possible from parallel advancement from its scanning mechanisms 
which can be performed either proximally or distally to the light source. The former’s location of 
scanning mirrors is distal to the optical fibres at the end of the endoscope and therefore occurs much 
faster than the latter which are located proximal to these fibres thereby acquiring narrower images. 
Whilst the benefits of access are clearly evident, the size constraints imposed by concurrently 
deployed endoscopes and luminal environment meant that trade-offs are inevitable between the field 
of view, resolution and probe sizes (16, 17).  
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Figure 2.2 An example of confocal microscope (reflectance microscope) being used to perform real-time 
imaging on excised parathyroid specimens [Adapted from White et al, (8)]. 
 
2.1.2 Confocal laser endomicroscopy 
Over the years, it was increasingly recognised that modifications were needed to increase accessibility 
of the microscope to in vivo tissues and faster image scanning and acquisition rate were required to 
counter movement artefacts. The introduction of a single mode fibre in place of a conventional 
confocal pinhole has been the cornerstone for clinical translation of confocal microscopy to in vivo 
clinical imaging on previously inaccessible endoluminal and intra-abdominal regions (14). The use of 
an optical fibre as the source and detector pinholes allows separation of the imaging arm from the light 
source and detector, this increases versatility of the confocal microscope for in vivo imaging (13, 18, 
19). Subsequently, the work of Martin Harris and Peter Delaney in the late 1980s and 1990s (20, 21) 
led to the development of the world’s first hand-held confocal microscope by Optiscan (Notting Hill, 
Australia) for dermatology and subsequently endoscopic applications. Following that, an endoscope-
based confocal laser endomicroscopy (eCLE) was developed commercially in collaboration with 
Pentax (Tokyo, Japan) with a miniaturized Optiscan confocal endomicroscope incorporated into the 
distal end of a conventional endoscope (EC-3870K, Pentax, Tokyo, Japan) (Figure 1a). It provides 
high resolution real time in vivo in situ images at cellular resolution and has been used for imaging in 
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the upper  and lower gastrointestinal tract mucosal imaging (8)(9)(10). Another commercially 
available system called probe-based confocal laser endomicroscopy (pCLE), for example, Cellvizio
®
 
(Mauna Kea Technologies, Paris, France) has been increasingly used for endoluminal applications. 
Cellvizio
®
 is a miniaturized form of confocal microscope that generally consists of a pCLE miniprobe, 
a laser scanning unit and personal computer for image data processing and display (Figure 2.3). Its 
platform utilises laser as its light source and the pCLE miniprobe transports a 488-nm-wavelength blue 
excitation laser light onto the tissue surface and the resulting emissions between 500 and 650 nm from 
fluorescing tissues are collected at 12 frames per second, hence resembling video quality (Figure 2.4).  
 
 
Figure 2.3 (A) Endoscope-based confocal endomicroscopy (eCLE) – Endomicrosope integrated at the distal tip 
of the endoscope (blue arrow). © 2012, Pentax  (B) pCLE Cellvizio stack consisting of a personal computer 
display (top deck), computer processing unit (middle deck) and a laser scanning unit (lower deck). (C) pCLE 
miniprobe at the point of entry into a working channel of an endoscope. (D) pCLE miniprobe at the distal end of 
an endoscope with the distal tip of confocal miniprobe abutting the surface of gastrointestinal mucosa during 
endoscopy (insert). [Adapted from Chang et al, (22)] 
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The optical slices, depth of imaging and field of view for each frame depends on the type of pCLE 
miniprobe used and its intended clinical application (Figure 2.4 and Table 2.1). These pCLE 
miniprobes are highly flexible and are designed to be introduced into the working channels of standard 
endoscopes. All images were scanned thought a bundle of more than 10 000 optical fibres with a rate 
of 12 frames per second, hence demonstrating a real-time video on a display screen. This information 
is then relayed to a personal computer for image data processing and display using a specially 
designed software package (Cellvizio, Mauna Kea Technologies, Paris, France) where single video 
frames were reconstructed into a larger linear static image using “mosaicing”, a post-procedure image 
reconstruction tool based on a hierarchical framework algorithm that is able to recover a globally 
consistent alignment of the input frames, to compensate for motion-induced distortions and to capture 
non-rigid deformations. The resulting image mosaics combine all moving images, cancel motion 
artifacts, and reconstitute panoramas of the tissue samples (Figure 2.5). At present, pCLE has emerged 
as the most widely used CLE device as it is more versatile, provides the option of acquiring highly 
magnified images and is not endoscope-constrained.  
 
 
Figure 2.4 Images depicting the relative sizes of pCLE miniprobes. (A) The Cholangioflex® probe (left) is used 
for visualization of biliary strictures and the GastroflexUHD® probe (right) is deployed for upper 
gastrointestinal tract imaging. (B) Mini-O® pCLE miniprobe, a pre-clinical pCLE miniprobe with similar 
physicial characteristics with a detachable plastic holder to facilitate stable apposition against tissue surfaces. 
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pCLE miniprobe types 
Gastroflex, 
Coloflex 
Gastroflex 
UHD,  
Coloflex 
UHD 
Cholangioflex Alveoflex AQ Flex Mini-O 
Intended  
usage 
 
Clinical Clinical Clinical Clinical Clinical Pre-
clinical 
Target 
deployment 
site 
Upper and 
lower GI 
tract 
Upper and 
lower GI 
tract 
Biliary tree Lung Pancreatic 
cyst 
Pre-
clinical 
studies 
Diameter  
(mm) 
 
2.5 2.5 1.0 1.4 0.9 2.6 
Probe length 
(m) 
 
3 3 4 3 4 0.9 
Depth of 
imaging (µm) 
 
70-130 55-65 40-70 0-50 50 60 
Field of view 
(µm) 
 
600 240 325 600 320 240 
Lateral 
resolution 
(µm) 
3.5 1.0 3.5 3.5 3.5 1.0 
Frames per 
second 
 
12 12 12 12 12 12 
 
Table 2.1 A summary of the optical specifications and trade-offs between probe sizes and resolution of some of 
commonly used pre-clinical and clinical pCLE miniprobes that are commercially available. Sourced from 
www.cellvizio.net . 
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Figure 2.5 Orientation of pCLE image acquisition planes and image mosaic construction. (A) The pCLE 
miniprobe tip is placed perpendicular to the surface of the tissue sample, enabling images to be obtained in an 
"en-face" plane. (B) A large pCLE image mosaic of colonic crypts was constructed by stitching adjacent video 
frames to its corresponding spatio-locations to give a representative panoramic view of the tissue architecture.   
  20 
 
2.1.3 Contrast agents for pCLE imaging 
pCLE image acquisition of tissues requires the use of fluorescent contrast agents to enhance 
visualization of cells. These contrast agents can be administered intravenously or topically. 
Intravenous fluorescein sodium 10% (FS) is the most widely used contrast agent in pCLE imaging. It 
is Food and Drug Administration (FDA) approved for diagnostic fluorescein angiography or 
angioscopy of the retinal vasculature. Although its use in pCLE is considered off-label, its safety 
record is well reported in numerous pCLE clinical trials (23). Utilizing intravenous FS, morphological 
structures of tissues are readily visualised within several seconds of administration and the 
fluorescence lasts for approximately 45 minutes. This however varies depending on the richness of 
vascular supply of the tissues imaged. Intravenous FS highlights the tissue vasculature and the 
surrounding extravascular spaces (Figure 2.6). The differences in fluorescence intensity between 
cellular constituents allow us to identify morphological architectures such as crypts (colon), gastric 
pits (stomach), gap junctions (small intestines) and network of capillaries (gastrointestinal tract, biliary 
tree, pancreatic cysts). It does not however highlight the nucleus of individual cells and thereby unable 
to confer information pertaining to degree of tissues. The intravenous dose required vary between 2.5 
to 10ml although most studies report that 2.5 to 5.0ml of intravenous FS given as a bolus injection 
followed by saline flush would suffice. It provides uniform staining to all layers of tissues and 
additional top-up doses are rarely needed during the period of endoscopy.   
Whilst severe adverse reactions to intravenous fluorescein contrast agent are very rare, many patients 
report transient (1-2 hours) yellowish discolouration of the skin and mucous membranes, and bright 
yellow coloured urine for 1-2 days. In the most recent large scale study on intravenous fluorescein for 
ophthalmology (11898 patients) nausea and vomiting occurred 0.7% and 0.4% respectively. In this 
study, there were no complications more significant than an urticarial rash (0.2%) (24). A recent 
smaller safety study of intravenous fluorescein in CE showed no serious complications in 410 
consecutive patients (25), and a study of 2272 patients in 16 centres undergoing CE procedures 
yielded no serious events, with mild events such as nausea and vomiting, injection site erythema, 
transient hypotension without shock, diffuse rash or mild epigastric pain occurring in 1.4% (23).  
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Our institution’s previous experience with intravenous FS for pCLE imaging to date has been 
consistent with the published literature. We had first-hand experience of using 2.5-5ml of intravenous 
FS to image pCLE changes in mucosal morphology in patients with radiation proctitis at Royal 
Marsden Hospital (REC  No. 11/SC/0036) and in patients with lung parenchymal diseases at Royal 
Brompton Hospital (09/H0708/18) (26). In both studies, no adverse reactions were reported and all 
patients demonstrated good tolerance following intravenous administration of FS.  
 
 
Figure 2.6 pCLE image mosaic and histology of FS-stained human colonic mucosa (A) pCLE image mosaic of 
crypts with dark central lumens. The fluorescent honey-comb patterns surrounding each crypt are capillary 
networks. (B) Histology image of the corresponding colonic crypts. 
 
Aside from intravenous FS, topical application of acriflavine hydrochloride (AH) can also be used to 
stain the tissues. It is compatible with the excitation wavelength laser used and it predominantly stains 
the nuclei of individual cells (Figure 2.7). The most commonly used dose is 0.05% and it is applied 
onto the tissue by using a spraying catheter (27, 28). It also demonstrates slight affinity to connective 
tissues in the stroma and therefore stains the extracellular components of tissues. Utilizing topical AH, 
morphological architecture of the gastrointestinal tract (27), respiratory epithelium (29) and brain 
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tissues (30) could be delineated on CLE images and correlates well with histology. The staining effect 
is immediate but limited to superficial layers. The unbound fluorescence needs to be flushed away to 
minimise artefacts. Additional top-up doses are not required and no adverse events have been reported 
to date. It has been used in conjunction with chromoendoscopy and no interference with the latter’s 
stains has been reported. Another topical agent, cresyl violet is a cytoplasmic stain used to outline the 
nucleus. Similar to AH, it is applied onto the tissue surface and immediate staining of morphology is 
conferred. The depth of staining is limited to the superficial layers. 
 
 
Figure 2.7 eCLE images and histology of AH-stained human colonic mucosa (A) eCLE image of colonic 
crypts. The nuclei of individual colonic epithelial cells are depicted by the red arrow. (B) Magnified eCLE image 
of a colonic crypt with basal nuclei polarity. (C-D) Histology slides of images A and B depicting similar 
morphological architecture at the same magnification (20x). [Adapted from Sanduleanu et al, (27)] 
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2.2 Overview of the potential clinical applications for pCLE  
 
2.2.1 Overview 
The potential endoluminal clinical applications for pCLE are broad, ranging from those within the 
gastrointestinal tract; surveillance of Barrett’s esophagus, identification of malignant biliary strictures, 
detection of neoplastic colorectal polyps; respiratory bronchial tree: assessment of respiratory tract 
lesions; urological tract: detection of neoplastic bladder lesions; pancreas: evaluation of pancreatic 
cysts; and respiratory tract: assessment of epithelial lesions. The majority of these were pertinent to 
differentiation between neoplastic and non-neoplastic tissues during elective endoluminal imaging. 
 
2.2.2 pCLE imaging in the upper gastrointestinal tract 
 In Barrett’s esophagus, current guidelines on surveillance recommend target biopsies for visible 
lesions followed by random four-quadrant biopsies every 2 cm (31). In practice, this is costly, time 
consuming and cumbersome to perform. Unsurprisingly, there is poor adherence to these 
recommendations in the UK at 41% (32) and the US at 44-56% (33). It is important to note that 
dysplastic or cancer changes are extremely focal and therefore may occupy small areas in a relatively 
large segment of Barrett’s. Random four-quadrant biopsies only allow sampling of 3.5% of the 
affected segment which is clearly inadequate and there are inherent concerns that biopsies might not 
always be taken from the site where high grade dysplasia or cancer has developed.  
 
In light of these challenges, the use of pCLE could potential help avoid biopsies on sites deemed 
‘normal’ on imaging and hence promote targeted biopsies on abnormal looking images. Furthermore, 
with the advent of real time in vivo, in situ diagnosis tools, clinicians now have the option of 
performing therapeutic procedures, i.e., endoscopic ablative therapy or mucosal resection on high 
grade dysplasia or intramucosal cancer in the same endoscopy session, which would otherwise be 
done at a repeat procedure after conventional biopsy results.  
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Recent work has looked into developing criteria for differentiating dysplastic from non-dysplastic 
segments of Barrett’s. This criterion is based on changes in the architectural appearances of columnar 
cells and blood vessels within the mucosa. An initial study by Kiesslich et al demonstrated that 
Barrett’s-associated dysplasia could be predicted with a sensitivity of 93% and a specificity of 98% 
(34). Compared with gastric metaplasia, Barrett’s metaplasia could be predicted with sensitivity and 
specificity of 98% and 94%, respectively. In healthy esophagus, the columnar epithelium appears as 
flat cells without any crypts or villous-like appearance. The blood vessels are located within papillae. 
In neoplastic segments of Barrett’s, the epithelium become dark and irregularly thickened and the 
surrounding blood vessels become irregular. In the presence of adenocarcinoma, there is haphazard 
arrangement of villiform structures and crypts and dark columnar cells. Using these criteria, Pohl et al 
tested the diagnostic characteristics of pCLE for the detection of invisible Barrett’s-associated 
dysplasia (35). The overall sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) were 80%, 94%, 44%, and 99%, respectively, with good inter-observer 
agreement (Kappa=0.6) (35). Further modifications to the classification by Wallace and colleagues 
demonstrated that the preliminary accuracy and interobserver agreement for the detection of 
intraepithelial neoplasia in Barrett's has very high accuracy (91%) and almost perfect interobserver 
agreement (κ=0.83). This led to the development of Miami Classification thorough consensus 
development among international experts from USA and Europe (Figure 2.8). A recent multicentre 
randomised controlled trial demonstrated an increased sensitivity and specificity of 73% and 84%, 
respectively of detecting high grade dysplasia or early carcinoma when pCLE was used in 
combination with white light endoscopy or narrow band imaging (36). 
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Figure 2.8 Miami classification for esophageal epithelium on pCLE image acquisition [Adapted from Wallace et 
al, (37)] 
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2.2.3 pCLE imaging in the lower gastrointestinal tract 
Similarly in the colon and rectum, it is well recognised that white-light endoscopic inspection alone 
cannot reliably distinguish between neoplastic and non-neoplastic lesions. It is therefore routine 
practice that all visualized lesions including small polyps are biopsied or removed during colonoscopy. 
However, the cumulative effect on costs of histopathology and complications are appreciable when 
multiple biopsies (>30) are performed during surveillance colonoscopy for ulcerative colitis (38). 
Furthermore, the prevalence of malignancy in small polyps are very low and over 90% of all polyps 
are <10 mm in diameter.  
 
Using clinically validated diagnostic criteria, Mainz and Miami classifications (Figures 2.9), several 
initial eCLE and pCLE studies demonstrated that it is feasible to differentiate neoplastic from non-
neoplastic mucosa of the colon and rectum with good diagnostic accuracy (28, 37, 39-41). When used 
in combination with narrow band imaging (NBI), the accuracy of pCLE and NBI was extremely high, 
approaching the accuracy of histopathology (42) and recent preliminary work by the same group 
reported that is also feasible to detect residual neoplasia following endomucosal resection of colorectal 
lesions (43). Additionally, the utilization of pCLE could potentially be considered as a supplementary 
tool for the marking of lateral margins of flat adenomas during transanal endoscopic microsurgery 
(TEMS). Whilst this has been described on eCLE imaging, the role of pCLE in ascertaining these 
margins warrants evaluation (44).  
 
From the practicalities of image interpretation, there are no obvious differences in the accuracy of 
interpretation between pathologists and endoscopists in post-hoc (offline) studies (45) and 
inexperienced endoscopists were able to learn to interpret images quickly with a short learning curve 
(46, 47). Evidently, its role as a supplementary imaging tool for point inspection of lesions identified 
by red flag techniques might be an interesting application in the future. However, further large-scale 
studies are needed to clarify which combination of red flag technique would increase the yield of 
neoplasia detection. A summary of all the original studies assessing the diagnostic accuracies of pCLE 
on colorectal polyps are provided in Table 2.2. 
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Figure 2.9 Miami classification for colorectal lesions on pCLE image acquisition [Adapted from Wallace et al, 
(37)] 
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Table 2.2 Original studies assessing the diagnostic accuracy of CLE on differentiation between neoplastic from 
non-nonplastic colorectal lesions. FS = Fluorescein sodium; AH = Acriflavine hydrochloride; WLE = White 
light endoscopy; NBI = Narrow band imaging; CE = Chromoendoscopy; RT = Real-time diagnosis; D = Delayed 
(offline) diagnosis. 
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Kiesslich 2004 98 99 N/A N/A 45 390 CE eCLE N/A FS  Mainz 
Kiesslich 2007 95 98 N/A N/A 153 134 CE &  
WLE 
eCLE RT FS Mainz 
Wang 2007 
 
N/A N/A N/A N/A 54 N/A WLE pCLE N/A FS* N/A 
Hurlstone 2008 97 99 95 100 43 802 
 
CE eCLE RT FS Mainz 
Hsiung 2008 
 
N/A N/A N/A N/A NA/A N/A WLE pCLE N/A FS* N/A 
Goetz 2009 
 
100 98 N/A N/A 36 67 CE 
 
eCLE RT CV Mainz 
Buchner 2010 
 
91 76 89 81 75 119 HD-
WLE 
pCLE D FS Miami 
Sanduleanu 
2009 
97 93 N/A N/A 72 116 CE eCLE RT FS 
AH 
Mainz 
Gomez 2010 
 
76 72 N/A N/A 53 75 WLE pCLE D FS Miami 
De Palma 2010 
 
100 85 91 100 20 32 WLE pCLE RT FS Mainz 
Buchner  2011 81-
96 
34-
67 
N/A N/A 54 76 WLE pCLE D FS Mainz 
Xie 2011 
 
94 96 97 92 115 115 WLE eCLE RT FS In-
house¥ 
Gunther 2011 N/A N/A N/A N/A 150 10 WLE; 
 CE 
eCLE RT FS Mainz 
Van den Broek 
2011 
65 82 N/A N/A 22 135 NBI  
WLE 
pCLE D FS Miami 
Hlavaty 2011 
 
100 98 66 100 45 100 CE  
WLE 
eCLE N/A FS Mainz 
 
Kuiper et al, 
2011 
66 83 N/A N/A 23 116 N/A pCLE D FS In-
house 
Shahid et al, 
2012 
86 78 76 88 65 130 NBI pCLE D FS Miami 
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In the era of personalised medicine, there has been increasing interest in using pCLE to visualise 
molecular markers of neoplastic cells. Development of targeted peptide probes and antibodies are 
rapidly underway and visualisation of neoplastic cells though targeted binding of these fluorescent-
tagged markers have now been reported. Hsiung et al demonstrated that it is possible to visualise 
increased fluorescence on dysplastic human colonocytes following administration of targeted 
heptapeptides labelled with fluorescein (48). Similarly, preclinical work on xenograft models and 
human tissue specimens demonstrated that colorectal cancer cells could be visualised and 
differentiated by using fluorescent-tagged antibodies that binds specifically to human epidermal 
growth factor (49) and vascular endothelial growth factor receptors (49). These novel approaches 
represent a more targeted method of identifying of neoplastic cells instead of relying on morphological 
appearances provided by non-specific fluorescent staining. 
 
2.2.4 pCLE imaging in the biliary tree 
Elsewhere, initial results from a multi-centre study reported a promising role of pCLE in 
discriminating benign from malignant biliary strictures (50). In a disease where low survival rates are 
often caused by late diagnosis, these findings could potentially contribute to earlier diagnosis as 
current available mainstay diagnostic options for endoscopic sampling such as cytology brushing, 
biopsy and fine needle aspiration are limited by their low sensitivities.  
 
The Miami classification was subsequently proposed to define the range of reticular patterns and dark 
bands seen on pCLE imaging (Figure 2.10) (51). Utilizing the proposed criteria for diagnosis of 
malignant strictures, Talreja and colleagues however reported that there was low inter-observer 
agreement was among the assessors (52, 53). Additionally, Loeser and colleagues suggested that a 
negative pCLE study of the biliary tree could potentially be used to rule out the presence of 
malignancy, but there are frequent false positives using the earlier classification (54). Evidently, the 
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higher false-positive cases were induced by benign inflammatory conditions, resulting in significantly 
lower test specificity (51). 
In light of these, the Paris classification was proposed as a refinement of the existing Miami 
classification to improve the accuracy of pCLE by including a further category to distinguish benign 
inflammatory strictures (55) (Figure 2.11). Whilst the preliminary inter-observer agreement findings 
were encouraging (56), it is evident that prospective multicentre studies are needed to further validate 
this refined classification criteria. A summary of all the original articles published to date on pCLE 
imaging of indeterminate biliary strictures is shown in Table 2.3. 
 
The diagnostic challenge in malignant tumours of the biliary tree pertains to poor sensitivity of tissue 
sampling techniques during ERCP. Unlike the aforementioned applications in the gastrointestinal tract 
where tissue sampling usually provides definitive diagnosis, it appears that pCLE could have the 
potential to overcome challenges associated with histological diagnosis. The clinical argument here no 
longer pertains to “to biopsy or not to biopsy”, instead the cellular information provided may facilitate 
the decision-making process pertaining to definitive management of these patients.   
 
Author, year, ref No. of 
patients 
Malignant 
strictures 
Sensitivity Specificity Accuracy 
Meining, 2009, 14 6 83 88 86 
Loeser, 2011, (54) 14 6 N/A N/A N/A 
Giovannini, 2011, (57) 37 23 83 75 86 
Shieh, 2011,(58) 11 N/A N/A N/A N/A 
Othman and Wallace, 2011,(59) 89 40 98 67 81 
Meining, 2011, (50) 102 40 98 67 81 
Talreja, 2012 (52) N/A 25 N/A N/A N/A 
 
Table 2.3 Original articles assessing the diagnostic accuracy of pCLE on differentiation between benign and 
malignant biliary strictures 
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Figure 2.10 Miami classification of the biliary tract from pCLE images [Adapted from Meining et al, (51)] 
 
 
Figure 2.11 The additional of pCLE description of inflammatory stenosis forms the Paris classification, a 
modification of the Miami classification [Adapted from Meining et al, (55)] 
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2.2.5 pCLE imaging in the urinary tract 
Similar to gastrointestinal tract applications, detection of neoplastic tissues during cystoscopy relies on 
white light imaging for accuracy and comprehensiveness. The pivotal short-comings of white light 
cystoscopy include that of flat lesion detection, real-time in situ tumor delineation to enable complete 
resection, differentiation between inflammatory changes from that of malignancy, and determination 
of the grade and stage of tumour (60, 61). Whilst the role of pCLE might be limited for the latter 
application, the rest are pertinent to the sub-surface imaging characteristics conferred by pCLE.  
  
The feasibility of using pCLE to detect histological differences between normal and neoplastic 
urothelium on acriflavine-stained, excised specimens were first described by Sonn and colleagues 
(62). Further in vivo validation studies confirmed that pCLE image acquisition of benign and 
neoplastic tissues were feasible in patients undergoing TURBT and nephrectomy (63) (Figure 2.12). 
Additionally, the interobserver agreement and diagnostic accuracies of neoplastic bladder pCLE 
images were comparable to that of WLC alone with a corresponding moderate inter-observer 
agreement (64). As with pCLE imaging of the biliary tree, its role in improving bladder cancer 
detection and completeness of tumour resection during transurethral procedures is still under 
evaluation. It is envisaged that a concurrent red flag technique is required to facilitate targeted imaging 
with pCLE. 
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Figure 2.12 pCLE images of (A) normal bladder urothelium depicting an umbrella cell layer: note the 
characteristic large polygonal-shaped cells; (B) Low grade urothelial carcinoma with crowding of uniform-
appearing cells; (C) Fibrovascular stalk with a thickened endothelial layer; (D) Cross-sectional view of the 
fibrovascular stalk with erythrocytes in the vascular core; (E) High-grade urothelial carcinoma with pleomorphic 
and distorted sheet of cells. (F) Distorted fibrovascular stalk with variation in vascular cores sizes. [Adapted 
from Wu et al, (63)] 
 
2.2.6 pCLE (nCLE) imaging of pancreatic lesions 
Endoscopic ultrasound guided fine needle aspiration (EUS-FNA) is a commonly performed procedure 
to assess cystic and solid lesions of the pancreas (65). However, that is frequently complicated by 
sampling errors, non-diagnostic cytology and limited on-site cytological services (66, 67). Multiple 
FNA passes are frequently performed to obtain diagnostic material (67). These are time-consuming 
and increase the risk of complications such as pancreatitis. It is envisaged that the use of pCLE could 
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potentially reduce the need to rely on EUS-FNA procedures as provision of real-time microscopic 
information could potentially provide diagnostic material safely and quickly. Utilizing a needle-based 
CLE (nCLE) probe that is compatible with a 19-gauge FNA needle, image acquisition were feasibly 
acquired under ultrasound guidance with the presence of epithelial villous structures on nCLE images 
being consistent that of neoplastic tissues (68, 69) (Figure 2.13). Preliminary data suggests that nCLE 
has a high specificity in the detection of PCN, but limited by a low sensitivity (68, 69). The safety of 
nCLE still requires further evaluation as a few patients developed post-procedure pancreatitis. Much 
work needs to be carried out to validate these findings and standardise feature descriptions. 
 
 
Figure 2.13 nCLE images of normal pancreatic tissue and intraductal papillary mucinous neoplasam. (A) 
Normal pancreatic tissue depicts thin dark bands with reticular pattern. (B-C) Histology images of tumor tissue 
cystic dilatation of ducts with papillary proliferation. (D-E) nCLE images of the tumor with papillary 
projections. [Adapted from Konda et al, (68)] 
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2.27 pCLE imaging of the respiratory tract  
Utilizing a pCLE miniprobe adapted for respiratory airways (1-mm flexible Alveoflex® miniprobe), 
several studies reported that both elastic fibres and macrophages were readily visible in the alveolar 
wall (26, 70-74). The latter were seen to be positively correlated with the number of cigarettes smoked 
per day (70). The presence of marked emphysema in patients with chronic obstructive pulmonary 
disease was depicted on pCLE images as loss of elastic walls, increased spacing between septal walls, 
loss of fluorescence from bullae and a subsequent reticular pleural image (26) (Figure 2.14). 
Conversely, the elastic fibres were reported to be thickened, rigid and in high concentration in patients 
with interstitial lung diseases (74) as compared to the thin and mobile fibres seen in healthy alveoli. 
The addition of intravenous FS resulted in overfluorescence of the alveolar wall and did not appear to 
depict any additional morphological features (26).  
 
A recent study by Fuchs et al shed some light on the potential role of pCLE in lung cancer diagnosis. 
In 32 patients that underwent bronchoscopy for suspected lung malignancies, neoplastic and non-
neoplastic features of respiratory epithelial lining on pCLE images could be predicted with high 
accuracy (sensitivity 96.0%, specificity 87.1%, accuracy 91.0%) when AH was applied topically as the 
contrast agent (29). Whilst this may potentially enable the rapid diagnosis of neoplasia during 
bronchoscopy, the relevance of these findings remain questionable as tissue biopsy from an obvious 
tumour is still warranted for definitive histological evaluation. Whilst transbronchial biopsies of the 
respiratory epithelium have its own aforementioned risks, the extent of biopsies required are not 
comparable to that of during surveillance of Barrett’s esophagus and ulcerative colitis. More 
importantly, the risks and benefits of obviating the need for biopsies on the basis of pCLE images in a 
patient with risk factors warrant a systematic evaluation before its potential benefits could be reliably 
ascertained.   
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Figure 2.14 pCLE images of disrupted elastic fibres (yellow circles) (A-C) with patients with lung emphysema. 
Image D depicts the “snapping” of elastic fibres on consecutive still pCLE images. On the background, 
fluorescent blobs of macrophages were visualised which is consistent with chronic tobacco smoking. [Adapted 
from Newton et al, (26)] 
 
2.3 Challenges associated with pCLE imaging 
2.3.1 Clinical challenges with envisaged applications 
Since the advent of pCLE in 2007, publications pertaining to pCLE images obtained from a variety of 
tissues were akin to that of ‘mushrooms after the spring rain’. Whilst the plethora of research 
composed of several promising high quality feasibility studies such as those pertaining to the 
surveillance of BE and assessment of indeterminate biliary strictures, much of it lacked thorough and 
rigorous evaluation on the practicality of its intended clinical role. Unlike traditional biopsies where 
bleeding occurs at sampling sites, the lack of visual cues to localise the sites where pCLE assessment 
was performed can be challenging. Given that the envisaged role of pCLE in surveillance of BE is to 
guide the need for biopsies, it is therefore important that the sites where biopsies are performed 
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correlate precisely to that of the sites assessed by pCLE imaging. The Barrett’s segment presents a 
unique challenge in that it could appear homogenously inflamed thereby lacking essential visual cues 
to facilitate precise localization of these sites. Evidently, the absence of bleeding points combined with 
tissue deformation secondary to peristalsis and intraluminal pressure changes could further impede the 
accuracy of localization. Consequently, this could lead to pCLE and biopsy assessment mismatch. The 
implications of this discordance could lead to diagnostic dilemma, inconsistent management and 
treatment for BE patients.  
 
On another note, it is important to recognise that all pCLE studies pertaining to BE to date relied to the 
yield of biopsy samples of suspicious lesions and four-quadrant random locations to determine the 
presence or absence of high grade dysplasia or carcinoma (35-37). It is obvious that this study design 
would have underdiagnosed its true prevalence in the study population. Therefore, the evidence 
gathered could only suggest that there might be a role for pCLE in reducing the need for biopsies 
during random sampling and from that of suspicious lesions. There is no evidence to date to suggest 
that it would increase detection rates of high grade dysplasia or carcinoma from a relatively 
inconspicuous Barrett’s region. These challenges are pertinent to that of lower gastrointestinal tract 
surveillance for ulcerative colitis. Whilst numerous studies have shown high diagnostic accuracies for 
neoplastic and non-neoplastic morphology on pCLE images, there is no evidence to suggest that the 
use of pCLE increases the overall detection rates of neoplasia (42, 47, 75). It reaffirms that the 
effectiveness of pCLE at reducing the need for biopsies for both upper and lower gastrointestinal tract 
applications is largely dependent on the ability of concurrent red flag imaging modalities such as 
narrow band imaging (NBI) and chromoendoscopy (CE) to facilitate targeted pCLE assessments. 
However unlike that of the Barrett’s segment, large colorectal polyps of more than 10 mm in diameter 
harbour a higher risk of neoplastic transformation as compared that of smaller polyps and thereby 
warrant excision for definitive histology (76). It is unlikely that pCLE assessment of large polyps 
would confer any advantage as it would not impact decision-making. On another note, hyperplastic 
polyps are known traditionally to be non-dysplastic (77, 78) and have little potential for malignant 
transformation. However, recent evidence showed that serrated variants with similar morphological 
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architecture to that of hyperplasia harbours malignant potential (79, 80). The discrimination between 
hyperplastic and sessile serrated polyp, the latter a well-recognised precursor to malignancy , has 
shown to be highly variable on histology, even among experienced pathologists (81). It remains 
doubtful whether pCLE imaging could project these subtle differences in architectural variation given 
it is already hugely challenging on conventional histology.  
 
Similarly, the challenges associated with localization of neoplastic sites are pertinent to pCLE urology 
applications. Approximately 30-44% of patients that underwent transurethral resection of bladder 
tumour (TURBT) for non-muscle invasive bladder cancer were found to have recurrence within 2-8 
weeks following the procedure (60). This is commonly attributed to the inherent inability to visualize 
synchronous neoplastic sites during white light cystoscopy (WLC) which evidently has sensitivities 
and specificities ranging from 62-84% and 43-98%, respectively (82). Emerging red flag techniques 
such as fluorescence cystoscopy (61) and NBI (83, 84) have shown promising potential to facilitate 
detection of these neoplastic sites but are hampered by its high false positive rates (85-87). There 
might be a role of pCLE to provide in situ confirmation of neoplastic morphology on these sites 
thereby facilitating targeted biopsies. Needless to say, its role is dependent on the ability of the 
aforementioned red flag techniques to identify the ‘needle in the haystick’ in the first place.   
 
The potential role of pCLE for assessment of indeterminate biliary strictures arguably holds one of the 
most exciting and promising of all envisaged clinical applications. Distinguishing between benign and 
malignant strictures is difficult, with 5.2 to 24.5 per cent of these found to be benign after histological 
examination of the resected specimens (88). Given that the diagnostic yield of multi-modality imaging 
with CT scan, MRCP, EUS, ERCP and biliary cytology is so low, any modest improvement in 
diagnostic accuracy conferred by pCLE would translate into a major improvement in the definitive 
management of these patients. However compared with the initial classification proposed in 2011 (50), 
Loeser et al reported that the presence of dilated blood vessels were not specific for malignancy as 
these were present on pCLE images from both normal CBD and malignant strictures (54). These 
vessel characteristics are still being used as one of the key features for malignancy in revised 
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classifications (51, 56). The low interobserver agreements reported by Talreja et al are a cause for 
concern (52). Additionally, there appears to be a lack of understanding on the histological meaning of 
the imaging patterns observed. It is evident that the current data is still sparse and consequently the 
diagnostic criteria are still evolving.  On another note, whilst the smaller pCLE miniprobe size confers 
more space for angulation of the probe tip towards stricture surface, it does come at the expense of 
image quality and spatial resolution (58). The trade-off between optical resolution and physical 
deployment warrants evaluation to ensure that a compromise is achieved that allows both image 
acquisition and interpretability of its images feasible.  
 
The role of pCLE in the respiratory tract remains unclear at present. A significant amount of 
diagnostic information is lost on pCLE imaging (26) and the structural changes visualised in patients 
with emphysema and interstitial lung diseases are non-specific findings. These conditions are 
diagnosed on clinical grounds and high resolution CT scan; therefore pCLE imaging might not be 
warranted. Whilst Fuchs reported that pCLE neoplastic changes could be discerned when AH was 
utilized (29), the clinical significance of these findings is unclear as biopsies would be required for 
definitive diagnosis. The origin of these neoplastic lesions could be primary or secondary, and both 
hold important prognostic information. Whilst it is recognised that transbronchial biopsies carry a 
small risk of pneumothorax, the requirement for multiple biopsies does not approximate to that of 
Barrett’s and ulcerative colitis surveillance.  
 
At present, there is still paucity of information pertaining to pCLE imaging of pancreatic cysts. The 
two studies published to date describe the safety and feasibility of the procedure (68, 69). The 
preliminary findings reported warrants further validation. It remains unclear whether pCLE images 
obtained from a single assessment site are representative of the entire cyst. The field of view conferred 
by AQ-Flex® pCLE miniprobe is relatively small (280 x 280 µm) and mosaics could not be 
constructed. Multiple imaging attempts at different sites might be required to provide representative 
images of the cysts. Additionally, the leakage of fluorescein from the puncture sites could potentially 
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impede visualization of morphology. These are some technical considerations that warrant systematic 
evaluations. 
 
2.3.2 pCLE image interpretation and miniprobe stability  
One of the challenges common to pCLE image acquisition across a range of clinical applications is the 
clinicians’ ability to obtain high quality and consistent in vivo, in situ images. It requires slow and 
controlled movements, often over a few millimetres, for large area surveillance. This is a challenging 
task in the presence of bowel peristalsis and cardiorespiratory movements. In gastrointestinal 
endoscopy, this requires the endoscopists to manipulate its wheels or change the direction of its 
torque. Variations in the intraluminal insufflation pressures can lead to unintended deflation of the 
lumen. Whilst this might not be appreciable from the endoscopic view, these motions can distort the 
quality of real-time mosaics. The mobility of the tissue of interest can pose an additional challenge 
especially in cases of pedunculated polyps of the colon. Protruding polyps are difficult to stabilise as it 
tend to flip over the tip of the confocal endoscope upon contact. The reported rates of failure to assess 
protruding polyps using eCLE can be as high as 57% with difficulty in stabilising polyps cited as the 
main contributing factor (89). A more recent study by Kuiper et al demonstrated that nearly a quarter 
of pCLE videos obtained during colonoscopy failed to demonstrate any crypts or vessels. This 
corresponded to almost 12% of lesions encountered and much of the problems encountered were 
difficulty stabilising the tip probe against the cohort of mobile lesions (90).  
 
These challenges are not confined to intraluminal imaging but to all solid organ and soft tissue pCLE 
imaging. The effect is magnified on applications in close proximity to the torso and neck where 
respiratory movements of the chest wall and strap muscles can lead to significant distortions during 
pCLE image acquisition. Rosa et al reported that these movements can be of several centimetres of 
magnitude which could lead to unstable images and inability to create meaningful mosaics (91). To 
reduce the effects of tissue deformation and movements associated with cardiorespiratory and bowel 
movements during in vivo pCLE imaging, the use of closed-loop, force sensitive robotic probes has 
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been proposed (92). The principle behind this is to maintain a desired contact force between the tissue 
surface and tip of the pCLE probe for image consistency. Using these smart instruments, 
predetermined contact forces which compensates for physiological movements of tissue and 
involuntary movements of the clinician’s hand have been shown to improve the consistency of images 
obtained as evidenced by minimal crypt translation on still images of bowel tissues obtained at per 
second interval. Initial in vivo studies on porcine rectal mucosa reported that pCLE images could be 
obtained at contact forces as low as 100 mN (93). Utilization of smart surgical instruments that reduce 
hand-held tremor or compensate for physiological movements could be pertinent to surgical 
applications of pCLE (92). More recently, the use of industrial lightweight robots such as KUKA as a 
means for controlling pCLE miniprobe navigation on simulated solid organs and cavity-based models 
have been investigated (94-96). Whilst the robustness of utilizing this method has been tested and 
preliminary results demonstrated that reconstruction large mosaics with accurate spatio-localization is 
possible, it remains to be seen whether integration of such approach would be feasible and thereby 
warrants further validation in clinical studies.    
 
 
2.4 Role of pCLE imaging in surgery  
2.4.1 Overview 
The role of pCLE outwith the endoluminal environment for surgical applications has been relatively 
unexplored. In particular, there is little reported on its ability to characterise morphological features 
beyond mucosal or luminal epithelium. This is unsurprising given that the pCLE miniprobes are 
currently CE-marked for clinical applications within the endoluminal tracts. Additionally, this is partly 
attributed to the commercially driven strategy to develop applications within the endoluminal tract 
given the miniprobe‘s unique physical and optical characteristics.  
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Most studies pubished to date consists of proof of concept work or feasibiility studies on animal 
models and humans. A study by Newton et al reported the feasibility of utilizing a flexible access 
robot known as i-Snake
®
 as a potential delivery tool to aid stable pCLE image acquisition of solid 
organs in the peritoneal cavity (Figure 2.15) (97). Morphological images from liver subsurface 
parenchyma, splenic subcapsular vessels and peritoneal lining were readily visualized. Similarly, 
studies by Goetz and colleagues reported the use of an in-house designed rigid CLE to image the liver 
microarchitecture during mini-laparoscopy (98, 99). The majority of publications on in vivo CLE 
imaging were pertinent to neurosurgery where completeness of excision of brain tumor and 
preservation of normal brain tissue is pivotal to overall morbidity and mortality of these patient (100, 
101). Neoplastic and non-neoplastic pCLE feastures of brain tissues were visualised and demonstrated 
good correlation with respective histology (30, 102-104) (Figure 2.16). However, the work described 
to date still revolves around the feasibility of in situ CLE imaging and evidence pertaining to its 
impact on achieving tumor-free resection margins or the overall morbidity in these patients is yet to be 
established.  
 
There were suggestions that pCLE could potentially be used to guide tumor resection margins during 
TEMS (44) and TURBT procedures (63, 105). Hence, its diagnostic potential during routine 
endoscopy could potentially be extrapolated to applications pertaining to endoscopic-based surgery. 
Additionally, it could also be used to confirm complete removal of neoplastic tissues on the lateral 
margins of mucosal defect created from surgery. To date, no clinical studies have evaluated the 
potential role of pCLE in these applications.  
 
It is evident that the role of pCLE as a potential imaging adjunct during surgery is still in its infancy. 
With the exception of neurosurgery applications, much of the published work has no clear clinical 
applications in mind and there is an obvious paucity of clinically driven pCLE research towards 
intraoperative  use. The provision of real-time information of the tissues encountered during surgery 
i.e. tissue tumor-free status, tissue type confirmation or tissue viability/vascularity, depending on the 
intended application, could potentially have a far greater clinical impact on the outcome of the 
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operation. Evidently, these information could be used to guide real-time surgical decision-making and 
the potential clinical applications in this unexplored surgical avenue warrants investigation.  
 
 
Figure 2.15 (A & B) A laparoscopic view of transvaginally inserted flexible robot i-Snake® performing 
retroflexion in the pelvis. (C) Tip of the pCLE probe deployed against the liver, (D) spleen and (E) peritoneum 
(F) pCLE image of liver hepatocytes (G) pCLE image of splenic cords of Billroth; (H) Parietal peritoneum of the 
abdominal wall with the arrow depicting a blood vessel. [Adapted from Newton et al, (97)] 
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Figure 2.16 System set-up of rigid CLE probe and AH-stained human brain tissue CLE morphology (A) The 
rigid CLE has a shaft diameter of 7mm. (B) Human brain tissues containing normal and adjacent tumor section. 
(C-D) Normal brain tissue with with neuron or microglial cells with appendices (arrows). (E-F) Tumor tissues 
reveals excessive growth with atypic nuclei and abnormal nuclear-to-cytoplasm ratio. [Adapted from Foersch et 
al ((30)]. 
 
2.4.2 Potential applications in breast and endocrine surgery   
It is evident that the role of pCLE as a potential imaging tool to faciliate intraoperative decision-
making is predicated on the following criteria: 
 An intraoperative problem that is currently unaddressed by current techniques / technologies   
 Information provided will have an impact on real-time intraoperative decision-making 
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 Time-efficient image acquisition and interpretation by the surgeon in the operating theatre 
 
Taking these into account, we envisage theat pCLE might have a promising role as an intraoperative 
imaging device in the following surgical applications (Figure 2.17):  
 Detection of residual disease on the cavity walls during breast conserving surgery (BCS) / 
wide local excision (WLE) for breast cancer 
 Differentiation between parathyroid from non-parathyroid tissues during parathyroidectomy 
for primary and secondary hyperparathyroidism 
 Assessment of viability status of preserved parathyroid glands during total or completion 
thyroidectomy for benign and malignant conditions 
 
Over the last 30 years, advances in mammographic screening have led to an increase in the diagnosis 
of small, non-palpable breast cancers (106). As a result, breast conserving surgery (BCS), which 
involves removal of the cancer together with a surrounding cuff of normal breast tissue, has become 
the standard intervention and is generally regarded as sufficient curative treatment in appropriately 
selected patients (107). 
 
In BCS, it is important to achieve an optimal balance between ensuring complete removal of breast 
cancer and preservation of tissues for good cosmesis (108). The former is generally assessed through 
histology on the margins of the excised tissue (109).  Positive surgical margins (the presence of tumor 
cells at the edge of excised tissue) are associated with a high risk of developing local recurrence and so 
the patient will often be required to return to theatre for a reoperation (110-112). This carries a further 
risk of postoperative infections (113), has a negative impact on cosmesis (114), and increases costs 
due to longer stays in hospital (114). At present, the proportion of patients with positive surgical 
margins ranges from 20% to 40%  and the national reoperation rates are 30% for non-invasive and 
18% for invasive breast cancer (114, 115).  
 
It is evident that the completeness of tumor removal rates achieved during WLE warrants 
improvement. There is increasing evidence that the tumour bed status is an independent predictor of 
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local recurrence (116, 117). Systematic cavity shaves were shown to  reduce re-excision rates 
following BCS (118). Hence, the role for pCLE could potentially reside on visualization of residual 
foci of  tumor cells that were inadvertently left behind on the cavity walls following WLE. Equipped 
with these information, the surgeon could potentially decide whether further excision of the 
corresponding cavity wall is needed based on real-time information provided by pCLE assessment. 
This will avoid the need for a reoperation as further excision, guided by pCLE, could be performed at 
the time of the index surgery.  
 
 
Figure 2.17 Venn diagram depicting the envisaged intraoperative pCLE application and subsequent 
decision-making processes. 
 
Parathyroid glands (PG) on the other hand are notoriously difficult to identify during surgery because 
of their small size and appearance that is often similar to lymph nodes, fat, and occasionally thyroid 
tissue (119). Even in the hands of an experienced surgeon, this could be challenging especially in 
reoperative cases (120) and multinodular goitres where tiny superficial nodules could mimic 
parathyroid glands (121). The sensitivities of the gold standard imaging modalities such as ultrasound 
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(USS) and sesitimibi scans (SS) are far from perfect, with rates of detecting disease PGs ranging 
between 51 to 96% and 34 to 100%, respectively (122, 123). Both their sensitivities decrease even 
further in the presence of multiglandular disease (MGD) (124, 125). Failure to localise PG  
preoperatively warrants bilateral neck exploration to identify the diseased gland (126). The location of 
these glands could vary signficantly, especially the inferior PG (127). Whilst intraoperative 
parathyroid hormone assay (ioPTH) has a role in confirming the removal of the diseased PG (128), it 
still requires the surgeon to identify these in the first place.  
 
This leads us to question whether is there a role for pCLE to help differentiate parathyroid from non-
parathyroid tissues? If so, could it provide the surgeon a recourse when equivocal tissues are 
encountered at the time of surgery?  This could obviate the need for current techniques such as frozen 
section analysis which is time consuming and unreliable (129). It may also provide valuable 
information when ioPTH is inconclusive (130) . The latter is less reliable when multiglandular disease 
and double adenomas are present. At this point of time, the role of pCLE in identification of PGs has 
yet to be evaluated. A systematic search performed in November 2013 on registered clinical trial 
databases (National Institutes of Health, Clinical Trials.gov,  European Union Clinical Trials Register) 
showed no current or planned studies addressing similar hypotheses.   
   
One of the most common complications following total or completion thyroidectomy is postoperative 
hypocalcaemia (131). Whilst these could easily be managed with calcium and vitamin D analogue 
supplementations (132), permanent hypocalcaemia secondary to inadvertent removal or injury to the 
PG vascular supply could potentially lead to life-long debilitating complications (133). It is common 
practice to routinely identify at least one PG during surgery and ascertain its viability status. If the PG 
appeared discoloured or its vascular supply was obliterated, the surgeon would normally 
autotransplant this PG onto a neighbouring muscle, most commonly the sternocleidomastoids, to 
preserve its function (132). However, the absence of tissue discolouration is not a reliable indicator of 
PG viability (134) and conversely, the presence of PG discolouration do not confer necessarily 
represent permanent loss of PG function (135) . Consequently, visual assessment of PG discoloration 
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as a predictor of viability is unreliable and decisions pertaining to autotransplantation of PGs remains 
controversial and rely heavily on the surgeon’s experience. Unsurprisingly, 24.9% of patients that 
underwent total thyroidectomy in the UK developed post-operative hypoparathyroidism (136). More 
worryingly, approximately 12% developed permanent hypocalcaemia (136). 
 
It is well recognised that the sub-surface vasculature of gastrointestinal, biliary and urological tract 
tissues were readily discernible on pCLE images (Figure 2.18) (37, 137). Most of the desciptions on  
vascular morphology of neoplastic tissues were in pertinence to its general architecture i.e. vessel 
thickness, distortion and dilatation; and visualization of individual erythrocytes. If similar vascular 
characteristics could be visualised on PGs, we could potentially ellicit valuable information on PG 
vascular supply and viability. Once again, this is an interesting avenue that has yet to be systematically 
investigated. We hypothesis that subcapsular and superficial parenchymal vasculature could 
potentially be visualised on pCLE imaging and that information pertinent to the presence, adequacy 
and quality of blood flow could be deduced. With that in mind, decisions pertaining to 
autotransplantation of PG could potentially be facilitated by findings on pCLE images. Chapter 6 will 
provide detailed descriptions of our evaluations utilising pCLE on preserved PGs.    
 
 
Figure 2.18 pCLE image depicting blood vessels (red arrows) with intraluminal erythrocytes (dark particles) on 
(A) Barrett’s segment; (B) Normal bladder mucosa; (C)  Normal bowel mucosa. [Image A adapted from Konda 
et al (138), Image B provided by Dr. Joseph Liao, Stanford University, CA, USA] 
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2.4.3 pCLE imaging of blood-stained tissues during surgery  
One of the main concerns pertinent to pCLE imaging during surgery is the effect of blood on pCLE 
image acqusition. Evidently, a bloodless surgical field is impossible to achieve during breast, thyroid 
and parathyroid surgery as these tissues are well vascularised, thus minor oozing from capillaries or 
small venous tributaries will occur during dissection. Most of these will be either be removed either by 
suction or gently dabbing with a swab after adequate haemostasis is achieved. Despite that, it is 
inevitable that dried blood stains will still remain on the tissue surface. Most pCLE imaging described 
in the literature to date were performed on relatively unperturbed epithelial surfaces with intact 
vasculature. The impact of blood-stained tissues on pCLE imaging of tissue architecture warrants 
evaluation before any aforementioned potential clinical applications is evaluated.  
 
To this end, a feasibility study was carried out on a live, anaesthesied porcine model to test the 
hypothesis that pCLE could be used to visualise soft tissue morphology in an intraoperative field. 
Under the study protocol approved by the Home Office (No. 80/2297), a neck dissection was 
performed on an anaesthetised six-month-old white Landrace crossbreed female pig (70kg). The neck 
was chosen as our anatomical region of interest because it is relevant to one of our clinical applications 
of interest. The porcine models available in our animal research facility had immature mammary 
glands and thereby inappropriate for us to perform a realistic cavity dissection. Additionally, the 
thyroid gland is a highly vascularised structure and minor oozing from surrounding vasculature would 
provide a realistic simulation to that of the breast.  
 
The neck dissection was performed by two surgeons (T.P.C., K.S.) who held valid personal and 
project licences for this study. A vertical midline incision was performed and the strap muscles, 
thymus, thyroid, carotid artery, internal jugular vein, trachea and esophagus carefully dissected and the 
respective vascular pedicle / vasculature of thyroid and thymus preserved (Figure 2.19). Haemostasis 
was achieved using bipolar diathermy. Following that, five mls of intravenous fluorescein sodium (FS) 
10% (Martindale’s, UK) was administered as tissue contrast and the pCLE  miniprobe (2.6-mm 
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diameter Ultra-Mini-O
TM
) was deployed in-situ. The morphological architecture of corresponding soft 
tissues are described in Figure 2.20.  
 
 
Figure 2.19 Intraoperative images of anatomical neck dissection in a porcine model. (A) Vertical neck incision 
was performed; (B) Self retractors were placed and a suture sling was used to retract the strap muscle. (C) 
Thyroid gland with a pCLE Mini-O miniprobe deployed perpendicular to its surface for image acquisition. 
Additional pCLE imaging was performed on the thymus (black arrow), trachea (yellow arrow), strap muscles 
(arrowhead) and (D) on the internal jugular vein (black arrow) and carotid artery (yellow arrow).  
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Figure 2.20 Real-time pCLE image mosaics of soft tissue morphology were readily discernible. (A) Polygonal 
shaped fat cells; (B) Cylindrical shaped longitudinal muscle cells of the esophagus; (C) striated cells of strap 
muscles; (D) Follicular cells of the thyroid gland using topical application of 0.05% AH as an additional contrast 
agent; (E) Fluorescent-stained thyroid follicles; (F) Opaque appearance of colloid in the central lumen of thyroid 
follicle; (G) Thymus lobule with a surrounding vascular septa.   
 
It was evident that morphological architecture of most soft tissues within the intraoperative field of the 
neck could be visualised in real time using pCLE, hence suggesting that image acquisition of tissue 
morphology is not just limited to the epithelial linings of the gastrointestinal tract, biliary tree, 
urological tract or lung, respectively. The respective tissues imaged were mildly stained with dried 
blood on its surface and that did not impede visualization of morphological architecture throughout 
our imaging sessions. However, we do not envisage that imaging would be possible in the presence of 
active bleeding as the resulting emissions from tissues would be absorbed by the intervening 
uncoagulated blood between the probe tip and tissue surface. Nevertheless utilizing a sterile swab to 
gently dap away any liquid blood or tissue debris would suffice and pCLE image acquisition should be 
fairly unperturbed.  
 
It is important to note that the timing of intravenous FS may play an important role on pCLE image 
acquisition of any tissues in the operative field. If FS is administered too early, any subsequent 
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haemorrhage would render these tissues overfluorescent. Given that the systemic dissemination of FS 
occurs within minutses of administration, it is envisaged that any time period following excision of the 
breast tumor, thyroid or parathyroid gland would suffice provided adequate haemostasis has been 
achieved.  We envisage the same principles apply when using AH as the topical fluorescent agent. 
However, the latter would require a generous rinsing or washout with warm saline after topical 
application to remove any excess unbound fluoresence.  
 
2.4.4 pCLE imaging through a sterile transparent sheath 
The sterility of pCLE miniprobes is of prime importance when it is deployed against the tissue surface. 
At present, the AQ-Flex® miniprobe is the only commercial pCLE miniprobe that is CE-marked for 
sterilization by STERRAD
®
 Sterilization System (139). All other pCLE miniprobes are currently not 
sterile and therefore may not be suitable for intraoperative deployment in a sterile surgical field. 
Whilst the AQ-Flex® miniprobe meets the strict sterility requirements, its physical properties may not 
be suitable for use as a hand-held probe. It has a relatively thin diameter (approximately 1.2mm) and 
its fibrebundle is not sufficiently rigid on its distal end to withstand perpendicular pressures and tissue 
surface frictions from lateral miniprobe movements. Consequently, construction of pCLE image 
mosaics might be difficult to orchestrate.  
 
One of the most common methods to overcome this problem is to use a sterile transparent drape as a 
sheath to maintain sterility in the operating field. Evidently, equipements such as the gamma probe 
detector for sentinel lymph node biopsies (140) and nerve monitoring devices for thyroid surgery 
(141) have benefited from this safe and cost effective approach. As part of our initial assessment on 
pCLE imaging towards surgical applications, we conducted a pilot study on five freshly excised 
parathyroid tissues. The aim is to determine the ability of pCLE to image morphological architecture 
of tissues with and without a sterile transparent drape (Clinicon
©
, Bristol, UK) as an external sheath.  
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The overall system set-up and imaging results are described in Figure 2.21.  
 
 
Figure 2.21 pCLE equipment and sterile transparent drape set-up. (A) The entire miniprobe is sheathed with the 
drape. The distal end of the drape is folded backwards and the small opening is obliterated with the blue tape. 
(B) The blue tape is secured around the fibrebundle so that interface between probe tip and sheath is taut. (C) 
pCLE image acquisition is performed utilising 2.6-mm diameter Ultra-Mini-O
TM 
miniprobe. (D) pCLE image 
mosaic of parathyroid cells with the sterile drape. (E) pCLE image mosaic without the drape. 
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Based on the results of this feasibility study, it is evident that the individual nuclei of parathyroid 
parenchyma were readily visualised through the transparent drape. Equally, the depth of imaging was 
not compromised as the thickness of the drape is approximately 8-10 µm. No movement artefacts were 
noted throughout image acquisition. The contrast between the nuclei and background stroma appear 
enhanced when the drape was used. Although this is unlikely to be of any clinical significance, the 
smooth interface conferred by the drape allowed translation of the probe tip onto the tissue surface 
relatively unperturbed. This could potentially faciliate creation of longer and meaningful mosaics. 
Importantly, we have demonstrated that utilization of a sterile transparent drape did not impede pCLE 
image acquisition and that the quality of images obtained were comparable to that of without the 
drape. This finding forms the basis for using a sterile-draped pCLE probe for imaging vascular 
morphology of parathyroid glands in Chapter 6 and the future work of Chapter 5. 
 
2.4.5 pCLE image interpretation by surgeons  
Little is known about the ability of surgeons to learn the basics of pCLE image interpretation and the 
training materials that are required. The training curriculum of the modern day surgeon rarely involve 
interpretation of histology slides. Whilst there is evidence that gastroenterologists were able to acquire 
pCLE image interpretation skills with a relatively short learning curve (142, 143), we are mindful that 
most of these studies originated from centres with vast amount of pCLE clinical experience and that 
received commercial funding for the development of pCLE applications.  
 
Since our aim is to evaluate the feasibility of utilizing pCLE as a potential imaging tool for surgical 
applications, it is prudent to establish whether surgeons who had no prior experience on pCLE 
imaging were able to learn the basics of pattern recognition. To that end, we developed a 15-minute in-
house video tutorial that provides detailed descriptions about Miami classification of colorectal lesions 
(142)and assess the ability of 10 surgeons to recognise mucosal crypts and vessel architecture of 
neoplastic and non-neoplastic pCLE images (Figure 2.22). Further training were provided to 
differentiate normal from hyperplasia and adenoma from adenocarcinoma images. Following that, 
  55 
 
participants were given a practice session that consists of 15 pCLE images followed by a question and 
answer session. Subsequently, all participants were then shown 50 colorectal pCLE video images* 
blinded to histopathology results (25 neoplastic and 25 non-neoplastic) and accuracy of interpretations 
were assessed.  
 
The overall accuracy for differentiation between pCLE neoplastic and non-neoplastic images was 
91.4% (range 82–96%) and interobserver agreement was 'substantial' (κ=0.7). Accuracy for the overall 
group was 87% for videos 1-10, 97% for videos 11-20, 97% for videos 21-30, 83% for videos 31-40 
and 93% for videos 41-50. The accuracy for specific diagnostic entities (normal vs hyperplasia vs 
adenoma vs adenocarcinoma) was 77.4% (range 70–84%). The accuracy rates were not significantly 
different with age, or by clinical or endoscopy experience. 
 
It is evident that utilizing a systematic and structured approach, surgeons with no prior expeience on 
pCLE image interpretation were able to learn the basics of pattern recognition training. Importantly, 
the clinical background i.e. lack of histopathologiy experience did not perturb the confidence of our 
participants. Most felt that the key features were clearly described and easily retained. In any effort to 
minimise any bias, we chose to use a video tutorial as a training tool so that delivery of the learning 
materials were standardised to all participants. Given that each participant assessed the pCLE images 
independently, there were no bias from peer pressure. We chose to use pCLE images from the lower 
gastrointestinal tract because it was one of the few applications that had a classification that was 
internationally validated with excellent inter-observer agreement.  
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Figure 2.22 Screenshots of a video tutorial designed to train inexperienced surgeons on Miami classification of 
neoplastic and non-neoplastic colorectal lesions  
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Chapter 3: Evaluation of Acriflavine-stained 
Breast Morphology on pCLE Images 
 
3.1 Introduction 
3.1.1 Positive margins in breast conserving surgery 
Breast cancer is the second most common newly diagnosed cancer and second leading cause of cancer 
death among women in the US and Europe. Breast conserving surgery (BCS) has become the ‘gold 
standard’ intervention for patients with smaller sized tumors and is generally regarded as sufficiently 
curative provided the tumor is excised with a margin of healthy breast tissue. Local recurrence 
following BCS is influenced by the patient’s age, tumor size and grade, the presence of multifocal or 
multicentric disease, and margin status (110, 112, 144, 145). Of these, the strongest predictor of local 
recurrence is margin status (115, 146, 147). Positive margins (disease at the edge of excised tissues) 
following BCS is a common indication for re-excision and it remains a significant problem with 
published rates varying between 15-50% (148-150). Re-excision rate estimates in the US following 
failed attempts at BCS ranges between 30 to 60%. Similarly in England and Wales, re-excisions are 
unacceptably high at 28% for non-invasive and 18% for invasive breast cancer (114). Re-excision 
leads to unnecessary anxiety, delays in delivery of adjuvant therapy, poor cosmesis and is cost 
inefficient (111).  
 
3.1.2 Challenges with margin assessment 
Whilst the impact of a positive margin on the risk of local recurrence is understood (115), the same 
cannot be said of ‘close’ margins. The lack of any universal consensus on what constitutes a ‘close’ 
margin and hence appropriate surgical management is reflected by the substantial surgeon and 
institutional variation observed in re-excision rates (151). Where cavity re-excision is performed for 
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‘close’ margins, a significant proportion (approximately 50%) will have no further disease identified 
on re-excision specimens (109). Neither gross examination by palpation (150), intraoperative 
radiography (152) nor frozen section (153, 154) of specimens are reliable methods for real-time 
margin assessment of excised specimens. Recent studies ulitizing radioguided occult lesion 
localization (ROLL) for non-palpable breast cancer did not demonstrate any difference in the 
proportion of negative margins achieved when compared with the gold standard wire-guided 
localization (155). Whilst intraoperative ultrasound guidance has shown a potential in reducing 
positive margins as compared with palpation-guided surgery, it may not be suitable for margin 
assessment where ductal carcinoma in situ (DCIS) and invasive lobular carcinoma (ILC) is involved 
(156). Additionally, it has also been reported that almost 50% of patients who undergo routine cavity 
wall shaving performed during BCS did not contain any evidence of residual disease within the shaved 
specimens (109). Finally, emerging techniques for intra-operative margin assessment such as 
radiofrequency spectroscopy (RFS) which provide the surgeon with feedback on the malignant 
potential of excised margins based on electromagnetic signatures (157) did not approach the accuracy 
of histopathological methods (158), and therefore have failed to lead to a reduction in the need for re-
operative intervention in certain randomised clinical studies (159).  
 
At present, the adequacy of local oncological treatment relies on the predictive value of histological 
assessment of the margins of excised tissues and yet the residual in situ disease burden i.e. cavity walls 
created following excision, is not known. Given that there is no evidence to prove that one particular 
margin width is more preferable to another, our theory is that it is not the arbitrary distance between 
the edges of the tumour that is most critical to outcome, but rather whether breast cancer cells have 
been inadvertently left in the patient. Rather than simply focusing on traditional histopathological 
assessment of the BCS specimens to guide the need for re-operation, arguably what is required are 
techniques that facilitate real-time assessment of the cavity bed and augment intraoperative decision 
making. The value of direct intraoperative assessment of the breast cavity wall has yet to be 
investigated arguably due to the lack of imaging technologies suitable for cavity deployment. 
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3.1.3 Potential role for pCLE 
Probe-based confocal laser endomicroscopy (pCLE) is an emerging optical imaging tool that has the 
technical and physical properties to provide high resolution in vivo, in situ imaging of tissue 
morphology at cellular and subcellular level. The technique  was initially developed to increase 
accessibility of the microscope for in vivo endoluminal tissue imaging and has since found promising 
clinical applications in surveillance of Barrett’s esophagus (35-37), assessment of indeterminate 
biliary strictures (160, 161) and pancreatic cysts (137). Utilizing fluorescent agents such as topical 
acriflavine hydrochloride and intravenous sodium fluorescein, morphological features of neoplastic 
and non-neoplastic tissues were shown to be readily visualized in real-time to the clinician during 
pCLE imaging. The ability of this flexible, hand-held and miniaturized endomicroscope to image 
neoplastic and non-neoplastic morphology in breast tissues as a potential real-time intraoperative 
imaging tool for in situ breast cavity wall assessment during BCS for breast cancer has yet to be 
systematically evaluated and in our opinion warrants further attention.  
 
3.1.4 Aims and hypothesis 
The hypothesis is that pCLE could potentially be used to distinguish breast cancer from normal breast 
tissues in real-time based on defining pCLE morphological features, utilizing acriflavine 
hydrochloride as a fluorescent nuclear staining agent (28). However, prior to assessing its potential to 
guide intraoperative decision-making, it is critical to first establish the morphological appearances of 
neoplastic and non-neoplastic breast tissues using histology as the gold standard for comparison. This 
study, performed on freshly excised breast tissues, demonstrates the feasibility of pCLE imaging 
towards intraoperative in situ margin assessment; and clarifies the ability of pathologists and surgeons 
to differentiate pCLE morphological images of neoplastic from non-neoplastic breast tissues using an 
in-house developed classification system. 
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3.2 Methods 
3.2.1 Patients and tissue preparation 
 From December 2012 to January 2014, tissue samples were obtained after written consent from 50 
patients undergoing wide local excision or mastectomy for histologically confirmed breast cancer at 
Imperial Breast Unit, Charing Cross Hospital (London, United Kingdom). Under an Imperial College 
London Institutional Review Board approved protocol (R12047a) for handling of human tissue, 
freshly excised cancer specimens were immediately transported to the pathology department where 
they were inked and underwent careful sectioning at 3- to 5-mm intervals by senior breast pathologists 
(S.S., R.R.). Each section was carefully examined by eye, palpation and specimen radiography where 
necessary, to locate the tumor. Thinly sliced samples measuring approximately 10 x 10 mm were 
retrieved from the center of tumor (n=50) and from macroscopically non-diseased appearing tissue 
away from the tumor margin (n=21) in mastectomy specimens (Figure 3.1). These samples were 
immersed immediately in acriflavine hydrochloride (AH) solution (0.01% in saline; Sigma Aldrich, 
UK) for 60 seconds and rinsed in normal saline solution.  
 
3.2.2 Equipment and image acquisition 
pCLE imaging of acriflavine-stained samples was performed using a pre-clinical probe-based confocal 
endomicroscopy system (Cellvizio, Mauna Kea Technologies, Paris, France) that consists of a 2.5 mm 
diameter flexible fibreoptic confocal miniprobe (Ultra Mini-O confocal miniprobe; Mauna Kea 
Technologies, Paris, France) connected to a laser scanning unit (LSU) that is connected to a standard 
personal computer for image data processing and display (Figure 3.2). The description of the pCLE 
system used in this study is detailed in Chapter 2 of this thesis.  
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Figure 3.1 Experimental workflow. (A) Freshly excised human mastectomy specimen. (B) Specimen carefully 
‘breadsliced’ at 3-5 millimeter intervals. (C) Tissue samples obtained from the section containing 
macroscopically visible disease (red box) and from adjacent normal tissues (blue box) at least 30 mm away from 
the diseased site. Specimens were immersed separately in AH 0.01% solutions for 60 seconds.  
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Figure 3.2 Image acquisition of tissue cut-outs. (A) pCLE system; (B) Handheld pCLE miniprobe. The 488-nm 
excitation laser transmitted onto the tissue surface through a bundle of more than 10 000 optical fibers. Tissue 
samples imaged en face (insert). (C) An example of pCLE image mosaic created in the direction of probe 
movement  
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3.2.3 Histopathology 
After completion of imaging, each sample was placed in individually labeled cassettes, fixed in 
formalin and underwent routine histopathological processing. All samples were horizontally sectioned 
and evaluated by histopathological means to confirm the presence or absence of tumor based on 
formal appraisal of the haematoxylin and eosin (H&E) slides and the final tumor histological 
classification was assigned in accordance to the Cellular Classification of Breast Cancer of National 
Cancer Institute. 
 
3.2.4 Correlation of image mosaics 
All pCLE image mosaics depicting cellular morphology of tumor samples and non-diseased breast 
samples were stored digitally in specific folders into a prospectively maintained database. These were 
subsequently evaluated with two senior pathologists (S.S., R.R.). Each pathologist independently 
reviewed the morphological architecture depicted on all pCLE image mosaics and compared it with 
those seen on the corresponding histology slides. In particular, distinctive morphological features that 
were consistently observed across all pCLE images of each diagnostic entity (neoplastic vs non-
neoplastic) were described in three distinctive categories: glandular, fibrous and adipose tissue 
components. During our analysis of glandular tissue component, careful attention was paid towards 
the size of ducts / acini, epithelial thickness and luminal cellularity. The evaluation of fibrous stromal 
component was focused on assessments pertaining to the relative degree of stromal cellularity and 
uniformity of stromal architecture. The adipose tissue component was focused on the recognition of 
individual fat cells and the degree of stromal cellularity interspersed between them. After the analysis 
of all pCLE image mosaics and respective histology slides were completed, a roundtable discussion 
between both pathologists and T.P.C., who had personal experience with the pCLE system, was 
carried out. The observations noted on each of these categories on pCLE image mosaics thought to be 
most consistent throughout our extensive analyses were discussed. All pCLE morphological features 
agreed by both pathologists were included as criteria in the new pCLE classification under the pre-
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defined categories. All disagreements on the criteria for pCLE morphological features were resolved 
by discussion. No third party reviewer was required.” 
 
3.2.5 Image interpretation assessment  
To assess the feasibility of differentiating neoplastic from non-neoplastic tissues, nine pathologists and 
eight surgeons who were not involved in pCLE image acquisition of samples and had no previous 
training in pCLE image interpretation were recruited. Each participant underwent an in-house 
developed pattern recognition training session consisting of a 15-minute video tutorial during which 
representative pCLE image mosaics and its corresponding histology images were shown and pCLE 
features characterizing neoplastic and non-neoplastic breast morphology using our classification 
system were explained.   
 
Subsequently, all participants were tested on a set of 50 de-identified pCLE image mosaics of 
histologically confirmed breast samples (25 neoplastic, 25 non-neoplastic) while blinded to the 
corresponding histology results. All pCLE images used in the training session were excluded from the 
test set. Each participant was asked to make a diagnosis of either neoplastic or non-neoplastic tissue. 
Neoplastic tissues included ductal carcinoma in situ and invasive carcinoma, whereas non-neoplastic 
tissues included normal breast tissues with no pathological changes. After diagnosing each pCLE 
image, the correct histopathological diagnosis was revealed to the participant. 
 
3.2.6 Statistical analysis 
The statistical analysis was performed using the statistical software package SPSS 21.0 (SPSS, 
Chicago, USA). The sensitivity, specificity, positive predictive value (PPV), negative predictive 
values (NPV), and accuracy of pCLE image interpretation were calculated, using the histology as the 
reference standard of diagnosis. The inter-observer agreement was expressed as the percentage of full 
agreement among the participants and by an overall kappa statistic with 95% confidence interval (CI). 
The interpretation of kappa values was done according to Landis and Koch (162). 
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3.3 Results 
3.3.1 Acriflavine hydrochloride dose  
Prior to the start of this study, a preliminary assessment was carried out on three tissue cut-outs 
obtained from neoplastic breast tissues. All three cut-outs were stained at AH concentrations of 0.01%, 
0.05% and 0.08%, respectively. The latter two had excessive fluorescence retained despite repeated 
washouts with PBS solutions (Figure 3.3) and the underlying morphological architecture could not be 
discerned on pCLE images. Based on these, all tissue cut-outs were stained using 0.01% AH solutions.    
 
 
 
Figure 3.3 pCLE images of AH-stained breast tissues at (A) 0.01%; (B) 0.05%; and (C) 0.08% concentrations.  
 
3.3.2 pCLE image mosaics 
The mean duration of pCLE imaging for each sample was 3 minutes (range, 1–6 minutes). A total of 
350 pCLE image mosaics (mean 5 per sample; range 2 to 10) were carefully compared with histology 
features from seventy-one samples. With slow and controlled hand-held movements of the pCLE 
miniprobe, it was possible to generate high quality mosaics to expand the field of view by up to eight 
times (approximately 2 mm) to create more representative and interpretable pCLE images. The final 
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histopathology diagnosis from these samples showed 38 invasive carcinoma, 12 DCIS and 21 non-
neoplastic tissues. No interference with H&E staining was noted in AH-stained samples.  
 
3.3.3 Correlation of pCLE image mosaics with histology (non-neoplastic) 
The nucleus of individual cells on pCLE image mosaics was visualized as fluorescent white dots. The 
glandular, fibrous and adipose tissues of normal breast tissues were discernible as shown in Figure 3.4   
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Figure 3.3 Each image depicts the morphological appearance on pCLE image (left panel) and the histology 
image of the corresponding sample (right panel). (A) A well-defined breast lobule with an aggregate of acini. 
Each acinar depicts a typical target-like appearance with dark-colored central lumen surrounded by a thin layer 
of homogenously lined fluorescent dots (nuclei of epithelium). (B) Fibrous connective tissue consisting of 
numerous fine, grey and linear strands of collagen fibers on a relatively acellular background. (C) Fibrous 
connective tissue with a mildly cellular stroma. Multiple small and discreet bright dots are seen scattered through 
the stroma. These represent the nuclei of individual fibroblasts. (D) Three adjacent dilated benign breast ducts 
are seen as larger-sized luminal structures with a thin layer of fluorescent dots. The lumen remained dark-
coloured as it is acellular. (E) Elastic fibers visualized as wavy, bright-colored strands which can give an 
impression of a haphazard architecture. However, the background tissue remains scantily cellular as depicted by 
the sparsely populated nuclei. (F) Adipose tissue with numerous fat cells depicted as dark-colored, polygonal-
shaped cells with thin well-defined bright borders. The nuclei of individual fat cells are visualized as distinct 
dots at its borders. 
 
3.3.4 Correlation of pCLE image mosaics with histology (neoplastic) 
In contrast, the breast ducts on ductal carcinoma in situ samples were visualized as markedly distended 
structures with hypercellular fluorescent dotted lumens. Invasive carcinoma had a distinctive 
appearance with increased cellularity and haphazard architecture characterized by hyperfluorescent 
infiltrating nests, sheets or files of tumor cells. In addition, pathognomic changes such as desmoplastic 
reaction and elastosis were noted in the adjacent stroma. Histopathological analysis of corresponding 
sample specimens from the same areas showed similar morphological architecture as highlighted in 
Figure 3.5. 
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Figure 3.4 Each image comprise of a pCLE image (left panel) and a histology image (right panel) of the 
corresponding sample. (A) Ductal carcinoma in situ: The epithelial lining of this duct appears markedly 
thickened and the luminal border of the epithelium is seen to be encroaching into the lumen. The entire duct 
appears markedly thickened and distended. (B) Invasive ductal carcinoma: Multiple irregularly organized 
clusters of fluorescent dots are seen infiltrating the stroma giving rise to a haphazard and disorganized 
appearance. Instead of the small and discreet bright dots of fibroblast nuclei, these clusters are larger in size and 
contain multiple fluorescent dots. A dense fibrous tissue response known as “desmoplastic reaction” is seen 
adjacent to these infiltrates producing a scirrhous-like appearance. (C) Invasive ductal carcinoma: Broad sheet of 
densely packed tumour cells. (D) Ductal carcinoma in situ: The lumen of the duct is occupied by an island filled 
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with multiple fluorescent dots. (E) Invasive ductal carcinoma: another example of multiple clusters of tumour 
cells with stromal infiltration. (F) Invasive lobular carcinoma: Tumour cells are observed to be loosely dispersed 
in single linear rows. These are known as Indian file pattern, a pathognomic sign of classical type invasive 
lobular carcinoma. (G) Metaplastic carcinoma with spindle-cell morphology: A relatively rare variant of invasive 
carcinoma with tumour cells seen here as adopting a spindle/comma shaped appearance. (H) Invasive tubular 
carcinoma: Tumour cells producing a ‘target cell’ appearance in the midst of a markedly hypercellular and 
elastotic background.  
 
 
3.3.5 pCLE classification for breast morphology  
Due to the technical differences of pCLE imaging compared with H&E histology (monochromatic 
images, smaller field of view), a unique pCLE classification system was developed which graduates 
neoplastic and non-neoplastic changes in three morphological entities (glandular, fibrous connective 
tissue and adipocytes) as shown in Figure 3.5. Utilizing our experience with pCLE imaging and breast 
histology, we postulated that the presence of residual deposits of carcinomatous foci on the edges of 
cavity walls could potentially be identified based on the presence of luminal or stromal 
hypercellularity, haphazard clustering of cells and loss of meaningful architecture.    
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Figure 3.5 New pCLE classification for neoplastic and non-neoplastic breast morphology with 
adjoining magnified views of image mosaics for visual comparison   
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3.3.6 pCLE image interpretation assessment 
A total of 850 pCLE image interpretations were made by nine pathologists and eight surgeons (Table 
1). When neoplastic pCLE morphological architecture was defined according to the combined changes 
to the glandular and stromal connective tissues as outlined in our classification, carcinomatous 
changes on pCLE image mosaics were predicted by pathologists with a sensitivity, specificity, PPV, 
NPV and accuracy of 96% (range, 88–100%), 92% (range, 84–100%), 90% (range, 69–98%), 100% 
(range, 71–100%) and 94% (range, 90–100%), respectively. Surgeons achieved a mean sensitivity of 
97% (range 92-100%), a specificity of 86% (range, 68-96%), a PPV of 88% (range, 76–96%), an NPV 
of 97% (range, 92-100%) and accuracy of 92% (range 84-98%) (Table 3.1). The mean inter-observer 
agreement for pathologists was ‘almost perfect’, κ=0.82 (95%CI, 0.79-0.85); and ‘substantial’ for 
surgeons, κ=0.74 (95%CI, 0.70-0.78). 
 
Histology 
diagnosis 
pCLE diagnosis 
Pathologists Surgeons 
Neoplastic Non-neoplastic Total Neoplastic Non-neoplastic Total 
Neoplastic 217 8 225 195 5 200 
Non-neoplastic 17 208 225 28 172 200 
Total 234 216  223 177  
 
Table 3.1. Correlation between pCLE image interpretation and gold standard histology.  
 
The overall and participant-specific accuracy for pCLE images 1 to 10, 11-20, 21-30, 31-40 and 41-50 
are shown in Table 3.2. The accuracy for pathologists was 94% (range 80-100%) for the first 10 pCLE 
images, followed by 96% (range 80-100%), 97% (90-100%), 97% (range 80-100%) and 89% (80-
100%) in their respective image groups. Surgeons achieved accuracy rates of 86% (range 79-100%), 
93% (80-100%), 96% (range 80-100%), 95% (90-100%) and 90% (70-100%) in the similar 
corresponding groups. When defining an acceptable accuracy rate of 90%, there were only 5 
participants (63%) with an acceptable accuracy for the first 10 pCLE images, 6 participants (75%) for 
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the second 10, 7 participants (88%) for the third 10, 8 participants (100%) for the fourth and six 
participants (75%) for the final group. 
 
Pathologists 
 
Participant 
pCLE images 
1-10 11-20 21-30 31-40 41-50 
1 10/10 8/10 10/10 8/10 9/10 
2 10/10 10/10 10/10 10/10 9/10 
3 9/10 9/10 9/10 10/10 8/10 
4 10/10 10/10 10/10 10/10 10/10 
5 9/10 10/10 10/10 9/10 9/10 
6 10/10 9/10 9/10 10/10 9/10 
7 8/10 10/10 10/10 10/10 8/10 
8 10/10 10/10 10/10 10/10 8/10 
9 9/10 10/10 9/10 10/10 10/10 
Overall accuracy 85/90 (94%) 86/90 (96%) 87/90 (97%) 87/90 (97%) 80/90 (89%) 
No. (%) neoplastic 3/10 (30%) 5/10 (50%) 5/10 (50%) 6/10 (60%) 6/10 (60%) 
Surgeons 
 
Participant 
pCLE images 
1-10 11-20 21-30 31-40 41-50 
1 9/10 10/10 10/10 10/10 10/10 
2 7/10 8/10 8/10 9/10 10/10 
3 9/10 8/10 10/10 10/10 9/10 
4 8/10 9/10 10/10 9/10 10/10 
5 9/10 10/10 10/10 10/10 9/10 
6 8/10 10/10 9/10 10/10 8/10 
7 10/10 9/10 10/10 9/10 9/10 
8 9/10 9/10 10/10 9/10 7/10 
Overall accuracy 69/80 (86%) 73/80 (93%) 77/80 (96%) 76/80 (95%) 72/80 (90%) 
No. (%) neoplastic 3/10 (30%) 5/10 (50%) 5/10 (50%) 6/10 (60%) 6/10 (60%) 
 
Table 3.2. Accuracy in pCLE images 1 to 10, 11 to 20, 21 to 30, 31 to 40, and 41 to 50 for each observer and 
overall. 
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3.4 Discussion 
 
pCLE is an emerging imaging tool that enables real-time high resolution in situ subsurface imaging of 
tissue morphology. Whilst this technique has found promising endoscopic applications (29, 35, 90, 
163), the ability to discriminate neoplastic from non-neoplastic breast morphology towards 
intraoperative in situ applications has yet to be systematically evaluated. This study is understood to be 
the first to report on the use of pCLE to facilitate prediction of breast cancer pathology on freshly 
excised specimens. By utilizing topical AH as a fluorescent agent and directly correlating pCLE 
images with the corresponding histology slides, common morphological architecture of glandular, 
fibrous and adipose tissue of normal human breast; and morphological changes that occur in the 
presence of carcinoma are readily identifiable on pCLE image mosaics.  
 
3.4.1 Understanding pCLE breast morphology 
Consistent with previous literature, AH crosses the cell membrane and displays a strong specificity for 
labeling acidic constituents (28, 29, 164, 165). It predominantly stains the nuclei of cells and has also 
been shown to demonstrate some staining specificity for collagen and elastin. Whilst AH is by 
definition a non-specific exogenous fluorescent agent, this study has shown that its relative affinity to 
these intra-cellular and tissue constituents has enabled sufficient delineation of breast morphological 
architecture to be made. For example, the presence of well-defined, individual fluorescent dots 
surrounding hollow dark lumens allows glandular structures to be easily distinguished from dark-
coloured adipocytes, which have homogenously fluorescent and thin hexagonal borders. Similarly, the 
linear and branching strands of collagen and elastic fibres are readily identified as structural 
constituents of normal fibrous connective tissue.  
 
By understanding common morphological changes that occur in carcinomatous disease using 
conventional histology, we were able to deduce the appearances of changes on respective pCLE image 
mosaics. In DCIS, the lumen of glandular structures are seen to be populated with hyperfluorescent 
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dots and form aggregates of islands, solid nests or thickened encroaching epithelium within a well-
defined, distended glandular structure. Invasive diseases share common morphological patterns 
comprising architectures that appear markedly hypercellular and haphazard. The lack of any obvious 
principal organization is caused by the arbitrary passage of tumor cells through the stroma and these 
often evoke a dense fibrous tissue response which gives rise to a distinctive scirrhous-like 
morphological appearance on pCLE images. These stromal infiltrations exhibit a variety of 
morphological patterns on pCLE image mosaics i.e., nests, cords, clusters, solid sheet or linear files of 
hyperfluorescent tumor cells. The latter is commonly seen in invasive lobular carcinoma as its tumor 
cells are often found loosely dispersed in the stroma. Whilst these features are readily identified, it is 
important to note that distinguishing specific histological types of invasive disease such as invasive 
lobular from invasive ductal carcinoma on pCLE image mosaics alone is not possible as both 
frequently have overlapping morphological characteristics and thus require additional stains (e.g. E-
Cadherin) on routine histology to establish definitive diagnosis. Furthermore, the importance of 
distinguishing between these two entities intra-operatively might be called into question given that the 
identification on cavity walls of either of these malignant pathologies mandates further excision. 
 
3.4.2 pCLE breast classification  
Whilst the new pCLE classification provided a structured and uniformed approach in pCLE image 
interpretation, it is important to note that considerable amount of work is still required to refine the 
objectivity of the diagnostic criteria. For example, we have yet to establish the predictive value of 
neoplasia for the presence or absence of specific morphological features outlined in each of the tissue 
components described in the classification. Consequently, one could argue that it is essentially a 
loosely defined and subjective classification, and that its effectiveness is highly operator dependent.  
 
Having said that, most pCLE classifications on other clinical applications (GI tract, lung, urinary tract 
and biliary tree) (27, 37, 39, 51) were developed through consensus decision-making of expert pCLE 
users and a relative degree of subjectivity was deliberately allowed to avoid the pitfalls of the 
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inordinately objective approach. For example, the presence of goblet cells visualised on pCLE 
imaging of the large bowel is one of the features described for normal mucosa (37). However, its 
absence does not necessarily confer presence of neoplasia. Similarly, the absence of round-shaped and 
well-defined crypts do not necessarily indicate presence of adenomatous changes because hyperplastic 
changes can also produce slit-like crypt appearances (37). The relative subjectivity conferred by these 
classifications has yielded high predictive values and accuracies when it is used in clinical practice. 
Based on these observations, our proposed breast pCLE classification might have provided much of 
the basic criteria needed for interpretation but further efforts to evaluate the impact of refining the 
criteria should be carried out given the novelty of the intended clinical application. 
 
3.4.2 pCLE image interpretation – a surgical armamentarium? 
The clinical usefulness of morphological architecture visualized on pCLE image mosaics is largely 
dependent on the ability of its user i.e., the operating surgeon, to interpret these images in real-time 
during surgery. Previous studies in the gastrointestinal tract demonstrated that the prediction of 
neoplasia and non-neoplastic lesions based on pCLE imaging has a relatively high diagnostic accuracy 
(28, 35, 36) compared with histological analysis and clinicians were able to learn to recognize pCLE 
morphological features with a short learning curve (143). In this study, we have demonstrated that 
pCLE images of breast morphology can be learned rapidly by both groups of histopathologists and 
surgeons with a short training session that consists of offline exposure to a range of pCLE images and 
their corresponding histology slides. Both groups of clinicians were able to distinguish neoplastic from 
non-neoplastic pCLE breast morphology with an overall accuracy that exceeds 90% and of the 50 
pCLE image mosaics interpreted, the proportion of pCLE images correctly interpreted was noted to be 
stable throughout five consecutive image cohorts.  
 
During image interpretation, we observed that surgeons tend to err on the side of caution when 
encountered with equivocal non-neoplastic pCLE images and opted for a diagnosis of neoplasia. This 
may in part be due to the inherent anxiety of inadvertently leaving neoplastic tissues behind, a 
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common clinical dilemma faced by surgeons. Unsurprisingly, this is reflected in the slightly lower 
specificity and PPV attained by surgeons. Alternatively, the lack of familiarity with assessment of 
microscopic images may be contributory but we envisage that increasing experience and tailored 
training may improve accuracy. Whilst intra-operative assessment of margins using conventional 
frozen section or touch imprint cytology has been described (166-169), these approaches add on 
average 20-30 minutes to the operating time, lengthen time under anaesthesia and reduce operating 
theatre productivity (158). Indeed, the pressure on pathology services has grown steadily over the 
years and arguably reached a stage where these methods are arguably no longer practical. In our 
opinion, it is imperative that the breast surgeon be able to use and interpret pCLE images reliably 
without having to depend on the pathologist to do so in the operating theatre.  
 
It is important to note that the inter-observer reproducibilities of conventional histopathological 
systems of breast cancer classification have historically yielded lower values [5]. In our feasibility 
study, we have shown that both surgeons and pathologists were able to attain high accuracies (>90%) 
and excellent interobserver agreements during pCLE image interpretation assessments. Whilst these 
results are highly promising, it must be stressed that image interpretation assessments were carried out 
based on high quality static pCLE image mosaics that clearly depicted a specific tissue entity. 
Additionally, these pCLE assessments were carried out in calm and controlled examination format. 
The combination of high quality and unambiguous pCLE images, facilitated with a relatively stress-
free environment, had unsurprisingly facilitated an overall superior performance from the participants 
in this study. This raised questions as to whether these results could be reproducible in the presence of 
time-constraint, movement artefacts and multi-tasking pressures in a busy operating theatre. Evidently, 
the impact of these factors must be systematically evaluated so that any reduction in the overall 
accuracies or interobserver agreements are subjected to rigorous evaluation to identify whether 
surgical ergonomics or pathological description (e.g. inconspicuous morphological features of pCLE 
pattern recognition that were insufficiently addressed), or both, could be the perpetuating factor. Given 
that breast pathology is uniquely complex even with conventional histology, the assessments of 
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various critical pathognomic features on a monochromic background with limited field of view 
warrants careful evaluation. 
 
3.4.3 Going beyond the endoluminal tract 
Previous studies using benchtop confocal reflectance (9) and rigid confocal fluorescence microscopes 
(170) have reported that histological architecture of breast core biopsies and excision specimens 
respectively could be visualized in real-time. Whilst these microscopes may have a role for imaging 
resection margins of excised specimens, in situ imaging of cavity walls during surgery warrants 
significant miniaturization to enable insertion through a small 3-4 cm skin incision and for deployment 
against the lateral walls of the breast cavity. The hand-held fiber-bundle pCLE probe used in this study 
is 2.5 mm in diameter, light and flexible throughout its length with the exception of the distal 10 mm 
rigid tip which aids stable abutment of probe against the tissue surface.  
 
We postulate that it would be ergonomically possible to deploy and orientate the distal tip of the pCLE 
probe perpendicular to the surface of the cavity walls for localized assessments guided by the 
intraoperative findings and as such the benefits of miniaturization for initial endoscopically-driven 
applications could potentially be extrapolated to applications outwith the confines of the endoluminal 
tract.  
 
3.4.4 Envisaged optical requirements 
Whilst miniaturization is essential for physical deployment, the optical properties of pCLE need to be 
equally optimized to provide adequate resolution and magnification for accurate differentiation of 
neoplastic from non-neoplastic tissues to be performed. Currently, pCLE image mosaics are generated 
with a lateral resolution of 1.0 µm. Based on the results of this study, we have established that this 
provided sufficient clarity to visualize common glandular and stromal characteristics of both 
neoplastic and non-neoplastic morphology.  
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Unlike conventional histology where images are magnified by switching between low and high power 
objectives, pCLE image frames are obtained under high power magnification with a limited field of 
view (240 x 240 µm). This renders image mosaicing an integral step to increase the field of view and 
to ensure representative pCLE images are obtained. This warrants slow and minute movements of the 
pCLE probe tip against the tissue surface and could potentially be time-consuming if extensive 
mosaics are to be created. A low power magnification probe may provide a wider field of view and 
potentially reduce the reliance on mosaicing. However, this may trade-off the clarity required to 
distinguish normal breast lobules from DCIS where small, well-defined epithelial-lined acini of a 
normal lobule could potentially be mistaken as constituents of a hypercellular lumen of DCIS on 
pCLE image mosaics. Similarly, adequate magnification is essential to facilitate differentiation of 
loosely dispersed tumor cells from non-diseased fibroblast nuclei.  
 
Future work to ascertain the appropriate balance between magnification and field of view is required 
in order to optimize the economy of movement for intraoperative cavity assessment whilst minimizing 
the impact on pCLE image interpretability. Additionally, devising a pCLE probe movement pathway 
to facilitate time-optimized assessment of cavity walls may be required to prevent surgeons’ fatigue 
from excessive probe micromanipulations and this may require collaborative efforts from the 
integration of robotic technology with pCLE to provide a unique solution(95, 96).  
 
3.4.5 Acute inflammatory response  
It is equally important to note that much of the clinical value of an ergonomically optimized pCLE 
imaging platform depend on various biological factors that could potentially confound the cellular 
composition of tissue morphology. Evidently, pCLE image acquisition of excised tissues may depict 
the dynamic morphological changes seen in acute inflammatory response. Tissue trauma as a result of 
thermal injury from intraoperative diathermy is a stimulus for acute inflammatory response which 
leads to alterations in vascular caliber that causes an increase in blood flow, structural changes in the 
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microvasculature that permit plasma proteins and leukocytes to emigrate from the circulation and 
accumulate at the focus of injury (edges of the cavity walls).  
 
The hallmark of the latter (cellular) phase is the aggregation of granulocytes, particular neutrophils on 
the margins of the cavity wall and this could potentially mimic neoplastic changes on pCLE image 
mosaics. However, this response takes place over a few hours as the leukocytes need to first undergo 
the process of margination and diapedesis before accumulating at the site of trauma, most typically 
during the first 6 to 24 hours. Given the estimated time to perform BCS is approximately  15-20 
minutes from skin incision to tumor excision and that pCLE imaging of cavity walls is envisaged to be 
performed immediately after excision, it is unlikely that accumulation of leukocytes at the edge of the 
cavity wall will significantly influence assessment.   
 
3.4.6 Benign breast conditions 
It should be noted that there are benign breast conditions that could potentially mimic the 
morphological appearances of neoplastic diseases during pCLE imaging. For example, distinguishing 
benign conditions such as ductal hyperplasia of usual type and atypical ductal hyperplasia (ADH), 
from DCIS on pCLE image mosaics alone may be challenging as it may not provide adequate 
information on cytology, architecture and lesion size for accurate differentiation to be performed. 
Ductal hyperplasia of usual type does not require excision and findings of such could potentially lead 
to over exuberant resection should this be misinterpreted as DCIS. Potential false positives arising 
from this scenario require careful evaluation in the context of number needed to treat during larger 
intraoperative in situ studies.  
 
Whilst findings of ADH on core biopsy warrants excision, there is insufficient evidence as to whether 
further excision is required when it is found on the margin of excised specimen. This is a controversial 
pathological diagnosis subject to large inter-observer variability and is beyond the scope of this paper. 
Nevertheless, it has been suggested that further excision of ADH at the surgical margin is considered 
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reasonable especially in the context resection for  DCIS and therefore distinguishing between the two 
on pCLE images may not be critical. It remains to be stressed that the intended application of pCLE is 
not to substitute conventional histology, but rather as an intraoperative adjunct to facilitate detection of 
residual disease that are often occult and inconspicuously left behind at the time of surgery.  
 
 
3.5 Conclusion 
pCLE imaging of tissue morphology has emerged as a highly promising imaging tool in cancer 
research, offering real-time, non-invasive, in situ differentiation of tissues. Until now, pCLE 
technology has not been evaluated for use towards margin assessment of cavity walls in BCS. We 
have demonstrated the ability of pCLE to image morphology of neoplastic and non-neoplastic breast 
tissues and that clinicians are able to learn to differentiate these images. The findings presented here 
are promising and require validation in an in situ study with a sufficiently large cohort of patients.  
 
We anticipate the clinical impact of pCLE to be the ability to identify the presence or confirm the 
absence of residual cancerous foci intraoperatively, thereby guiding operative decision-making during 
breast conserving surgery based on real-time in situ cavity scanning. In addition, our results provide a 
basis to develop an in-house pCLE system that addresses potential intraoperative challenges and to 
this end, further work is planned to improve the optical platform and mechatronic configurations to 
improve the field of view, image quality and consistency. 
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Chapter 4: Evaluation of Fluorescein-stained 
Breast Morphology on pCLE Images 
4.1 Introduction 
4.1.1 Overview 
The findings from the previous chapter demonstrated that morphological features of neoplastic and 
non-neoplastic breast tissues were readily visualized and distinguished when acriflavine hydrochloride 
(AH) was used as the topical fluorescent agent. The nuclear-staining characteristics of AH has 
provided a distinct advantage by allowing definitive assessment of tissue cellularity to be carried out. 
Whilst this provided useful information pertaining to the presence of neoplasia, little is known about 
the morphological architecture of stromal component of neoplastic tissues. The presence of 
desmoplastic reaction, a fibrous tissue response to tumor cell infiltrations(171), was predicted based 
on the direction and organization of the thin streaks of tumor cells. Evidently, the morphological 
characteristics of adjacent tumor-induced fibrosis could not be clearly delineated. Whilst its affinity to 
fibrous connective tissues of non-neoplastic specimens was clearly elucidated, similar findings could 
not be deduced on that of neoplastic tissues despite the obvious presence of pathological fibrosis.  
 
Intravenous fluorescein sodium (FS) is one of the few non-specific fluorescent agents that are 
compatible for use with pCLE imaging. Due to its partial binding to albumin, a small proportion of FS 
leaks into the surrounding parenchyma. Combined with its prominent vasculature, morphological 
architecture of FS-stained colonic crypts, gastric pits and gap junctions of gastrointestinal mucosa   
were readily delineated on pCLE images (172). Additionally, characteristic features of neoplastic 
changes of the corresponding tissues were distinguishable and agreed upon in several internationally 
developed classifications (55, 172). However, its ability to stain fibrous connective tissues – a key 
component of the breast stroma that consists of fibroblasts, collagen fibres, elastic fibres and ground 
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substance, has yet to be elucidated. Previous studies utilizing a rigid confocal microscope probe 
(Optiscan
©
) have shown that fibrous tissues of the bowel mesentery were visualized and 
distinguishable from adipocytes (173). More recently, the fibrous component pancreatic cysts were 
also described on pCLE images as thin sheets of fluorescent fibres (68).  
 
4.1.2 Hypothesis 
 Our hypothesis is that the use of intravenous FS could further improve delineation of the stromal 
component of neoplastic tissues. Equipped with that knowledge, differentiation between pathological 
fibrosis and normal fibrous tissues would be possible and that the use of AF as a topical fluorescent 
agent would serve as an adjunct to confirm the presence of neoplasia on pCLE images. By 
accentuating multiple tissue constituents, we hypothesis that higher quality and longer mosaics would 
be created given that pCLE’s ability to construct mosaics is partly dependent on the amount of 
morphological information captured in the preceding image frame. 
 
4.1.3 Study design rationale 
However prior to assessing its potential to guide intraoperative decision-making, it is important to first 
ascertain the morphological appearances of FS-stained tissues using conventional histology as the gold 
standard for comparison. To achieve this, the pCLE miniprobe needs to be deployed against the 
surface of a freshly sectioned tumor for image acquisition. For the purposes of this study, it is an 
onerous task to achieve as tumor deposits are often conspicuous. This may be ethically challenged as 
multiple tissue biopsies of the cavity walls might need to be performed to ascertain the pathologies of 
sites imaged. Whilst one could argue that the surgeon could potentially expose the tumor by 
diathermising through it in situ, this carries the risks of margin disruption and could potentially seed 
tumor cells in the cavity. In light of all these challenges, we decided that the best course of action 
would be for intravenous FS to be given shortly before exteriorization of the tumor is complete and 
pCLE image acquisition is carried out immediately as per protocol described in the previous chapter. 
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4.1.4 Study aims  
The primary aim of this study is to establish the effect intravenous FS had on visualization of the 
stromal component of neoplastic (tumor) and non-neoplastic (non-tumor) breast tissues. The 
secondary aim is to ascertain whether provision of FS increased the lengths of pCLE image mosaics 
constructed as compared to that of AH-stained tissues.  
 
4.2 Methods 
4.2.1 Patients 
In this prospective, cross-sectional, observational study, 10 patients who were at least 18 years of age 
and who underwent breast conserving surgery i.e., wide local excision (WLE) for biopsy confirmed 
breast cancer at a tertiary breast unit (Imperial Breast Unit, Charing Cross Hospital, Imperial College 
Healthcare NHS Trust, London, United Kingdom) were recruited in this study. Each patient signed 
full informed consent prior to their surgery, which was approved by the institutional review board 
(West London REC 13/LO/1507).  Patients who were pregnant, breast feeding, impaired renal 
function or had documented allergy to fluorescein were excluded from this study.  
 
4.2.2 Intravenous fluorescein  
All patients received between 1.5ml to 3.5ml of intravenous bolus of 10% fluorescein sodium (FS) 
(Martindale Pharmaceuticals, Romford, UK) in the operating theatre following induction of general 
anaesthesia. The timing of intravenous FS administration was scheduled to approximate the 
predetermined duration of intravascular dissemination prior to specimen exteriorization. The time of 
fluorescein injection, breast skin incision and specimen exteriorization was calculated to the nearest 
minute.  
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4.2.3 Specimen handling 
Freshly excised WLE specimens were transported to the histopathology lab for immediate inspection 
by two experienced breast histopathologists (S.S., K.L.). All specimens had its margins inked and 
vertically sectioned to generate 3-5 mm thick slices. Specimen radiography was performed on all 
slices with the appropriate orientation preserved. Each slice was carefully examined to ascertain the 
location of the tumor while guided by findings on specimen radiography (Figure 4.1). Small cut-outs 
measuring 10 x 10 mm across were obtained each from the tumor and fibrofatty tissues distant from 
the tumor. Where cut-outs were judged not feasible to perform due to technical difficulties (small 
tumor size, impalpable or indistinct tumor) or risk of margin interference, the tumor was imaged in 
situ and digitally photographed thereafter to facilitate correlation with histology.  
 
 
Figure 4.1 Freshly excised fluorescein-stained wide local excision (WLE) breast specimen with the surrounding 
margins inked. (A) Tumor site (shown between the forceps) identified during vertical sectioning. (B) Small cut-
out containing the tumor for pCLE imaging. (C) Small WLE specimen with tumor approximating the margins. 
The tumor was imaged in situ as cut-outs might interfere with subsequent margin assessment.        
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4.2.4 Image acquisition and equipment 
All cut-outs were imaged using a 488-nm wavelength laser probe-based confocal laser 
endomicroscopy (pCLE) system (Cellvizio, Mauna Kea Technologies, Paris, France) with a 2.5mm 
diameter, hand-held, confocal miniprobe (UltraMiniO, Mauna Kea Technologies, Paris, France) 
deployed perpendicular to the surface of the tumor. The equipment specifications are similar to those 
described in Chapter 2 of this thesis. The first set of image acquisition sessions were performed on the 
FS-stained tumor and fibrofatty cut-outs for up to five minutes each. These cut-outs were then 
subjected to further staining with 0.01% AH solutions for approximately 60 seconds and gently rinsed 
with phosphate buffer solution (PBS) to remove the excess fluorescence. A second set of pCLE 
imaging sessions were carried out on the previously imaged tumor and fibrofatty sites to facilitate 
comparison of FS-stained cut-outs with that of FS and AH-stained.   
 
4.2.5 Correlation with histology 
Each specimen cut-out was placed in individually labelled cassettes and returned for routine 
histopathology processing. Post-hoc evaluation of all pCLE images were carried out with the 
assistance of two experienced breast histopathologists (S.S., R.R.) using the corresponding histology 
slides as the gold standard for comparison. Both histopathologists had previous experience on 
interpretation of AH-stained pCLE images described in the previous chapter. The key features on FS-
stained pCLE images thought to be predictive of morphological constituents of conventional histology 
were reviewed and agreed upon by consensus.    
 
4.2.6 Evaluation of pCLE mosaic length 
To evaluate the effects of FS and AH staining on pCLE mosaic construction, the top three longest 
combined FS and AH-stained mosaics from each patient in this study were retrieved. A randomised, 
single blinded selection from 10 patients with invasive carcinoma from the AH-stained tissue database 
used in the previous chapter was carried out and the top three longest AH-stained mosaics from each 
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patient were retrieved for comparison. The longest mosaic was defined as the longest length extending 
along the longitudinal axis of the image mosaic (Figure 4.2).  
  
 
Figure 4.2 Length of image mosaic was calculated along the centre-point in the longitudinal axis as depicted by 
the yellow dotted lines.  
 
4.2.7 Statistical analysis 
The inter-observer agreement was defined as the percentage of full agreement among the surgeons and 
by an overall kappa statistic with 95% confidence interval (CI). The interpretation of kappa values was 
performed according to Landis and Koch classification. Continuous variables were presented as mean 
and standard deviation (SD). Comparison of pCLE mosaic lengths between both groups of staining 
were performed using two-sample t-test. The statistical analysis was performed using the SPSS 22.0 
software (SPSS, Chicago, USA). 
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4.3 Results 
4.3.1 Baseline characteristics 
All patients were female with a median age of 57 years (range, 48 to 84 years). None of the patients 
experienced any adverse reaction to FS, with the exception of transient yellow discoloration of the 
urine, which resolved within 24 hours after the operation. The median times between FS injection and 
breast skin incision and exteriorization of WLE specimens were 3 minutes (range, 2 to 25 minutes) 
and 18 minutes (range, 11 to 73 minutes), respectively. The median dose of FS injection in absolute 
volume was 1.5 ml (range, 1.0ml to 2.5ml). When this was calculated according to volume per 
kilogram, the median dose was 0.02 ml/kg (range 0.01-0.04 ml/kg). (Table 4.1)  
 
 
FS, Fluorescein sodium; eGFR, Estimated glomerular filtration rate; Inj-Inc, Injection to skin incision time; Inj-
Ext, Injection to Exteriorization; IDC, Invasive ductal carcinoma; ILC, Invasive lobular carcinoma; DCIS, Ductal 
carcinoma in situ. 
Table 4.1 Baseline characteristics of patients undergoing BCS, intravenous FS dosage and circulation time.   
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4.3.2 Correlation with histology 
Figures 4.3, 4.4, 4.5 and 4.6 summarize the findings of pCLE mosaics acquired from FS-stained tumor 
samples and following topical staining with AH whereas Figure 4.7 depicts the appearances fibrous 
connective tissues and adipocytes of normal breast tissues with the aforementioned stains.   
 
 
Figure 4.3 pCLE images and corresponding histology of invasive ductal carcinoma. (A) pCLE mosaic acquired 
from FS-stained tumor sites demonstrated a markedly hyperfluorescent appearance. These findings were in line 
with the presence of dense fibrous tissue response on the corresponding site on histology slides. Within these 
hyperfluorescent regions, multiple haphazardly arranged shades of white opaque patches were discernible giving 
rise to a heterogeneous texture. Additionally, numerous stellate-shaped dark spaces were seen interspersing this 
region and are likely to represent the ground substance of the stroma. (B) Invasive ductal carcinoma on histology 
with desmoplastic reaction visible in the stroma. (C) pCLE mosaics following additional staining with topical 
AH, the characteristic clusters and streaks of infiltrating tumor cells were seen embedded on these heterogeneous 
shades with the adjacent dark stellate-shaped spaces preserved.  
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Figure 4.4 pCLE images of infiltrating tumor cells from an invasive ductal carcinoma specimen. (A) pCLE 
mosaic of heterogeneously fluorescent regions depicting areas of tumor-induced fibrosis; (B) Histology image of 
infiltrating tumor cells evoking a desmoplastic reaction in the stroma; (C) pCLE mosaics of the corresponding 
area with bands and clusters of tumor cells (yellow arrows) surrounded by tumor-induced opaque white fibrosis. 
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Figure 4.5 pCLE images of infiltrating tumor cells admixed with adipocytes. (A) FS-stained specimens 
depicting a heterogeneously appearing opaque stroma (yellow arrows) suggesting the presence of pathological 
fibrosis around aggregates of dark-colored adipocytes. (B) Histology of the corresponding site containing 
invasive ductal carcinoma. (C) Following topical staining with AH, clusters of tumor cells (yellow arrows) were 
seen embedded on the opaque stroma.   
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Figure 4.6 pCLE images of ductal carcinoma in situ (DCIS) (A-B) Histology images of low grade DCIS. (C) 
The distended ducts of DCIS are clearly evident on FS-stained tissues. There are opaque material within the 
lumen of these ducts which might represent the presence of comedonecrosis. (D) Hypercellular epithelium 
encroaching the lumen (yellow arrows) were discernible. The presence of nuclei on the edges of these dark oval 
shaped structures confirms the presence of glandular structures and not that of adipocytes.    
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Figure 4.7 pCLE images of the stromal component of normal breast tissues. (A-E) Following topical AH 
staining of FS-stained tissues, the borders of adipocytes are well delineated with nuclei visible on its edges. The 
fibrous tissues here appear relatively homogenously stained (yellow arrows) as compared to that of tumor-
induced fibrosis. The haphazard and whirl-like background seen on tumor stroma is absent. (F) pCLE mosaic of 
adipocytes on FS-stained tissues prior to AH application. 
 
 
The aforementioned morphological features seen on FS-stained tissues were readily visualized in nine 
patients who had their WLE specimens exteriorized between 11 to 47 minutes post-injection. One 
patient who had her specimen removed at 73 minutes post-injection had minimal fluorescence retained 
on both tumor and non-tumor sites. The dose of intravenous FS did not appear to have an effect on the 
overall tissue morphology.   
 
4.3.3 Length of pCLE mosaics 
The mean length (+ SD) of pCLE image mosaics for combined FS- and AH-stained neoplastic tissues 
was significantly longer than that of AS-stained (1.47 mm + 0. 47 vs 1.08 mm + 0.35; p= 0.001). 
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4.4 Discussion 
4.4.1 Pathological fibrosis 
To the best of our knowledge, this is the first study to describe the use of intravenous FS to visualise 
breast tissue morphology using pCLE. When injected intravenously, approximately 75-80% of the dye 
binds to plasma proteins such as albumin (28). The remaining unbound dye either remained 
intravascularly or diffused across the vessel wall to highlight the surrounding stromal tissues (28). It 
has been reported that fibrous connective tissues are readily visualised as fluorescent sheets of thin 
parallel lines on pCLE. However, its morphological appearance on fibrotic tissues induced by 
infiltrating tumor cells has yet to be ascertained.  
 
It is important to note that fibrous connective tissues and fibrosis are two distinct entities. The former 
consists of collagen fibres that are present physiologically in the stroma whereas the latter denotes the 
abnormal growth of fibrous tissues in response to a stimulus i.e. trauma or neoplasia (174). In invasive 
breast cancer, infiltrating tumor cells often evoke a dense fibrous tissue response in the surrounding 
stroma. This led to overproliferation of fibroblasts and increased formation of collagen fibres which 
served as a scaffold to facilitate further infiltration of tumor cells (174). Evidently, this chain of events 
resulted in fibrosis and thereby depicted on pCLE images as fluorescent regions with haphazardly 
arranged, amorphous-looking collagen fibres. 
 
4.4.2 Potential pitfalls of image interpretation 
However, several potential pitfalls were observed during pCLE image evaluations. Indeed our ability 
to distinguish them emanated from the fluorescence intensity created by collagen fibres. Evidently, 
these haphazardly arranged collagen fibres appear prominent when pathological fibrosis is present. 
Conversely, they appear less distinct in its absence, as depicted on pCLE images obtained from normal 
fibrous tissues. Several non-invasive tumours such low grade DCIS are relatively indolent and may 
not evoke fibrous tissue response (175). Consequently, the lack these stromal responses on pCLE 
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images does not equate to absence of tumorigenesis. Whilst the fluorescent regions appear relatively 
heterogeneous on invasive tumors, the same could not be extrapolated to that of non-invasive tumors. 
Clearly, the presence of residual disease cannot be ascertained purely on the basis of pathological 
fibrosis on pCLE images and that an additional staining method that allows assessment of tissue 
cellularity remains pivotal. 
 
4.4.3 Envisaged benefits of FS-staining 
This study confirmed that AH provided more critical information pertaining to visualization of 
neoplastic diseases as compared to FS staining. Nevertheless, the presence of FS-stained stroma did 
not perturb the clarity of nuclei highlighted by AH. The combination did not result in excess 
fluorescence retained and their respective tissue staining affinities appeared to complement each other. 
The morphological features depicted by AH-stained tumor cells in this study were consistent with that 
of the previous chapter. Despite the lack of pivotal information, the FS-stained background conferred a 
halo effect which was congruent with the direction and pattern of tumor cell infiltration.  
 
Collectively, the wealth of morphological features depicted by both stains facilitated the creation of 
longer pCLE mosaics. Given that AH confers superficial staining of tissues, changes to the depth of 
imaging that occur as a result of tissue deformation from miniprobe movements would inevitably 
impede further expansion of mosaics. When FS is added to the background stroma, the stain 
uniformity it imparts to all tissue layers allow mosaics to be further expanded when AH-stained layers 
intermittently fail to coincide with the optical slice imaged at the respective depth.  
 
As mentioned in the previous chapter, the creation of expansive mosaics is envisaged to provide a 
distinct advantage in breast cavity wall scanning applications. Evidently, large scale coverage of tissue 
surface area could potentially be carried out in a time efficient manner without having to recommence 
orchestration of pCLE miniprobe movements whenever the preceding mosaic was prematurely halted. 
Given that the aim is to rule out the presence of residual deposits of tumor cells, it is evident that a 
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thorough coverage is required to reliably ascertain the local oncological status. The construction of 
multiple short mosaics poses the risk of inadvertently missing out on tumor cells that exist in the gaps 
between adjoining mosaics. Furthermore, definitive analysis of mosaics warrants clear and complete 
representations of any features deemed suspicious to the surgeon – a task that is difficult to achieve 
from short mosaics where partial or obscured views were often acquired.  
 
4.4.4 FS-staining in the algorithm of cavity scanning 
The concurrent administration of intravenous FS and topical AH has yet to be used in patients. Given 
the potential advantages in pCLE mosaic orchestration and the magnitude of the clinical problem 
addressed, further validation of its role for pCLE in situ detection of residual disease is clinically 
warranted. The timing and duration of FS staining do not appear to be a rate-limiting factor as the 
staining characteristics it confer is projected in the stroma within five minutes and remained so up to 
an hour post-injection without the need for additional doses. The envisaged application of intravenous 
FS in relation to pCLE imaging and topical application of AH is summarised in Figure 4.8.  
 
It is anticipated that intravenous FS is administered after WLE specimen is exteriorized and 
haemostasis is achieved. The latter is critical to minimize coating of tissue surface with FS-containing 
blood. Whilst a small amount of dried blood is negligible, excessive oozing could potentially impede 
visualization of tissue morphology due to overfluorescence. The cavity wall that corresponds to 
suspicious findings on specimen inspection / radiography is then targeted for topical application of AH 
and pCLE imaging. Our experience dictates that one must be cognizant of the potential non-uniformity 
in the level of staining conferred by topical fluorescent agents. Where FS-stained fluorescent regions 
were judged to be heterogeneous, further application of AH solutions might be warranted to fully 
ascertain its degree of cellularity.     
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Figure 4.8 The proposed algorithm for intravenous FS during preparation for pCLE cavity scanning  
 
 
4.4.5 Study limitations 
There are several limitations to this study. Firstly, it is performed on freshly excised and smoothly 
sectioned tumor specimens with post-hoc image evaluations performed in a controlled environment. It 
therefore does not take into account the challenges associated with intraoperative probe deployment, 
FS-containing haemorrhage and tissue surface irregularity. Secondly, this is a feasibility study on 
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small sample sizes which did not include non-invasive breast carcinomas such as DCIS. To this end, 
efforts to include mastectomy specimens with these tumor types are currently underway.     
 
4.4.6 Conclusion 
This study has shown that the morphological architecture of neoplastic and non-neoplastic breast 
stromal tissues were readily visualised when FS was used as the fluorescent agent. The presence of 
pathological fibrosis and its associated fibroblasts depicted a markedly heterogeneous appearance that 
comprise of haphazardly arranged fluorescent fibres. When combined with topical AH, infiltrating 
tumor cells were seen embedded on these heterogeneous regions. The creation of expansive pCLE 
mosaics was attributable to the full thickness staining that FS conferred. Intravenous FS might have 
role in facilitating identification of residual deposits of tumor cells and its combination with topical 
AH warrants intraoperative in situ breast cavity evaluation.  
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Chapter 5: Evaluation of Acriflavine-stained 
Parathyroid and Non-parathyroid Morphology 
on pCLE Images 
 
5.1 Introduction 
5.1.1 Minimally invasive parathyroidectomy 
Surgery is the only definitive cure of primary hyperparathyroidism. A four gland parathyroid 
exploration has been for several decades the gold standard surgical treatment (176). However 
advances in preoperative localization imaging modalities such as high resolution ultrasound (US), 
sestamibi scintigraphy (SS) and increasingly 4D CT have allowed surgeons to identify patients who 
are suitable for a more focused, minimally invasive approach (176). Positive preoperative localization 
tests in patients with primary hyperparathyroidism mean that these patients can be offered targeted 
surgical cure without the need for more extensive surgical dissection and the associated additional 
risks (including the damage of normal PG), increase in operative time and poorer cosmesis (176).  
 
5.1.2 Challenges with inconclusive localization tests 
However, both US and SS are imperfect with sensitivity rates of detecting parathyroid adenomas 
ranged between 51 to 96% and 34 to 100%, respectively (122, 123), and both their sensitivities 
decrease further in the presence of multiglandular disease (MGD) (124, 125).Negative localization 
necessitates a bilateral neck exploration. Intraoperative identification of parathyroid disease in such 
circumstances is more challenging as the likelihood of MGD with parathyroid hyperplasia and even 
ectopic gland location is much higher (177). The appearances of tiny superficial nodules on the surface 
of a multinodular thyroid gland, adjacent ‘brown’ fat and small lymph nodes can often mimic the 
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appearances of a small parathyroid adenoma or a suppressed normal parathyroid gland. These 
challenges are equally pertinent to bilateral neck exploration for tertiary (renal) hyperparathyroidism 
and evidently more conspicuous in reoperative parathyroidectomy where accurate preoperative 
localization and visual discrimination of parathyroid tissues in obscured dissection planes are onerous 
to achieve (178).  
 
Whilst ioPTH provides confirmation of the removal of the solitary parathyroid adenoma (179), it is 
less reliable in predicting the presence of MGD. Initial studies have shown that the use of ioPTH in 
MIP for primary hyperparathyroidism improved cure rates in patients with MGD (180, 181). However, 
other studies have reported that despite concordant preoperative localization scans and an appropriate 
PTH drop, additional abnormal parathyroid glands were found on complete exploration in up to 15% 
of patients (182). False positive reduction in ioPTH levels of 55% and 75% were also reported in the 
presence of double adenomas (183) and multiglandular disease (184), respectively. Additionally, the 
delayed renal clearance of PTH levels render ioPTH unsuitable for use during surgery for secondary 
(renal) hyperparathyroidism (185).  
 
These findings suggest that the surgical treatment of primary hyperparathyroidism with negative 
localization studies is still challenging and that combined with the limitations of ioPTH, differentiating 
the mildly enlarged parathyroid gland from its mimics intraoperatively remains challenging. 
Evidently, what is required are imaging adjuncts that facilitate real-time assessment of tissue 
differentiation and facilitate intraoperative decision making. In particular, the role of in situ, real-time, 
virtual evaluation of morphological features of parathyroid tissues, the ‘optical biopsy’, has yet to be 
investigated arguably due to the lack of imaging technologies suitable for in situ deployment. 
 
5.1.3 Potential role for pCLE 
As mentioned in the previous chapters, pCLE is an emerging optical imaging tool that has the 
technical and physical properties to provide high resolution in situ, in vivo imaging of tissue 
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morphology at cellular level. It was initially developed to increase accessibility of the microscope for 
in vivo endoluminal tissue imaging by utilizing an optical fibrebundle to deliver its light source onto 
the tissue surface. It has since found promising clinical applications in the assessment of indeterminate 
biliary strictures(186), surveillance of Barrett’s esophagus (37), lung (26) and pancreatic cysts(68). 
Utilizing fluorescent agents such as topical acriflavine hydrochloride (AH) and intravenous sodium 
fluorescein, morphological features of neoplastic and non-neoplastic tissues were shown to be readily 
visualized in real-time during pCLE imaging (26, 28, 29, 37). The ability of this flexible, hand-held, 
probe-based endomicroscope to image parathyroid and non-parathyroid morphology as a potential 
real-time intraoperative imaging tool for tissue differentiation during parathyroidectomy for primary 
and secondary hyperparathyroidism has yet to be systematically evaluated.  
 
5.1.4 Aims and hypothesis 
The hypothesis is that pCLE could potentially be used to distinguish parathyroid from non-parathyroid 
tissues in real-time based on defining pCLE morphological features, utilizing AH as a fluorescent 
nuclear staining agent. However, prior to assessing its potential to guide intraoperative decision-
making, it is critical to first establish the morphological appearances of parathyroid and non-
parathyroid tissues using conventional histology as the gold standard for comparison. This study, 
performed on freshly excised tissues, demonstrates the feasibility of pCLE imaging towards 
intraoperative in situ tissue differentiation; and establishes the feasibility of pathologists and surgeons 
to differentiate pCLE morphological images of parathyroid from non-parathyroid tissues. 
 
5.2 Methods 
 
5.2.1 Patients and tissue preparation 
From April 2013 to December 2013, tissue specimens were obtained after written consent from 35 
patients undergoing parathyroidectomy (n=23) for primary and secondary hyperparathyroidism and 
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thyroidectomy (n=12) for multinodular goitre (MNG) and malignant solitary nodule(s) at Department 
of Endocrine and Thyroid Surgery, Hammersmith Hospital (London, United Kingdom). Under an 
Imperial College Institutional Review Board approved protocol (R12083) for handling of human 
tissue, freshly excised parathyroid, thyroid and adjacent fibrofatty specimens were immediately 
transported to the pathology department where they were carefully sectioned by an experienced 
endocrine pathologist (R.F.). Parathyroid specimens were bisected whereas thyroid specimens were 
sectioned at 3- to 5-mm intervals and thinly sliced samples measuring approximately 10 x 10 mm were 
retrieved from the macroscopically non-diseased (non-neoplastic) section of thyroid specimens and 
from adjacent fibrofatty tissues. Based on our previous experience where 0.01% AH provided the best 
staining for breast tissues, we decided to compare the effects of three AH concentrations (0.005%, 
0.01% or 0.05%) on parathyroid tissue staining. Each sample was stained immediately in one of three 
aforementioned AH concentrations (Sigma Aldrich, UK) for 60 seconds followed by gentle rinsing 
with PBS solution. 
 
5.2.2 Equipment and image acquisition 
pCLE image acquisition of AH-stained samples was performed using a probe-based confocal 
endomicroscopy system (Cellvizio, Mauna Kea Technologies, Paris, France) that consists of a pCLE 
miniprobe (Ultra Mini-O confocal miniprobe; Mauna Kea Technologies, Paris, France) connected to a 
laser scanning unit that is connected to a personal computer for image data processing and display 
(Figure 5.1). The pCLE system and miniprobe used in this study is similar to those used in Chapters 3 
and 4 of this thesis. Further descriptions of the system are detailed in Chapter 2. 
 
5.2.3 Histopathology 
After completion of imaging, each sample was placed in individually labeled cassettes, fixed in 
formalin and underwent routine histology processing. All samples were horizontally sectioned and 
evaluated by formal appraisal of the haematoxylin and eosin (H&E) as per local protocol. 
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Figure 5.1 (A) pCLE system set-up with an example of an image mosaic depicted on the display screen. (B) 
pCLE miniprobe emitting a 488-nm, blue light excitation wavelength laser at its distal tip. (C) The tip of the 
pCLE miniprobe is placed perpendicular to the cut-surface of a freshly excised parathyroid adenoma specimen. 
 
5.2.4 Correlation of image mosaics 
All pCLE images depicting cellular morphology of parathyroid, thyroid and fibrofatty samples were 
stored digitally in specific folders into a prospectively maintained database. These were subsequently 
evaluated with an endocrine pathologist (R.F.) using the corresponding H&E stained histology as the 
gold standard for comparison. Following discussion between the pathologist (R.F.) and T.P.C., who 
had experience with the pCLE system, morphological characteristics that were thought to be 
distinctive on pCLE images and predictive for histological results were noted.  
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5.2.5 Image interpretation assessment  
To assess the feasibility of accurately identifying specific tissue entities and differentiating parathyroid 
from non-parathyroid tissues on pCLE images, four pathologists and four surgeons who were not 
involved during pCLE image acquisition of samples and who had no previous training in pCLE image 
interpretation were invited to participate in an image interpretation study. Each participant underwent 
an in-house developed pattern recognition training session that consists of a 10-minute video tutorial 
during which characteristic cellular architecture of hypercellular parathyroid, non-diseased thyroid and 
fibrofatty tissues on H&E slides were elucidated. 
 
Subsequently, the interpretation ability of all participants were evaluated based on a set of 70 de-
identified pCLE image (32 hypercellular parathyroid, 26 normal thyroid, 12 fibrofatty tissues) of 
histological confirmed tissue entities while blinded to its corresponding histology results. For each 
pCLE image, each participant was individually asked to identify the tissue entity it most likely 
represents and to rank the difficulty of image interpretation on a five-point Likert scale (1 = very easy; 
2 = easy; 3 = average; 4 = difficult; 5 = very difficult). 
 
5.2.6 Statistical analysis 
The statistical analysis was performed using the SPSS 21.0 software (SPSS, Chicago, USA). The 
sensitivity, specificity, positive predictive value (PPV) and negative predictive values (NPV) and 
accuracy of pCLE image interpretation were calculated, using the histology as the reference standard 
of diagnosis. The inter-observer agreement was defined as the percentage of full agreement among the 
participants and by an overall kappa statistic with 95% confidence interval (CI). The inter-observer 
agreement was calculated for each group of participants, resulting in six different kappa values each, 
namely the agreement of observer 1 and 2, 1 and 3, 1 and 4, etc. The interpretation of kappa values 
was performed according to Landis and Koch classification (162). 
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Level of difficulty of image interpretation between tissue types were analyzed using a one-way 
analysis of variance (ANOVA) with tissue types as the independent variable and Likert scores as 
dependent variable. When significance at the p<0.05 level was found, Tukey’s post hoc comparison 
was performed to compare pairs of means within the ANOVA. Comparison of Likert scale scores of 
pathologists to surgeons for overall and tissue-specific image interpretations were performed using 
two-sample t-test.  
 
5.3 Results 
5.3.1 Baseline pCLE image mosaic characteristics 
The mean duration of pCLE imaging for each sample was 2 minutes (range, 1–5 minutes). Preliminary 
analysis of samples obtained from the first four parathyroid specimens revealed that minimal 
discernible architecture were visualized at 0.005% whereas over-fluorescence of tissues were noted at 
0.05% AH concentrations (Figure 5.2). Meaningful morphological features were readily visualized at 
0.01% AH concentration, consistent with the findings from our breast experiments in Chapter 3. 
Consequently, further analysis of all remaining samples was performed at the latter concentration.  
 
A total of 178 pCLE image mosaics depicting cellular morphology (mean 5 per sample; range 2 to 10) 
were carefully compared with the corresponding histopathology slides from 35 samples. Utilizing 
image mosaicing for real-time feedback on the distal tip positioning, the miniprobe was moved slowly 
and studiously to facilitate construction of high quality pCLE image mosaics up to four to six times 
the original field of view (approximately 1 mm). Evidently, this enabled image acquisition of a wider 
range of morphological architecture displayed on the tissue surface and consequently, the pCLE 
images obtained are readily interpretable and representative of its respective samples. No interference 
with H&E staining was noted on AH-stained samples. 
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Figure 5.2 pCLE image mosaics of parathyroid morphology stained at various AH concentrations. (A) 
Excessive fluorescence noted at 0.05% concentration; (B) Individual nuclei delineated when 0.01% was used; 
(C) Some nuclei remain unstained at 0.005% and construction of image mosaics were not possible. 
 
5.3.2 Correlation of pCLE image mosaics with histopathology 
Consistent with the findings from previous chapters, the nuclei of individual cells are seen as discreet 
fluorescent dots on pCLE images. Equipped with this knowledge, the morphological architecture of 
parathyroid adenomas and hyperplasia are readily discernible on pCLE images as markedly 
hyperfluorescent dotted tissues with parenchymal cells arranged in densely packed nests and 
microfollicles. Other common morphological constituents in parathyroid tissues such as fibrovascular 
septa and cystic changes are visualised. (Figures 5.3, 5.4, 5.5 and 5.6)  
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Figure 5.3 Comparison of morphological architecture of hypercellular parathyroid tissues seen on histology (left 
panel) and pCLE image (right panel) of the corresponding sample. (A & B) Hypercellular parathyroid 
parenchyma are seen here as numerous fluorescent dots organized in little nests and appear more densely packed 
in Image B. Fat cells are invariably absent in parathyroid adenoma and sparsely admixed within the parenchyma 
in parathyroid hyperplasia samples. (C) Microfollicular variant of parathyroid hyperplasia. 
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Figure 5.3 (cont.) Comparison of morphological architecture of hypercellular parathyroid tissues seen on 
histology (left panel) and pCLE image (right panel) of the corresponding sample. (D)Another example of  
microfollicular variant of parathyroid hyperplasia. (E & F) The parathyroid vascular network, represented by 
numerous fibrovascular septa are characterized here by interconnecting dark-coloured, hollow-looking, relatively 
acellular cord-like / slit-like spaces (yellow arrows) that traverse the densely packed parenchymal cells giving 
rise to a trabeculated appearance. 
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Figure 5.4 Comparison of cystic changes on hypercellular parathyroid tissues seen on histology (A) and pCLE 
images (B and C). Histology from a section on a large 20-mm parathyroid adenoma depicting multiple small 
cystic spaces interspersed with parenchymal cells. These are represented on pCLE images by multiple pockets of 
capacious, amorphous and acellular spaces. 
  115 
 
 
Figure 5.5 Magnified views of pCLE mosaics of parathyroid microfollicular architecture interspersed with 
adipocytes.  
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Figure 5.6. Magnified views of pCLE mosaics of fibrovascular spaces within the parathyroid parenchyma. Nests 
of parenchymal cells seen between these spaces. 
 
Similarly, the epithelial-lined follicles of thyroid tissues are easily discernible and are distinct from 
parathyroid tissues on pCLE images (Figures 5.7 and 5.8). These are distinguishable from adipose 
tissue which has an acellular thin rim of cytoplasm surrounding a central dark-coloured vacuole. 
Constituents of stromal tissues such as collagen and elastic fibers with fibroblast nuclei are discernible 
(Figure 5.7). 
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Figure 5.7 Comparison of non-parathyroid tissues on histology (left panel) and pCLE images (right panel). (A) 
Thyroid follicles are seen as dark-coloured, luminal structures, lined by a discreet layer of fluorescent dots 
depicting that of an epithelium. Several lumens are seen permeated with opaque grey-like substance which 
connotes the presence of colloid material. (B) A thyroid follicle with adjacent fibrous stroma. 
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Figure 5.7 (cont.) Comparison of non-parathyroid tissues on histology (left panel) and pCLE images (right 
panel). (C) Adipose tissues populated by dark-colored, polygonal-shaped cells. (D) Fibrous tissues that populates 
the thyroid stroma.  
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Figure 5.8 pCLE images of thyroid tissues depicting follicles of various sizes and shapes consistent with that of 
a multinodular goitre specimen. 
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5.3.3 Accuracy of pCLE image interpretations  
A total of 560 pCLE image interpretations were carried out by four pathologists and four surgeons. 
The accuracy of pCLE tissue type identification were predicted by pathologists and surgeons with a 
mean accuracy of 94% (range 93-94%) and 93% (range 91-94%), respectively. The most common 
misidentification on pCLE images by pathologists occurred between parathyroid and thyroid tissues, 
which accounted for 15 out of 17 (88%) errors. Surgeons on the other hand committed a wider range 
of errors involving all three tissue types. Accounting for 52% (11 out of 21) errors, surgeons most 
commonly misidentified thyroid for parathyroid tissues (11 out of 13 errors) (Table 5.1). The mean 
inter-observer agreement for tissue type identification among pathologists was ‘almost perfect’, 
κ=0.86 (95%CI, 0.82-0.90); and ‘substantial’ among surgeons, κ=0.80 (95%CI, 0.75-0.85). 
 
Pathologists 
 
Histology diagnosis 
pCLE diagnosis 
Thyroid Parathyroid Adipose / 
Fibrofatty 
 
Total 
Thyroid, n (%) 97 (93) 6 (6.0) 1 (1.0) 104 
Parathyroid, n (%) 9 (7.0) 119 (93) 0 (0) 128 
Adipose / Fibrofatty, n (%) 0 (0) 1 (2.0) 47 (98) 48 
Total 106 126 48 280 
Surgeons 
 
Histology diagnosis 
pCLE diagnosis 
Thyroid Parathyroid Adipose / 
Fibrofatty 
 
Total 
Thyroid, n (%) 91 (87) 11 (11) 2 (2.0) 104 
Parathyroid, n (%) 4 (3.0) 124 (97) 0 (0) 128 
Adipose / Fibrofatty, n (%) 1 (2.0) 3 (6.0) 44 (92) 48 
Total 96 138 46 280 
 
Table 5.1 Correlation between tissue type identification on pCLE images and histology 
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To illustrate the potential difficulties in interpreting pCLE images, several examples of commonly 
made errors are shown in Figure 5.9.  
 
 
Figure 5.9 Examples of errors encountered during pCLE image interpretation using typical thyroid follicles for 
comparison (A). B, Thyroid follicles mistakenly identified as adipocytes due to the visibly sparse epithelial 
nuclei. C, Parathyroid microfollicles misinterpreted as that of the thyroid. D, Adipocytes with a central cluster of 
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fibroblast nuclei misidentified as parathyroid tissues. E, Cystic spaces of parathyroid tissues thought to represent 
thyroid follicles.  F, Multinodular goitre with follicles of varying sizes misinterpreted as parathyroid tissues due 
to adjacent degenerative changes. 
 
When thyroid and adipose/fibrofatty tissues were grouped together as non-parathyroid tissues, 
parathyroid tissues on pCLE images were predicted by pathologists with mean sensitivity, specificity, 
PPV and NPV of 93% (range, 88%-100%), 95% (range, 89%-100%), 94% (range, 89%-100%) and 
94% (range, 90%-100%), respectively.  
 
Surgeons achieved a mean sensitivity of 97% (range 91%-100%), a specificity of 91% (range, 84%-
100%), a PPV of 90% (range, 84%-100%) and an NPV of 97% (range, 93%-100%) (Table 5.2).  
 
Histology 
diagnosis 
pCLE diagnosis 
Pathologists Surgeons 
Parathyroid Non-parathyroid Total Parathyroid Non-parathyroid Total 
Parathyroid 119 9 128 124 4 128 
Non-parathyroid 7 145 152 14 138 152 
Total 126 154 280 138 142 280 
 
Table 5.2. Correlation between pCLE image interpretation and histology on parathyroid and non-parathyroid 
tissues  
 
5.3.4 Level of difficulty of pCLE image interpretation 
The overall mean level of difficulty score for surgeons was significantly lower than that of 
pathologists and remained significantly lower when categorised into correct and incorrect 
interpretations. The mean scores for both pathologists and surgeons were notably higher for incorrect 
interpretations. When grouped according to tissue-specific categories, the mean scores were 
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significantly higher for pathologists on parathyroid tissues as compared to surgeons (Table 5.3). The 
overall level of difficulty of image interpretation based on type of tissues assessed was significantly 
different and remained so when grouped according to pathologists and surgeons (Figure 5.10).  
 
 
Specialty 
Overall  Tissue-specific  
All 
(n=560) 
Correct 
(n=522) 
Incorrect 
(n=38) 
Thyroid 
(n=208) 
Parathyroid 
(n=256) 
Adipose / 
Fibrofatty 
(n=96) 
Pathologists 
(n=4) 
3.1 + 1.4 
 
3.0 + 1.4 4.5 + 0.8 
 
2.9 + 1.5 
 
3.5 +1.2 
 
2.3 + 1.3 
 
Surgeons 
(n=4) 
2.6 + 1.2 
 
2.5 + 1.2 3.8 + 0.9 
 
2.9 + 1.2 
 
2.5 + 1.2 
 
2.1 + 1.3 
 
p value <0.001* <0.001* 0.016* 0.839 <0.001* 0.488 
 
Table 5.3 Comparison of mean level of difficulty of assessments on pCLE image interpretation measured on a 
five-point Likert scale grouped according to tissue type and specialty. Data are presented as mean ± SD. * 
denotes p value of <0.05 
 
Post hoc analysis demonstrated significant pair-wise differences between the mean scores and all 
tissue types for pathologists; and between thyroid and fibrofatty tissues for surgeons (Figure 5.10). 
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Figure 5.10 Histogram of difficulty levels of assessment on pCLE image interpretation measured on a 
five-point Likert scale grouped according to (A) Tissue type; (B) Pathologists; (C) Surgeons. Data are 
presented as mean ± SD. *ANOVA comparisons of all three groups were significant at p<0.05. There 
was significant pair-wise differences between the mean scores and all tissue types for pathologists 
(p<0.05); and between thyroid and fibrofatty tissues for surgeons (p<0.05). 
 
5.4 Discussion 
This study is to our knowledge the first to report on the use of pCLE to obtain high-resolution, real-
time images of parathyroid and non-parathyroid morphology on freshly excised specimens. By 
utilizing topical AH as a fluorescent agent and directly correlating with the corresponding histology 
slides, the morphological architecture of parathyroid and non-parathyroid parenchymal cells are 
readily visualized and distinguishable by both pathologists and surgeons with high accuracies.  
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5.4.1 Pattern recognition   
The ability of pCLE to differentiate tissue morphologies emanated from the preferential binding of AH 
to cell nuclei and staining specificity for collagen and elastic fibers (27-29). Whilst it is commonly 
described as a non-specific fluorescent agent, it is evident that its relative affinity to these intra- and 
extracellular constituents has endowed the clinician with three pivotal tissue staining characteristics 
from which specific morphological features can be deduced.  
 
 Firstly, its nuclei staining characteristics has enabled assessment of tissue cellularity to be made 
objectively. Whilst this readily differentiates parathyroid from non-parathyroid tissues, we 
envisage that a potential clinical application of pCLE would be to distinguish diseased from non-
diseased parathyroid tissues in situ intraoperatively when equivocal glands are encountered. 
Evidently, the findings of sparsely populated fat cells or its absence in the presence of 
hypercellular parathyroid morphology on pCLE images should raise suspicion that the observed 
gland is diseased and thereby warrants excision.  
 
 Secondly, the relatively anucleate structures such as fibrovascular spaces, follicular lumens, 
cystic spaces, central vacuole of fat cells provide a dark contrast to its neighboring nucleated 
constituents. The lack of fluorescence retention in these regions enables recognition of coherent 
patterns that facilitates differentiation of important structural entities e.g. uniformly lined thyroid 
follicle from irregularly shaped cystic spaces and finger-like projections of fibrovascular spaces.  
 
 Lastly, its affinity to collagen and elastic fibers provide a homogenously hazy backdrop which 
indicates the presence of structural component in the adjacent stroma instead of vacuous spaces.  
 
It should be noted that given the hypercellular nature of the tissues imaged, a lower concentration of 
AH (0.01%) was expectantly found to provide the best staining characteristics for tissue morphology 
visualization as compared those used in the aforementioned studies (0.05%).   
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5.4.2 Image interpretation 
As mentioned in the previous chapters, it is clear that the clinical value of real-time pCLE image 
acquisition is determined by the ability of the operating surgeon to interpret these images accurately 
and efficiently. Previous pCLE studies have shown the morphological features of neoplastic and non-
neoplastic changes obtained from gastrointestinal mucosal lesions could be predicted in real-time by 
the endoscopist with accuracies of over 90% (45, 47). Additionally, the learning curve for pCLE 
image interpretation was reported to be short following structured training sessions (47). These 
studies, however, used intravenous fluorescein as a contrast agent, and when coupled with the 
different tissue types analyzed, render objective comparison with our study difficult to perform.  
 
Nevertheless, our study demonstrated that by utilizing a short and focused training session on basic 
histology, surgeons with no prior experience in pCLE image interpretation were able to acquire 
relevant pattern recognition skills to differentiate parathyroid from non-parathyroid tissues with 
overall accuracies and interobserver agreements that approximate to that of the pathologists. 
Interestingly, pathologists experienced more difficulties interpreting pCLE images of parathyroid 
tissues than surgeons and consequentially committed most of their image interpretation errors in this 
tissue cohort.  
 
This could plausibly be explained by the fact that the vast experience pathologists possess could have 
led to over-interpretation of pCLE images and more importantly, that their performance may project a 
more realistic representation of the potential complexities and pitfalls that could occur when 
differentiating parathyroid from thyroid tissues.  
 
Evidently, smaller sized follicular structures could well be that of the thyroid gland and similarly, the 
collapsed edges of the epithelial lining of parathyroid cystic spaces could be misidentified as the 
infolding of thyroid follicles, a common metabolic consequence of an overactive thyroid gland that 
has just been rendered euthyroid at the time of surgery (187). This undoubtedly warrants further 
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analysis on a wider morphological variant of parathyroid and thyroid tissues and its effect on image 
interpretation.    
 
Nonetheless, unperturbed by the complexities, surgeons were able to acquire the basic skills to 
differentiate pCLE images of different tissue types. Furthermore, both pathologists and surgeons 
recorded a higher mean level of difficulty when errors were made which suggests that both groups 
demonstrated insight when faced with equivocal pCLE images. 
 
5.4.3 Intraoperative deployment 
Real-time assessment of morphological features of parathyroid tissues using bench-top confocal 
reflectance microscopes have been reported by White and colleagues (8). Similar to our findings, 
tissue cellularity and fat cells were readily observable in diseased and non-diseased parathyroid 
tissues, albeit having a lower resolution than the pCLE used in our study. However, the feasibility of 
image interpretation by surgeons was not systematically evaluated. Additionally, it is not miniaturized 
and therefore unsuitable for intraoperative deployment for in situ assessments.  
 
Our evaluation of pCLE’s feasibility towards surgical applications could potentially represent an 
advent of bringing the microscope to the patient in the operating theatre and we anticipate that several 
physical characteristics it possesses make it suitable for intraoperative use. The current diameter of 2.5 
mm at the miniprobe tip is essential for optimal surface area contact as most normal parathyroid 
glands measure 3 to 6 mm in the largest dimension. The flexible, 90 cm miniprobe length used in this 
study allows placement of the LSU adjacent to the operating table, convenient deployment of the 
miniprobe onto the operative field at the surgeon’s accord and devoid of cumbersome manouvers of 
repositioning when assessment of multiple tissue sites are required. With the exception of the distal 
2cm tip, the flexibility it confers allows it to be bent to achieve perpendicular contact against the tissue 
surface without compromising image quality.  
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5.4.4 Potential intraoperative challenges 
On the other hand neighboring respiratory movements could arguably impede the creation of high 
quality mosaics and thereby impact on the interpretability of the images generated. The technique of 
creating pCLE mosaics is akin to the notion of path dependency whereby accurate spatial localization 
of the subsequent image frame is highly dependent on the clarity and amount of morphological 
features imaged in the preceding frame. This undoubtedly warrants steady, controlled and purposeful 
probe tip movements whilst utilizing the concurrently generated pCLE mosaic as a real-time feedback 
tool to further orchestrate its expansion. However, given that image acquisitions are performed at high 
magnifications, these are expectantly susceptible to minimal movements which cause the images to be 
less distinct and potentially introduce artifacts. Whilst these are well described in endoluminal 
environments (37, 92), our experience in this study suggests that similar challenges are pertinent to the 
hand-held approach.  
 
A potential strategy to address this challenge would be to reduce over-reliance on the need for 
excessive mosaicking by increasing the field of view of individual frames. These modifications 
warrant a systematic evaluation to establish the optimal trade-off between resolution, field of view and 
probe diameter. Whilst the size constraints pertaining to probe diameter might not constitute a critical 
requisite as in the case with endoscopic applications, any enlargement of probe diameter needs to take 
into account the clinical accessibility of deployment and optimization of adequate tissue surface 
contact.  
 
Other possible approaches to circumvent the challenge with physiological movements could 
potentially necessitate the integration of robotic technologies (96) and hand-held force adaptive 
instruments (92, 93) to minimize inadvertent probe tip movements. Preliminary results from pre-
clinical studies in endoscopic- and cavity-based tissue models have shown promising results (92, 93, 
96) and we are currently exploring the feasibility of applying these technological adjuncts to an in-
house developed pCLE system to parathyroid surgery.    
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5.4.5 Study limitations 
There are several limitations to this study.  
 First, it is performed on freshly excised specimens with post-hoc image interpretation assessments 
performed in a controlled environment and therefore does take into account the challenges 
associated with probe deployment and real-time decision-making in a time-constraint operating 
theatre environment. Whilst we do not envisage pCLE assessments to be time-consuming, a 
formal appraisal of its potential impact on the operative time needs to be assessed.  
 
 Second, we did not differentiate diseased from non-diseased parathyroid tissues in this study due 
to ethical concerns of removing normal parathyroid glands when it is clinically not indicated and 
the associated risks of hypoparathyroidism. Additionally, it is difficult to harvest an incidental 
parathyroid gland from a thyroid specimen given our institution’s low rates of inadvertent 
parathyroidectomy (120).   
 
 Third, lymphatic tissues such as lymph nodes are potential mimics of parathyroid glands and 
therefore warrant evaluation in prospective in situ studies.     
 
5.4.6 Conclusion 
This study has described a novel and innovative approach to visualization of morphological 
architecture of parathyroid and non-parathyroid tissues utilizing pCLE, an emerging imaging tool, to 
provide real-time, high magnification imaging at cellular resolution. The pivotal findings include 
excellent correlation of pCLE images with gold standard histology and feasibility of attainment of 
pattern recognition skills by surgeons.  
 
We envisage that this could potentially be a useful adjunct to visual identification of parathyroid 
tissues without the removal of the tissue and to provide the surgeon recourse by performing multiple 
assessments when encountered with several equivocal tissues. Based on these promising findings, the 
  131 
 
priorities for future research include systematic evaluation of in situ imaging acquisition of 
parathyroid glands and adjacent soft tissues; objective differentiation between diseased and non-
diseased parathyroid glands; methodological quantification of the aforementioned intraoperative 
challenges; and assessment of optical trade-off requirements and mechatronically enhanced 
technological adjuncts as a potential solution to these challenges. 
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Chapter 6: Evaluation of Vascular Morphology 
of Fluorescein-Stained Parathyroid Glands on 
pCLE Images 
 
6.1 Introduction 
6.1.1. Postoperative hypoparathyroidism 
Postoperative hypocalcemia is a well-recognized complication of total thyroidectomy. The incidence 
of transient hypocalcaemia after total thyroidectomy range from 24 to 37% whereas permanent 
hypocalcemia has been estimated at 0.3 to 8.3% (136, 188). The latter is a major concern as the 
consequences of chronic hypocalcaemia is often insidious, debilitating and could potentially lead to 
life threatening complications (188-190). Additionally, it is also a common cause of medico-legal 
litigation (191). In the majority of cases, postoperative hypocalcemia following total thyroidectomy is 
secondary to impairment of parathyroid function – a consequence of inadvertent removal, traumatic 
injury or devascularisation of parathyroid glands (PG) during dissection (188). It is widely advocated 
that if the devascularised PG was recognised intraoperatively, these glands should be autotransplanted 
to a neighbouring muscle, most commonly the sternocleidomastoid, to preserve parathyroid viability 
and function (192-194).  
 
6.1.2. Challenges with PG viability assessment 
Whilst the decision to autotransplant the excised gland or conspicuously transected vascular pedicle is 
relatively straight forward, the same cannot be iterated for those that are of uncertain viability such as 
those that are discoloured from traumatic injury. A study by Promberger et al showed that the function 
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of discoloured PGs are only transiently impaired and that full recovery returns shortly after surgery 
(135). It has also been suggested that autotransplantation should not be the first-line management of 
discoloured PG in the absence of other risk factors (135). Given that PG discolouration may indicate 
the presence of venous stasis or possibly haemorrhagic infarction, most surgeons would however 
choose to autotransplant these to maximise function preservation (192-195). 
On the other hand, the absence of discolouration is an equally unreliable method of confirming PG 
viability. A study by Kuhel and Carew showed that devascularized or excised PGs did not appear 
discoloured at the time of surgery (134). The authors reported that when incisional biopsies were 
performed to ascertain its vascular supply, these PGs demonstrated no evidence of active capsular 
bleeding. Evidently, the reduction in blood flow or devascularisation has not inflicted obvious 
morphological changes that were discernible to the surgeon within the short time frame.  
The lack of a reliable method to ascertain viability of PG remains a course for concern. The relevance 
of this limitation extends to all forms of neck surgery where the aim is to retain as much functional PG 
as possible. Despite meticulous dissection utilizing the well-described technique of capsular 
dissection, there remains a small proportion of PG who will inevitably lose their function through 
inadvertent removal or devascularisation.  
In light of the prevailing nature of this problem, several groups have suggested that routine 
autotransplantation should be performed as a prophylactic measure to minimize the risk of 
postoperative hypoparathyroidism (193, 196). However, the removal of the undamaged gland appears 
to offer no reduction in the incidence of permanent hypoparathyroidism. Whilst autotransplantation is 
a well-established procedure, it harbours a small risk of graft failure (success rate range between 85 to 
99%) and therefore a selective approach is usually preferred to minimize inflicting unnecessary injury 
to the unperturbed PG.  
Despite the obvious limitations, routine decisions pertaining to selective autotransplantation still rely 
on the predictive value of visual assessment of PGs and yet the in situ vascular supply to these glands 
is still not known. Rather than simply focusing on the predictive values of operative procedures (e.g. 
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central neck dissections), thyroid conditions (Grave’s disease, recurrent goitre, thyroid carcinoma) and 
serum measurements (preoperative calcium and intraoperative PTH levels) to guide the need for post-
operative supplementation, arguably what is required are techniques that facilitate real-time 
assessment of the viability status of PG and augment intraoperative decision making. 
 
6.1.3 Vascular morphology on pCLE imaging  
Utilizing intravenous fluorescein sodium (FS) as the contrast agent, vascular morphology of 
superficial vessels in the gastrointestinal tract mucosa, bladder mucosa and biliary epithelium were 
readily discernible during pCLE image acquisition (63, 172, 197, 198). In particular, the 
morphological characteristics displayed by the respective vascular architecture on pCLE images forms 
an essential component of tissue neoplasia assessment (28, 37). The presence of dilated, tortuous and 
elongated vessels visualized alongside distortion of crypt or gastric pit architecture are well recognised 
characteristics of neoplastic changes – all evidently visible on pCLE image acquisition (37).   
However, most descriptions pertaining to vascular morphology focus on the static appearances of 
these vasculatures. In particular, little has been reported pertaining to visualization of vessel flow as 
potential indicators of tissue viability. In light of the aforementioned challenges in PG viability 
assessment, it would be prudent to investigate whether pCLE has a role in confirming viability of 
these glands intraoperatively.  
 
6.1.4 Aims and hypothesis  
The hypothesis is that pCLE could potentially be used to distinguish viable from non-viable PG in 
real-time based on defining dynamic morphological features.  
However, prior to assessing its potential to guide intraoperative decision-making, it is critical to first 
establish the morphological appearances viable and non-viable PG utilizing carefully preserved and 
excised PG, respectively as the gold standard for comparison.  
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This pilot study aims to demonstrate the feasibility of pCLE imaging towards intraoperative in situ 
viability assessment; and clarifies the relationship between pCLE vasculature findings and post-
operative PTH function. 
 
6.2 Methods 
6.2.1 Patients 
The study protocol was approved by the institutional review board (West London REC 14/LO/0016) 
and all patients provided written, informed consent. Between March to July 2014, a total of 20 patients 
undergoing parathyroidectomy for primary hyperparathyroidism and thyroidectomy (total and 
completion) for benign and malignant thyroid diseases were prospectively recruited to the study from 
a tertiary endocrine surgery unit (Hammersmith Hospital, Imperial College Healthcare NHS Trust, 
London, United Kingdom). Patients who were pregnant, breast feeding or had previous documented 
allergy to intravenous sodium fluorescein were excluded from this study.  
 
6.2.2 Equipment  
Image acquisition of vascular morphology of PG tissues was performed using a probe-based confocal 
endomicroscopy system (Cellvizio, Mauna Kea Technologies, Paris, France) that consists of a pCLE  
miniprobe (Coloflex, Mauna Kea Technologies, Paris, France) connected to a laser scanning unit 
(LSU) that is connected to a personal computer for image data processing and display. The system 
description for LSU was described in Chapter 2 of this thesis. However the pCLE miniprobe used in 
this study has slightly different optical properties. The optical slices of images were obtained at 
approximately 10 µm thickness. These were created in real-time at a depth of 90 µm below the tissue 
surface with a field of view of 240 x 240 μm and lateral resolution of 1 μm. Similar to previous 
studies, all images were scanned with a rate of 12 frames per second, hence demonstrating a real-time 
video on a display screen.  
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6.2.3 Intraoperative pCLE image acquisition 
Two experienced endocrine surgeons (F.P., N.T.) with a combined volume of more than 400 
endocrine cases per year performed all the operations and pCLE image acquisitions. All patients 
received between 1.5 to 3.0ml of intravenous bolus of 10% sodium fluorescein (Martindale 
Pharmaceuticals, Romford, UK) intraoperatively at least five minutes prior to commencement of 
pCLE imaging. Utilising a sterile-draped, hand-held mini-probe, pCLE image acquisition was 
obtained following perpendicular contact of the miniprobe tip with the exposed surface of PG. The 
stack system is positioned across the operating table in direct view of the surgeon so that the 
concurrently generated pCLE images were used as a real-time feedback tool to orchestrate the 
direction of miniprobe movement (Figure 6.1).  
 
 
Figure 6.1 pCLE system set-up in the operating theatre. (A) The display screen is placed within the vicinity of 
the operating surgeon. (B) The pCLE miniprobe is draped with a sterile transparent sheath that is reinforced with 
a layer of Tegaderm at its distal tip to ensure uniform abutment of the miniprobe tip with the PG surface during 
image acquisition. (C-D) In patients undergoing parathyroidectomy, further imaging is performed following 
excision or devascularisation of the PG. 
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6.2.4 pCLE imaging for parathyroidectomy 
For patients undergoing parathyroidectomy, pCLE imaging was performed on the diseased PG with its 
vascular pedicle carefully preserved to ensure that its viability was maintained. In order to validate the 
vascular morphology visualized, further pCLE imaging was repeated immediately on the same site of 
the diseased PG following devascularisation or excision for gold standard comparison.  
 
6.2.5 pCLE imaging for thyroidectomy 
For patients undergoing total or completion thyroidectomy, every effort was made to isolate as many 
normal PG where it was operatively safe to do so. With its respective vascular pedicles carefully 
preserved, pCLE imaging was performed on normal PG towards the end of the operation, i.e. 
following excision of the diseased thyroid gland but prior to fascia closure. All normal PGs imaged 
were judged to be viable on the basis of its macroscopic appearance and preservation of its vascular 
supply. The decision to preserve PG in situ was made prior to the commencement of pCLE image 
acquisition and this remained unchanged following completion of imaging. All pCLE videos were 
stored digitally in specific folders into a prospectively maintained database for post-hoc analysis and 
comparison with post-operative calcium and parathyroid hormone levels (PTH).  
 
6.2.6 Assessment of pCLE vascular morphology  
Preliminary evaluations of pCLE videos between the surgeons (F.P., N.T.) and T.P.C., who had 
clinical experience with the pCLE system, were carried out during and after image acquisitions where 
morphological characteristics that were thought to be distinctive of vascular flow were noted.  
 
To independently assess the validity of our observations, a structured assessment was designed to 
systematically evaluate recognition of vascular morphology on each pCLE video based on the 
following components: video stability, vessel recognition, vessel flow, flow rate and level of 
confidence (Figure 6.2). Assessments of video stability were performed according to an in-house 
developed classification (Figure 6.3).   
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Figure 6.2 Flow diagram of structured evaluation of vascular morphology for each pCLE video clip 
 
To evaluate the interobserver agreements and accuracies of individual component assessments, six 
surgeons who had previously reviewed pCLE videos of non-parathyroid vascular architecture from the 
published literature were invited to independently assess each pCLE video obtained from PGs using 
the aforementioned structured approach while blinded to patient details and macroscopic appearance 
of its respective PGs.  
 
Video assessments were carried out in two distinct cohorts, namely Cohort 1 which consists of video 
clips retrieved from pre-excision and post-excision/devascularized pCLE imaging of parathyroid 
adenomas, followed by Cohort 2 that was composed of those acquired from preserved normal PGs. 
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Figure 6.3 Classification to facilitate grading of pCLE video stability taking into account aspects related to video 
movement and visual strain   
 
6.2.7 Comparison with post-operative PTH and calcium levels  
The findings on vascular morphology assessment for pCLE videos in Cohort 2 were compared with 
post-operative serum calcium and PTH levels taken on the night after surgery and the following 
morning at 2100 and 0600 hours, respectively. Post-thyroidectomy hypocalcaemia and 
hypoparathyroidism was defined as corrected serum calcium levels of < 2.10 mmol/l (reference range 
2.15-2.60 mmol/l) and PTH levels of < 1.0 pmol/l (reference range 1.1-6.8 pmol/l) on the first 
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postoperative day 1 (POD1), respectively. The lowest corrected calcium and PTH levels on POD1 
were used to define POD1 hypocalcaemia and hypoparathyroidism.  
 
6.2.8 Statistical analysis 
The statistical analysis was performed using the SPSS 22.0 software (SPSS, Chicago, USA). The 
inter-observer agreement was defined as the percentage of full agreement among the participants and 
by an overall kappa statistic with 95% confidence interval (CI). The inter-observer agreement was 
calculated for each surgeon, namely the agreement of observer 1 and 2, 1 and 3, 1 and 4, etc. The 
interpretation of kappa values was performed according to Landis and Koch classification.  
 
For Cohort 1, the sensitivity, specificity and accuracy of pCLE prediction of viability were calculated 
using the pre-excision PGs (adenomas) as the gold standard reference for viability. Comparison of 
Likert scale ratings were performed using two-sample t-test and the association between the ratings 
were determined using Spearman rank correlation.  
 
For Cohort 2, comparison between pCLE video evaluations and post-operative PTH and calcium 
levels were presented using simple percentage agreement between six observers. 
 
6.3 Results 
6.3.1 Baseline characteristics  
Twelve patients underwent total thyroidectomy for primary malignancy (n=6) and multinodular goitre 
(MNG) (n=6), seven patients had parathyroidectomy for primary hyperparathyroidism and one had 
completion thyroidectomy for residual malignant disease. For parathyroidectomy patients, a total of 22 
pCLE video clips were extracted from 14 image acquisition sessions that were acquired from seven 
diseased PG. Of the 14 sessions, seven were performed prior to excision and the remaining was 
repeated on the same PG following devascularization.  
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All PGs imaged were confirmed histologically as hypercellular parathyroid tissues. For total and 
completion thyroidectomy patients, thirty-three pCLE video clips were retrieved from 23 PG. All 
patients completed pCLE image acquisition with no adverse events reported. All pCLE videos were 
presented as 10-20 second anonymized short clips.  
 
6.3.2 Vascular morphology description 
Consistent with published literature on pCLE vascular morphology from non-parathyroid tissues, 
blood vessels on PGs were readily visualized on pCLE videos as well-delineated tubular structures 
containing individual erythrocytes, each represented by dark-colored, discrete, mobile particles against 
a bright backdrop of fluorescein-containing plasma.  
 
A wide spectrum of vessel architecture were discernible, ranging from networks of capillaries with 
vessel diameter as small as 10-µm, to larger sized single or branching vessels up to 100-µm in 
diameter. Within these vessels, the presence of blood flow was distinctively recognized on viable PG 
as unidirectional thrusts of erythrocytes whereas complete cessation of flow was noted on 
devascularised PG.  
 
Variations in the flow dynamics were readily discernible with brisk vessel flow characterized by high 
velocity, steady unidirectional stream of erythrocytes whereas sluggish flow was depicted as lower 
velocity momentary spurts interspersed with brief moments of cessation of flow or retrograde 
movements. Adjacent stromal tissue constituents such as adipocytes and fibrous connective tissues 
were also visualized (Fig. 6.4)  
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Figure 6.4 pCLE images of PG vascular morphology with the vascular pedicle preserved. The respective 
vasculatures are denoted by the yellow arrows (A) Interconnecting network of capillaries; (B) Large vessel with 
individual erythrocytes (red arrow); (C) Single vessel in between aggregates of intraparenchymal fat cells. (D) 
Branching and tortuous looking vessels; (E) Overlapping vessels; (H) Branching vessels with adjacent 
adipocytes. Asterisk (*) denotes fat cells.     
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Figure 6.5 pCLE images of PG vascular morphology following devascularisation or excision. (A) Network  of 
capillaries with empty and contracted lumens (dark coloured); (B) Empty branching vessels interspersing the 
parenchymal adipocytes; (C) Parallel empty vessels; (D) FS containing network of capillaries with no 
erythrocytes visible within the lumen; (E) Single vessel with FS within. No erythrocytes seen; (F) Single vessel 
containing FS with static erythrocytes visible (red arrow).      
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Figure 6.6 Magnified views of pCLE image mosaics of blood vessels and individual erythrocytes 
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Figure 6.7 An example of pCLE image mosaic of the vast networks of capillaries on preserved PG   
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Figure 6.8 pCLE image mosaic depicting PG branching vessels and fibrous connective tissue (bottom half) 
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6.3.3 Vascular morphology evaluation 
A total of 132 structured evaluations of pCLE videos were performed in Cohort 1. Of these, 98 (74%) 
assessments had blood vessels judged to be sufficiently visualized. Of the 34 assessments where 
vessels were not visualized, 28 (82%) were imaged from non-viable PG and six (18%) were from 
viable PG. The mean stability of all 132 evaluations was 3.6 + 1.0 (mean + SD). The overall 
interobserver agreement for vessel recognition was moderate (κ=0.52; 95 CI% 0.41-0.63). Based on 
the remaining 98 pCLE videos, further assessments on vessel flow and flow rate demonstrated 
excellent (κ=0.95; 95% CI 0.90-1.0) and strong (κ=0.62; 95 CI% 0.49-0.75) interobserver agreement, 
respectively (Table 6.1).  
 
 Group A Group B 
Kappa (κ)  95% CI Agreement Kappa (κ)   95% CI Agreement 
Vessel recognition 0.52 0.41-0.63 Moderate 0.38 0.27-0.49 Fair 
Vessel flow 0.95 0.90-1.0 Excellent 0.86 0.78-0.94 Excellent 
Flow rate  0.62 0.49-0.75 Strong 0.68 0.60-0.76 Strong 
 Mean + SD Spearmans correlation Mean + SD Spearmans correlation 
Video stability 3.6 + 1.0 rs = 0.49, p < 0.001 3.4 + 1.0 rs = 0.51, p < 0.001 
Confidence level 3.9 + 0.9 4.0 + 0.8 
 
Table 6.1 Interobserver agreements on components of vascularity assessment, and correlation between pCLE 
video stability and level of confidence  
 
When viable PG on pCLE videos were objectively defined as the presence of brisk or sluggish flow, 
the presence of non-viable PG were predicted with an overall sensitivity, specificity, PPV, NPV and 
accuracy of 92% (range 78-100%), 97% (range 90-100%), 95% (range 83-100%), 95% (range 83-
100%) and 95% (range 85-100%), respectively (Table 6.2). The overall mean for level of confidence 
of assessments was 3.9 + 0.9 (mean + SD) and this was moderately correlated with that of video 
stability (3.6 + 1.0 (mean + 1.0) (rs=0.49, p<0.001)). 
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Intraoperative evaluation  
pCLE diagnosis  
Viable Non-viable Total 
Viable  58 2 60 
Non-viable  3 35 38 
Total 61 37 98 
 
Table 6.2 Correlation between pCLE vessel flow assessments and intraoperative evaluation on viability status of 
parathyroid glands from Cohort 1. 
 
For Cohort 2, a total of 198 pCLE evaluations were carried out, of which 29 (15%) had vessels 
deemed insufficiently visualized. The mean stability of all 169 evaluations were 3.4 + 1.0 (mean + 
SD) and the interobserver agreement on vessel recognition was fair (κ=0.38; 95 CI% 0.27-0.49). The 
remaining 169 assessments demonstrated comparable interobserver agreement to that of Cohort 1 on 
vessel flow (κ=0.86; 95 CI% 0.78-0.94) and flow rate (κ=0.68; 95 CI% 0.60-0.76). Similarly, there 
was moderate correlation between the level of confidence of assessments (4.0 + 0.8 (mean + SD)) and 
video stability (3.4 + 1.0 (mean + SD) (rs=0.51, p<0.001)).  
 
6.3.4 Comparison with post-operative PTH function 
Post-operative bloods showed that 10 out of 12 patients (83%) who had presence of blood flow on at 
least one of the PG identified had normal PTH levels with normocalcaemia or POD1 hypocalcaemia 
which resolved within four weeks (Table 6.3). Of the three patients (23%) who developed post-
operative permanent hypoparathyroidism, two had both presence and absence of vessel flow discerned 
on pCLE videos obtained from the one and only PG visualised, whereas the remaining patient had 
complete cessation of vessel flow on videos obtained from two PG. All respective video assessments 
of vessel flow in these three patients had full percentage agreement by the assessors. When 
distinguishing vessel flow rate on pCLE videos, the proportion of assessments with full percentage 
agreement for sluggish flow was significantly higher than that of brisk flow (92% vs 42%, p=0.01).   
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Pt 
No. 
Video 
No. 
PG 
imaged 
Primary 
disease 
Op POD1 
↓CCal 
POD1 
↓PTH 
Vessel 
flow 
Agreement 
(%) 
 
Flow rate Agreement 
(%) 
1 1 
2 
Rt sup 
Rt inf 
MNG  TT* Yes Yes Absent 
Absent 
2/2 (100%) 
2/2 (100%) 
- 
- 
- 
- 
2 3 
4 
Lt sup 
Rt inf 
MNG TT No No Present 
Present 
5/5 (100%) 
2/2 (100%) 
Brisk 
Brisk 
4/5 (80%) 
1/2 (50%) 
3 5 
6 
Lt sup 
Rt inf 
Papillary 
CA 
TT Yes No Present 
Present 
6/6 (100%) 
6/6 (100%) 
Brisk 
Brisk 
6/6 (100%) 
4/6 (67%) 
4 7 
8 
Lt sup Papillary 
CA 
CT Yes Yes Present 
Absent 
6/6 (100%) 
4/4 (100%) 
Brisk 
- 
6/6 (100%) 
- 
5 9 
10 
Lt sup Papillary 
CA 
TT Yes No Present 
Present 
6/6 (100%) 
6/6 (100%) 
Brisk 
Sluggish 
6/6 (100%) 
6/6 (100%) 
6 11 
12 
13 
Rt sup 
Lt sup 
Lt inf 
Large 
MNG 
TT No No Present 
Present 
Absent 
6/6 (100%) 
6/6 (100%) 
6/6 (100%) 
Brisk 
Sluggish 
- 
6/6 (100%) 
6/6 (100%) 
- 
7 14 
15 
Rt sup Papillary 
CA 
TT 
CND 
Yes Yes Present 
Absent 
3/3 (100%) 
4/4 (100%) 
Sluggish 
- 
3/3 (100%) 
- 
8 16 
17 
Rt sup 
Lt sup 
Papillary 
CA 
TT 
LND 
Yes No Present 
Absent 
6/6 (100%) 
3/3 (100%) 
Brisk 
- 
6/6 (100%) 
- 
9 18 
19 
20 
Lt sup Follicular 
CA 
TT Yes No Present 
Present 
Present 
6/6 (100%) 
6/6 (100%) 
6/6 (100%) 
Sluggish 
Sluggish 
Sluggish 
4/6 (67%) 
6/6 (100%) 
6/6 (100%) 
10 21 
22 
23 
Lt sup 
 
Rt inf 
Large 
MNG 
TT No No Present 
Present 
Present 
6/6 (100%) 
6/6 (100%) 
6/6 (100%) 
Sluggish 
Brisk 
Sluggish 
6/6 (100%) 
3/6 (50%) 
6/6 (100%) 
11 24 
25 
26 
27 
Rt inf 
 
Lt inf 
Follicular 
CA 
TT 
CND 
No No Present 
Present 
Present 
Present 
6/6 (100%) 
5/5 (100%) 
6/6 (100%) 
6/6 (100%) 
Sluggish 
Sluggish 
Brisk 
Sluggish 
6/6 (100%) 
5/5 (100%) 
3/6 (50%) 
6/6 (100%) 
12 28 
29 
Rt inf 
Lt inf 
MNG TT No No Present 
Present 
5/6 (83%) 
5/5 (100%) 
Sluggish 
Sluggish 
5/5 (100%) 
5/5 (100%) 
13 30 
31 
32 
33 
Lt sup 
 
Rt inf 
Large 
MNG 
TT No No Absent 
Absent 
Present 
Present 
2/2 (100%) 
3/4 (75%) 
6/6 (100%) 
6/6 (100%) 
- 
- 
Brisk 
Brisk 
- 
- 
5/6 (83%) 
3/6 (50%) 
 
PG, Parathyroid gland; Op, Operation; POD1 CCal: Post-operative Day 1 hypocalcaemia; POD1 PTH: Post-operative Day 1 
hypoparathyroidism; MNG, Multinodular goitre; CA, Carcinoma; TT, total thyroidectomy; CT, Completion thyroidectomy; 
CND, Central neck dissection; LND, Lateral neck dissection 
* Had autotransplantation of one PG and inadvertent excision of another PG which was not autotransplanted. 
Table 6.3 Post-operative corrected calcium and parathyroid hormone levels compared to vessel flow and flow 
rate assessments on pCLE videos from Cohort 2. 
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Figure 6.9 pCLE images depicting presence and absence of vascular flow on PG from three patients (A & B) 
Empty vessels seen on both PGs from Patient 1; (C) Single vessel with vascular flow from Patient 4; (D) Parallel 
empty vessels on the same PG from Patient 4; (E) Large and small vessels with vessel stasis from Patient 7; (F) 
Network of capillaries with sluggish flow on the same PG from Patient 7.  
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6.4 Discussion 
6.4.1 Overview 
Utilising intravenous fluorescein as the contrast agent, vascular morphology on PG was readily 
visualized during pCLE image acquisition and variations in vessel flow rates were distinguishable by 
surgeons. When excised or devascularized PG was used as the gold standard comparison for non-
viability, characteristic features of viable and non-viable vascular morphology were deducible with 
high accuracies and interobserver agreement.  
 
Preliminary validation on preserved PG during total and completion thyroidectomies revealed that the 
presence of blood flow on PG did not confirm viability of preserved PG. Instead, those with empty or 
static vessels detected on the sole PG identified during high risk operations demonstrated post-
operative hypoparathyroidism. These findings demonstrate the importance of detecting empty / static 
vessels on pCLE images and highlight the need for a robust method to improve vessel recognition 
through strategic modifications of the current pCLE system and better pattern recognition training.       
 
6.4.2 Visualization of vascular morphology  
Consistent with previous pCLE studies on endoluminal applications (27, 28), vascular morphology of 
PG were distinguishable within minutes of intravenous fluorescein administration and remained 
discernible up to 90 minutes post-injection. Our ability to visualise PG vasculature is emanated by the 
relative difference in fluorescence intensity between the vessels and its surrounding parenchyma. 
Intravenous fluorescein binds strongly to serum albumin, thereby retaining most of the substance in 
the vessels. A fraction of the unbound molecules diffuses pass the vessel wall and enter the interstitial 
spaces, highlighting the extracellular matrix of parenchymal tissues (25). Evidently, this attributes the 
prominent cell walls of interspersing adipocytes, parallel-lined collage fibres and relatively dark 
particulate appearance of cellular components of the blood. Elucidation of fluorescein-stained chief 
and oxyphil cells is not feasible at present in light of its non-nuclear staining properties and 
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additionally, distinguishing these cells on conventional histology rely largely on the relative 
differences on its cytoplasmic color shades – an endeavour that is not possible on monochromatic 
pCLE images.  
 
Nevertheless, our primary focus is on vessel visualization which plausibly explains our observations 
that lower fluorescein doses of 1.5 to 2.0 ml provided sufficient contrast as compared to those used for 
gastrointestinal tract applications (~ 2.5 to 5.0ml) which often mandates a diffuse and uniformly 
stained parenchyma in addition to vascular morphology for diagnostic interpretation. Additionally, this 
study also confirmed that the relatively thin PG capsule has negligible light scattering effect as pCLE 
imaging from the subcapsular and superficial parenchymal vasculature was feasibly achieved.  
 
6.4.3 Vessel recognition   
Whilst approximately 20% of all structured evaluations demonstrated absence of vessels, the findings 
from our control arm in Cohort 1 showed that more than 80% of these were from non-viable tissues. 
Unsurprisingly, the absence of organised columns of particulate movements renders vessel 
discernment conspicuously difficult given that these tubular structures could adopt several possible 
appearances.  
 
 Firstly, the lack of propulsive forces meant that pooling of erythrocytes at pre-capillary sphincter 
regions could result in network of capillaries appearing as featureless white bands akin to that of 
adipocyte cell walls.  
 
 Secondly, the lack of uniform dispersement of fluorescein renders these tubular structures a dark 
hollow appearance. Although these are potentially recognisable on larger sized arterioles where 
luminal patency is maintained, vasculature such as post-capillary venules would expectantly 
collapse when it is empty, rendering elucidation of its thread-like appearance extremely 
challenging.  
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 Lastly, despite the wealth of descriptions on pCLE vasculature, there is paucity of published 
information pertaining to that of empty or static vessels. Consequently, our vessel recognition 
ability during assessments might represent the early stages of the learning curve and could 
potentially improve with increasing experience. 
 
6.4.4 Vessel flow and flow rate 
Nevertheless upon definitive recognition of these vessels, assessment of flow could be determined 
with excellent interobserver agreements. Utilizing the control group in Cohort 1, the findings of 
complete cessation of vessel flow on devascularized PG confirmed that our observations were indeed 
that of the vasculature and not movement artefacts. Once vessel flow has been confirmed, further 
scrutiny into flow rates pertaining to brisk and sluggish vessel flow could be ascertained with strong 
interobserver agreements.  
 
Whilst this may appear relatively straight forward on still pCLE videos depicting lone vasculatures, 
the task becomes less conspicuous when presented with videos of vessels with various sizes. 
Evidently, the brisk flow observed on larger sized vessels could translate into intermittent movements 
within the capillary beds depicting that of sluggish flow. Indeed these physiological variations need to 
be factored into future assessments where flow rates are localized objectively to their respective vessel 
type, i.e. large, medium or small vasculature. The clinical question that needs to be answered here is 
does the presence of concurrent sluggish and static flow on larger and smaller sized vessels; 
respectively indicate impending non-viability of the PG.  
 
6.4.5 Comparison with post-operative PTH function 
Perhaps the most intriguing observation in this study is that the presence of vessel flow alone did not 
confirm viability of preserved PG. Instead those with concurrent empty or static vessels adjudicated 
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with full agreement by assessors on sole PG identified during high risk operations were found to 
develop post-operative hypoparathyroidism. The marked variations in vessel flow within the same PG 
confirms that the adequacy its blood supply are indistinguishable macroscopically and profoundly 
capricious. Additionally, our observations could suggest that there might be watershed regions within 
the PG indicating its susceptibility to ischemia. In the presence of vessel flow, one would expect 
collaterals to develop around the non-vascularised regions to salvage the PG function. However, the 
lack of PTH levels post-operatively indicated that this did not occur sufficiently to preserve viability.  
 
It is important to note that conclusions on the resultant PTH levels could not be definitively attributed 
to the specific PG assessed in this study. Instead the findings of absent flow on those assessed might 
suggest that devascularisation to the other PG had occurred as a result of inadvertent traumatic injury 
or excision that were not appreciated during surgery.     
 
6.4.6 Future work 
In our quest of ascertaining PG viability status, the findings of this study suggest that recognition of 
vessels with no vascular flow is of paramount importance. Evidently, this requires an extensive and 
detailed appraisal of the PG vasculature, one that is onerously difficult to achieve with the current 
small field of view that the miniprobe confers.  
 
Adaptive modifications on both the optical configurations and physical characteristics of the current 
pCLE system are warranted to facilitate image acquisition of a wider surface area. Importantly, this 
require systematic evaluation of optimal trade-offs between pCLE image resolution and miniprobe 
size for intraoperative deployability. Additionally, integration of the miniprobe with robotic-actuated 
or mechatronically-enhanced devices has been shown to improve stability of miniprobe and assist in 
large surface area scanning on other applications necessitates evaluation on PG.  
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Ultimately, what we need is an integrated pCLE system that allows image acquisition of a wide 
surface area while preserving the image resolution and consistency of miniprobe deployment so that 
panoramic evaluation of the surface vasculature could be systematically and objectively evaluated 
with reference to post-operative PG function.  
 
6.4.7 Conclusion       
This study is to our knowledge the first to report on the use of pCLE to obtain high-resolution, real-
time in situ images of PG vascular morphology intraoperatively. Characteristic features of vessel wall, 
erythrocyte flow and variations in flow rate were deducible on post-hoc evaluation. The absence of 
vessel flow particularly on larger sized vasculature may serve as a ‘red flag' warning sign of an 
impending PG ischemia. Further evaluations to examine its relationship with coexisting adjacent 
vessel flow over a broader surface area are warranted. To this end, strategic modifications of the 
current pCLE system is required to provide the optical means to systematically evaluate its full 
potential as an intraoperative imaging adjunct to facilitate decision-making pertaining to 
autotransplantation of non-viable PG. 
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Chapter 7: Conclusions  
7.1 Achievements of this thesis and the foundations for future work 
Prior to this thesis, the role of pCLE imaging as an intraoperative in situ imaging tool for surgical 
applications had been sparsely investigated. With the exception of tumor margin assessment in 
neurosurgery (199, 200) , its role in general surgery applications was confined to ‘proof of concept’ 
studies which demonstrated the feasibility of image acquisition on a variety of tissues and organs with 
no clear clinical application in mind (97, 98). The overarching aims of this thesis are evaluation of 
feasibility and practicalities of pCLE image acquisition in pre-defined clinical applications. Chapter 2 
began this journey through systematic expellment of the myth that pCLE imaging was confined to 
epithelial surfaces of intact endoluminal surfaces. This was shown to be not the case as pCLE image 
acquisition was found to be feasible on soft tissue surfaces albeit in a slightly blood-stained 
environment. Additionally, the use of a sterile transparent drape to maintain sterility of the 
intraoperative field did not impede the clarity or consistency of image acquisition of tissues. Instead, it 
facilitated probe movements by acting as a smooth interface between probe tip and tissue surface, 
hence avoid the dragging effect that has long deterred meaningful mosaics to be built. These findings 
laid the foundations on which subsequent Chapters were built upon.  
Chapter 3 provided a detailed description of common morphological features seen on breast tissues 
and subdivided these into neoplastic and non-neoplastic morphology with the help of corresponding 
histology slides as the gold standard for comparison. While some findings reaffirmed old information 
such as the role of topical AH as a nuclear-staining agent, we discovered numerous morphological 
features that held pivotal information that distinguished neoplastic from non-neoplastic breast tissues. 
The interpretation of pCLE images by clinicians with little or no histopathology background remained 
a contentious topic and often evoked feelings of anxiety as to who should be assigned to interpret 
these images. We anticipated these concerns to be relevant in real-time intraoperative breast cavity 
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wall margin assessments. To this end, we created a pCLE classification to facilitate a systematic 
approach in pCLE image interpretation and validated this in a structured assessment of 17 surgeons 
and histopathologists. Consistent with studies from endoluminal applications, we have shown that the 
pCLE pattern recognition skills were readily learnt and that the interpretation accuracies from both 
groups were comparable. The key chapter findings here were that neoplastic features were readily 
distinguishable from those acquired from non-neoplastic tissues and that the relevant pattern 
recognition skills were readily learnt by surgeons with little or no histopathology background.      
Given that intravenous SF is the most commonly used contrast agent in pCLE imaging of the 
endoluminal tract, Chapter 4 explored whether it had a diagnostic role in the aforementioned breast 
cavity wall margins assessment. Consistent with previous studies, SF was well tolerated with no 
adverse events. However, the lack of nuclear visualization rendered assessment of tissue cellularity 
impossible on intravenously stained ex vivo specimens. Consequently, there was no role for 
intravenous SF as the sole staining agent for differentiation between neoplastic and non-neoplastic 
morphology. However, the staining uniformity conferred by intravenously administered SF rendered 
construction of pCLE image mosaics comparatively easier as evidenced by a significantly higher mean 
longitudinal length of pCLE image mosaics in tissues stained with SF with or without AF as compared 
to those with AF alone. In the presence of tissue deformation, these subtle advantages that SF 
conferred could potentially have a significant impact in facilitating the consistency of pCLE image 
acquisition. Nevertheless, these warrants intraoperative evaluation and an algorithm have been 
proposed to include the envisaged timing of SF administration to ascertain its intraoperative role. 
The findings from Chapter 3 provided the building blocks for Chapter 5 where evaluation of the role 
of pCLE in parathyroid surgery was investigated utilizing topical AH as the fluorescent agent. Given 
the lack of nuclei visualization (shown in Chapter 4), we decided not to investigate the role of 
intravenous SF in Chapter 5. This chapter provided novel morphological descriptions of PG and 
adjacent non-PG tissues using histology as the gold standard for comparison. The morphological 
architecture depicted by PG tissues were markedly distinct from that of non-PG tissues and were 
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readily distinguished by surgeons with little or no histopathology background following a similar 
pattern recognition training session used in Chapter 3 but adapted to the relevant tissue entities. In the 
context of parathyroid surgery for non-localized hyperparathyroidism and re-operative surgery, these 
findings sparked a new enthusiasm pertaining to its potential role in facilitating tissue differentiation 
as an alternative to frozen section and IOPTH assay which has its own well-known limitations. The 
use of pCLE as an extension to the surgical eye during parathyroid surgery warrants intraoperative 
evaluation and the findings from this Chapter will provide the baseline information required for tissue-
specific pattern recognition in the upcoming studies.  
Chapter 6 summarized perhaps one of the most intriguing intraoperative pCLE findings discovered to 
date. In a feasibility study on 20 patients utilizing intravenous FS as the contrast agent, the vasculature 
of PGs were readily visualized in real-time using a sterile-draped pCLE probe. The findings of this 
study re-affirmed those reported in Chapter 2 and provided a valuable insight on the structural and 
dynamic constituents of PG vasculature. Consistent with endoluminal mucosal vascular architecture, 
vessels of various sizes and shapes including cellular constituents such as red blood cells were 
distinguishable from non-vascular components.  The morphological characteristics of viable and non-
viable PGs were investigated in a well-designed study through careful preservation of the vascular 
pedicle for the former and following PG devascularisation (post-excision) for the latter. The 
interobserver agreements of viable and non-viable vascular architecture were shown to be substantial 
amongst six assessors with minimal pCLE image acquisition experience. Equipped with these pattern 
recognition skills, the next obvious step would require a well-powered intraoperative in situ study that 
assesses the correlation between these findings with post-operative PG function in the form of post-
operative corrected calcium and PTH levels. However, the preliminary findings of well-vascularised 
PGs with absence of post-operative parathyroid function raised the possibility that the regions imaged 
might not be truly representative of the overall vascular supply of the PG and thereby conclusions 
pertaining to PG viability could not be reliably deduced at this stage.      
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7.2 Bridging the gap between novel discoveries and clinical applications  
While the physical properties of pCLE was designed clearly to allow flexibility and accessibility in 
endoluminal applications, these confer similar advantages in open surgery where image acquisition of 
tissues could be obtained by direct deployment of probe tip surface based on the surgeon’s judgement 
without having to engage in the cumbersome manouvres of multiple probe position re-adjustments 
through a third-party stabilizer or deployer. However, there are consequences as a result of the current 
state of miniaturisation. The field of view of image frames reduces with decreasing probe diameter, an 
inevitable optical trade off. Consequently, we rely on mosaicking to create field of views that are 
representative of the tissues imaged. These warrant deployment of the pCLE probe with precision and 
accuracy. In the presence of intraoperative time constraint and soft tissue deformation, technological 
adjuncts to promote stability and precision are warranted. It is inevitable that the transition of pCLE 
from a ‘research tool’ to ‘clinical device’ require integration with concurrently developed medical 
engineering tools that are specifically adapted to augment pCLE image acquisition in challenging 
intraoperative environments. Given the potential pCLE imaging hold as evidenced from the findings 
of this thesis, our next research priority should involve systematic evaluation of technological adjuncts 
to augment intraoperative usage of pCLE. These should include systematic assessment of the ideal 
optical trade-offs for pCLE intraoperative deployment and integration of robotic assisted technologies 
and pervasive sensing to promote accuracy, precision and reproducibility (Figure 7.1).   
The concept of integrating an imaging tool with technological adjuncts is best described in the 
example of endoscopic ultrasound (EUS) and the adoption of fine needle aspiration (FNA) (201, 202). 
First described in 1980, EUS was initially an experimental research tool, but over the years, the 
combination of FNA with EUS has transformed its role to a validated diagnostic tool in a variety of 
clinical applications such as the diagnosis of indeterminate pancreatic cysts and gastrointestinal 
stromal tumors (GIST) (202-204). It remains to be seen whether recent advances in surgical robotics 
and microprecision tools would augment the full potential of pCLE imaging and thereby warrants 
evaluation. 
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Figure 7.1 This flow-diagram depicts the three phases of research development of pCLE image towards real-
time applications in surgery. This thesis established the foundations whereby promising intraoperative 
applications were discovered as shown in Phase 1 (highlighted in yellow). Additionally, it laid the building 
stones for Phase 2 which comprises of systems evaluation using technological adjuncts to augment image 
acquisition. This constitutes our next research priority prior to embarking on the relevant clinical trials.     
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7.2.1. Adaptive optical imaging  
The ideal trade-off between pCLE probe diameter and field of view warrants careful consideration of 
the following tissue-specific and morphology-specific factors:  
- Surface area of coverage (tissue-specific factor) 
For applications pertaining to breast cavity wall assessment, the surface area of a quadrant of 
interest presents a significant challenge to cover within the time-constraints in an operating 
theatre. A potential solution to this might include initial scanning with larger field of view 
frames for detection of foci of hypercellularity. The image processing software should offer 
real-time options of magnifying the foci of concern whilst preserving the resolution required 
for detailed morphological assessments. This inevitably warrants a large diameter pCLE probe 
(Figure 7.2).         
- Accessibility and degree of angulation (tissue specific factor)  
The challenges pertaining to accessibility of breast cavity wall assessment are unique in that in 
situ angulation of the probe tip is required to achieve perpendicular contact against the tissue 
surface of the lateral cavity walls. The degree of angulation allowed is dependent on the 
number and physicial properties of optical fibres contained within the pCLE probe. A larger 
diameter confers ability to image a wider field of view. However, that could potentially 
restrict the degree of angulation. Hence, an assessment of pCLE probe size, degree of 
angulation and resolution threshold are warranted, perhaps in a simulated breast cavity model 
in the first instance.     
- Morphological requirements of tissue differentiation (morphology-specific factor) 
The degree of resolution required for detection of neoplastic foci during initial breast cavity 
wall scanning differ from those required for vascularity assessment of PGs. The latter warrants 
high resolution images to ascertain the presence of vascular flow albeit a wider field of view 
simultaneously. An objective assessment with small-scale increments in the field of view and 
amount of diagnostically important morphological details preserved might provide a solution 
to establishing an optimal tradeoff.   
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Figure 7.2 A selection of endomicroscopy probes to be tested for optical tradeoffs in the aforementioned 
surgical applications. (a) A bare-tipped 10k core, 0.6 mm diameter Sumitomo bundle; (b) A 30k core, 0.5 mm 
diameter Fujikura bundle with an integrated x2 magnification distal lens assembly (1.4 mm in diameter); (c) an 
ultra-flexible 17,000 core Schott leached imaging bundle with a diameter of 1.2 mm; (d) a semi-rigid, 100k core 
Fujikura fibre bundle, 1.7 mm in diameter; and (e) a 50k core Schott rigid image conduit, 3.2 mm in diameter. 
[Image courtesy of Dr Michael Hughes, Research Associate, The Hamlyn Centre, Imperial College London] 
7.2.2. Robotic technologies and pervasive sensing 
Efforts have also begun integrating the use of a light-weight 7 degrees-of-freedom compliant robotic 
manipulator to create simultaneous CLE mosaicing and localisation in a simulated breast cavity 
(Figure 7.3). The pCLE probe tip position produced by the robot was combined with image 
registration was capable of generating a functional three-dimensional map of the simulated cavity 
surface [18]. A hand-held force-adaptive instrument was integrated into the robotic arm to aid 
maintenance of a constant predetermined contact force against the tissue surface (95, 96). It 
automatically adjusts the forces exerted based on the regularity of the tissue surface it encounters 
during cavity scanning thus improving the consistency and quality of CLE images acquired. The 
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kinematic redundancy of a light weight robot is a key advantage in that it offers enhanced dexterity 
and flexibility, allowing maintenance of a consistent perpendicular positioning of the CLE probe tip 
against the tissue surface. Based on our early experience, amongst the perceived benefits of a robotic 
manipulator include providing stable positioning and movement precision of the CLE probe while 
eliminating the aforementioned global registration problem given that the CLE images are registered 
to the manipulator frame of reference i.e. simultaneous tracking of the probe position.  
 
 
Figure 7.3 (a) Robotic manipulator system set-up comprising of a light weight KUKA© robot with 
the force adaptive control instrument mounted at the end-effector of the robotic arm with CLE image 
mosaic construction obtained from a simulated breast cavity; (b) During CLE image acquisition, the 
position of robot in 3-dimensional space were recorded and surface reconstruction with mapping of the 
CLE image mosaic were mapped to its corresponding location in the simulated breast cavity. [Adapted 
from Simaiaki et al, (95)] 
 
7.3 Alternative technologies for real-time tissue diagnostics 
Whilst this thesis embodied numerous novel and exciting pCLE results, albeit preliminary at this 
stage, it is important to be cognizant of the various emerging real-time tissue diagnostic technologies 
within which pCLE works. Of note, two competing technologies have recently stimulated significant 
interest and were developed during the timeline of pCLE expansion.      
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7.3.1 Intelligent surgical knife  
One of the most promising emerging technologies that garnered significant scientific and media 
attention of late is the “intelligent surgical knife” (iKnife). This technology is derived from the 
coupling of electrosurgery with rapid evaporative ionization mass spectrometry (REIMS) for real-time 
tissue diagnostics (205). Electrosurgery is a technology invented in the 1920s that is commonly used 
in surgery today. Electrosurgical knives use an electrical current to rapidly heat tissue, cutting through 
it while minimising blood loss. In doing so, they vaporise the tissue, creating aerosol that is normally 
sucked away by extraction systems. REIMS on the other hand is an emerging technique that allows 
near–real-time characterization of human tissue in vivo by analysis of the aerosol released during 
electrosurgery. In a recent study on freshly excised human tissue samples by Balog et al, iKnife was 
shown to be able to differentiate accurately between distinct histological and histopathological tissue 
types, with malignant tissues yielding chemical characteristics specific to their histopathological 
subtypes (205). Tissue identification via intraoperative REIMS matched the postoperative histological 
diagnosis in 100% (all 81) of the cases studied (205). Whilst these results are promising, it has yet to 
be shown whether these results are reproducible in in vivo settings and its potential impact on patient 
oncological outcomes warrants prospective evaluation.  
The unique advantage that pCLE possesses is that it obviates the need to engage in cauterisation of 
tissues to yield diagnostic information. It merely presents valuable information pertaining to 
morphological architecture in its original state through high powered magnification and contrast 
agents to augment the appearances of its cellular constituents. In essence, it allows the tissues to retain 
its cellular and architectural integrity without having to go through the process of tissue destruction. 
Evidently, pCLE allows prospective evaluation of the specific area of the tissues analysed following 
the completion of its image acquisition. However, the process of obtaining wide breast cavity surface 
area coverage might pose significant challenges for pCLE imaging. Given that the breast cavity walls 
were created by eletrosurgery in the first place, it is envisaged that continuous monitoring of aerosol 
produced during tumour excision might provide valuable adjunct information by iKnife technologies.  
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It is worth reminding that the envisaged intraoperative applications of pCLE imaging include 
parathyroid and thyroid surgeries. It does not appear that there is a clear role for iKnife in either of 
these applications. The diseased PG needed to be localised first (where the problem lies in parathyroid 
surgery) before electrosurgery is used on them, Evaluations on vascularity of PGs during thyroid 
surgery warrants meticulous preservation of its blood supply and destruction of tissues from 
electrosurgery will  not generate any relevant information pertaining to the viability of PGs.   
7.3.2 Optical coherence tomography 
Optical coherence tomography (OCT) is an optical imaging technique that provides high resolution, 
real-time and multi-dimensional microscopic images of subsurface tissue structure. It is the optical 
analogue to ultrasound imaging but utilises near-infrared light waves instead of sound waves to create 
images. One of the key advantages of OCT when compared to pCLE is the former’s ability to provide 
superior penetration depth of up to 1-2 mm. This depth is not possible to achieve with pCLE as 
increasing overlying sections of tissue constituents will reduce the clarity of images and cause more 
image artefacts.  
The ability of OCT to differentiate various breast tissue entities was described in a landmark study by 
Nguyen et al which showed that OCT has the potential to generate high quality images similar that of 
the histopathological controls (206). Whilst these results are promising, the OCT images were 
generated at a lateral resolution of 35 μm (far lower than that of 1 μm generated from pCLE). The 
trade-off for this would be its larger field of view on a single frame (1 cm
2
). These optical 
characteristics might facilitate wider surface area coverage in the context of breast cavity scanning but 
the reduction in the magnification and clarity of stromal and glandular characteristics might render 
occult and inconspicuous tumour foci difficult to be identified. From our pCLE experience, subtle and 
loosely dispersed neoplastic deposits such as those often found in invasive lobular carcinoma warrants 
high magnification imaging to ascertain. Similarly, evaluation of luminal cellularity in glandular 
tissues warrants detailed assessments to differentiate groups of acini from ductal carcinoma in situ. As 
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highlighted in the earlier chapters, what is needed are systematic evaluations on the ideal optical trade-
off pertaining to the demands of specific applications are required for both pCLE and OCT.   
Recently a study Conti de Freitas et al in Massachusetts, Boston, showed that OCT images from 
tissues obtained at thyroid and parathyroid surgeries correlated well with histopathology and 
participants in their study were capable of recognizing and differentiating neck tissues encountered 
during thyroid and parathyroid surgeries (207). A more recent study by Sommerey et al showed that 
OCT was capable of distinguishing between parathyroid, thyroid, and adipose tissue (208). However, 
an accurate differentiation between parathyroid tissue and lymph nodes was not possible (208). The 
authors attributed these findings to problems handling the endoscopic probe intraoperatively (208). 
We envisaged similar challenges with the pCLE probe and we therefore support the need for further 
refinement of these technologies to augment the surgical ergonomics. It is important to note that the 
requirements for highly magnified images of parathyroid morphology are not as critical as that of 
breast tissues because the former (when diseased), often adopt a more uniformly hypercellular 
architecture which should be deduced easily on low power magnification. For thyroid surgery 
applications, there has yet to be any data pertaining to the ability of OCT to provide real-time dynamic 
information pertaining to vascular flow and therefore no conclusions could be drawn at this stage.  
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7.4 Closing comments 
Currently pCLE holds the potential to yield useful information that could guide decision-making 
during surgery. It is a niche that has yet to be explored in the aforementioned surgical applications. It 
is evident that its present state is not best optimised for use intraoperatively. Perhaps, co-registration of 
technological adjuncts could provide the solution to augment its potential and applicability in an 
increasingly time-constraint operating theatre. A systematic approach to investigate the optimal trade-
offs between the optical resolution requirements of tissue morphology visualization and deployability 
of pCLE probe holds the key to successful clinical translation. It also undoubtly requires an 
economical, robust and intelligent platform equipped with the flexibility to cater for tissue surface 
deformation and precision mechanisms that generates accurate spatio-temporal localisation in real-
time to aid intraoperative decision making.  
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